
### [MONDO:0004993](http://purl.obolibrary.org/obo/MONDO_0004993)
**Label:** carcinoma

**Subclasses:** [MONDO:0015075](http://purl.obolibrary.org/obo/MONDO_0015075) (thyroid gland carcinoma), [MONDO:0005028](http://purl.obolibrary.org/obo/MONDO_0005028) (esophageal adenocarcinoma), [MONDO:0005026](http://purl.obolibrary.org/obo/MONDO_0005026) (endometrioid adenocarcinoma), [MONDO:0006358](http://purl.obolibrary.org/obo/MONDO_0006358) (parotid gland squamous cell carcinoma), [MONDO:0006116](http://purl.obolibrary.org/obo/MONDO_0006116) (breast carcinoma by gene expression Profile), [MONDO:0006357](http://purl.obolibrary.org/obo/MONDO_0006357) (parotid gland carcinoma ex pleomorphic adenoma), [MONDO:0003087](http://purl.obolibrary.org/obo/MONDO_0003087) (breast mucoepidermoid carcinoma), [MONDO:0006356](http://purl.obolibrary.org/obo/MONDO_0006356) (parotid gland adenoid cystic carcinoma), [MONDO:0006355](http://purl.obolibrary.org/obo/MONDO_0006355) (parotid gland acinic cell carcinoma), [MONDO:0003086](http://purl.obolibrary.org/obo/MONDO_0003086) (thymus mucoepidermoid carcinoma), [MONDO:0003089](http://purl.obolibrary.org/obo/MONDO_0003089) (bile duct mucoepidermoid carcinoma), [MONDO:0004175](http://purl.obolibrary.org/obo/MONDO_0004175) (mucin-rich endometrial endometrioid adenocarcinoma), [MONDO:0005023](http://purl.obolibrary.org/obo/MONDO_0005023) (ductal breast carcinoma in situ), [MONDO:0006352](http://purl.obolibrary.org/obo/MONDO_0006352) (paranasal sinus adenoid cystic carcinoma), [MONDO:0004173](http://purl.obolibrary.org/obo/MONDO_0004173) (adenocarcinoma of skene gland origin), [MONDO:0004174](http://purl.obolibrary.org/obo/MONDO_0004174) (secretory uterine corpus endometrioid adenocarcinoma), [MONDO:0006350](http://purl.obolibrary.org/obo/MONDO_0006350) (papillary transitional cell carcinoma), [MONDO:0018330](http://purl.obolibrary.org/obo/MONDO_0018330) (mucinous adenocarcinoma of the appendix), [MONDO:0005037](http://purl.obolibrary.org/obo/MONDO_0005037) (gastric intestinal type adenocarcinoma), [MONDO:0006367](http://purl.obolibrary.org/obo/MONDO_0006367) (pharyngeal adenoid cystic carcinoma), [MONDO:0005036](http://purl.obolibrary.org/obo/MONDO_0005036) (gastric adenocarcinoma), [MONDO:0005278](http://purl.obolibrary.org/obo/MONDO_0005278) (serous adenocarcinoma), [MONDO:0005034](http://purl.obolibrary.org/obo/MONDO_0005034) (follicular thyroid carcinoma (disease)), [MONDO:0003093](http://purl.obolibrary.org/obo/MONDO_0003093) (mucoepidermoid esophageal carcinoma), [MONDO:0004182](http://purl.obolibrary.org/obo/MONDO_0004182) (stage IVb bladder cancer), [MONDO:0003095](http://purl.obolibrary.org/obo/MONDO_0003095) (laryngeal mucoepidermoid carcinoma), [MONDO:0006360](http://purl.obolibrary.org/obo/MONDO_0006360) (penile carcinoma), [MONDO:0003090](http://purl.obolibrary.org/obo/MONDO_0003090) (extrahepatic bile duct carcinoma), [MONDO:0003092](http://purl.obolibrary.org/obo/MONDO_0003092) (lacrimal gland mucoepidermoid carcinoma), [MONDO:0003091](http://purl.obolibrary.org/obo/MONDO_0003091) (cutaneous mucoepidermoid carcinoma), [MONDO:0005008](http://purl.obolibrary.org/obo/MONDO_0005008) (colorectal adenocarcinoma), [MONDO:0004159](http://purl.obolibrary.org/obo/MONDO_0004159) (pancreatic non-invasive mucinous cystadenocarcinoma), [MONDO:0005007](http://purl.obolibrary.org/obo/MONDO_0005007) (colon mucinous adenocarcinoma), [MONDO:0005004](http://purl.obolibrary.org/obo/MONDO_0005004) (clear cell adenocarcinoma), [MONDO:0006335](http://purl.obolibrary.org/obo/MONDO_0006335) (ovarian endometrioid adenocarcinoma), [MONDO:0005005](http://purl.obolibrary.org/obo/MONDO_0005005) (clear cell renal carcinoma), [MONDO:0004158](http://purl.obolibrary.org/obo/MONDO_0004158) (pancreatic invasive mucinous cystadenocarcinoma), [MONDO:0004155](http://purl.obolibrary.org/obo/MONDO_0004155) (adult central nervous system embryonal carcinoma), [MONDO:0004156](http://purl.obolibrary.org/obo/MONDO_0004156) (pancreatic colloid cystadenocarcinoma), [MONDO:0004153](http://purl.obolibrary.org/obo/MONDO_0004153) (pediatric CNS embryonal cell carcinoma), [MONDO:0004394](http://purl.obolibrary.org/obo/MONDO_0004394) (maxillary sinus squamous cell carcinoma), [MONDO:0005017](http://purl.obolibrary.org/obo/MONDO_0005017) (diffuse gastric adenocarcinoma), [MONDO:0006348](http://purl.obolibrary.org/obo/MONDO_0006348) (pancreatic small cell neuroendocrine carcinoma), [MONDO:0006347](http://purl.obolibrary.org/obo/MONDO_0006347) (pancreatic large cell neuroendocrine carcinoma), [MONDO:0006346](http://purl.obolibrary.org/obo/MONDO_0006346) (pancreatic acinar cell carcinoma), [MONDO:0004166](http://purl.obolibrary.org/obo/MONDO_0004166) (hereditary fallopian tube carcinoma), [MONDO:0006102](http://purl.obolibrary.org/obo/MONDO_0006102) (basaloid carcinoma), [MONDO:0004164](http://purl.obolibrary.org/obo/MONDO_0004164) (lymphoepithelioma-like acinar prostate adenocarcinoma), [MONDO:0006343](http://purl.obolibrary.org/obo/MONDO_0006343) (ovarian transitional cell carcinoma), [MONDO:0005496](http://purl.obolibrary.org/obo/MONDO_0005496) (bile duct carcinoma), [MONDO:0005494](http://purl.obolibrary.org/obo/MONDO_0005494) (triple-negative breast carcinoma), [MONDO:0004163](http://purl.obolibrary.org/obo/MONDO_0004163) (bladder urachal urothelial carcinoma), [MONDO:0001702](http://purl.obolibrary.org/obo/MONDO_0001702) (labia majora carcinoma), [MONDO:0017292](http://purl.obolibrary.org/obo/MONDO_0017292) (well-differentiated fetal adenocarcinoma of the lung), [MONDO:0006157](http://purl.obolibrary.org/obo/MONDO_0006157) (colorectal adenosquamous carcinoma), [MONDO:0006397](http://purl.obolibrary.org/obo/MONDO_0006397) (renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene Fusions), [MONDO:0005063](http://purl.obolibrary.org/obo/MONDO_0005063) (medullary breast carcinoma), [MONDO:0005061](http://purl.obolibrary.org/obo/MONDO_0005061) (lung adenocarcinoma), [MONDO:0006390](http://purl.obolibrary.org/obo/MONDO_0006390) (prostate small cell carcinoma), [MONDO:0002806](http://purl.obolibrary.org/obo/MONDO_0002806) (bronchus carcinoma), [MONDO:0017288](http://purl.obolibrary.org/obo/MONDO_0017288) (dicer1 syndrome), [MONDO:0017048](http://purl.obolibrary.org/obo/MONDO_0017048) (pseudomyxoma peritonei), [MONDO:0017289](http://purl.obolibrary.org/obo/MONDO_0017289) (fetal lung interstitial tumor), [MONDO:0021300](http://purl.obolibrary.org/obo/MONDO_0021300) (adenoid cystic carcinoma of oropharynx), [MONDO:0007256](http://purl.obolibrary.org/obo/MONDO_0007256) (hepatocellular carcinoma), [MONDO:0006167](http://purl.obolibrary.org/obo/MONDO_0006167) (combined lung carcinoma), [MONDO:0006165](http://purl.obolibrary.org/obo/MONDO_0006165) (colorectal squamous cell carcinoma), [MONDO:0005075](http://purl.obolibrary.org/obo/MONDO_0005075) (papillary thyroid carcinoma (disease)), [MONDO:0006163](http://purl.obolibrary.org/obo/MONDO_0006163) (colorectal Serrated adenocarcinoma), [MONDO:0005074](http://purl.obolibrary.org/obo/MONDO_0005074) (papillary cystadenocarcinoma), [MONDO:0021538](http://purl.obolibrary.org/obo/MONDO_0021538) (verrucous carcinoma of oral cavity), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0008566](http://purl.obolibrary.org/obo/MONDO_0008566) (thyroid cancer, nonmedullary, 2), [MONDO:0008567](http://purl.obolibrary.org/obo/MONDO_0008567) (thyroid cancer, nonmedullary, 1), [MONDO:0021537](http://purl.obolibrary.org/obo/MONDO_0021537) (undifferentiated carcinoma of nasopharynx), [MONDO:0011739](http://purl.obolibrary.org/obo/MONDO_0011739) (pancreatic cancer, susceptibility to, 1), [MONDO:0006139](http://purl.obolibrary.org/obo/MONDO_0006139) (cervical metaplasia), [MONDO:0006138](http://purl.obolibrary.org/obo/MONDO_0006138) (cervical large cell neuroendocrine carcinoma), [MONDO:0006137](http://purl.obolibrary.org/obo/MONDO_0006137) (cervical intraepithelial neoplasia grade 2/3), [MONDO:0004199](http://purl.obolibrary.org/obo/MONDO_0004199) (vulvar keratinizing squamous cell carcinoma), [MONDO:0006135](http://purl.obolibrary.org/obo/MONDO_0006135) (cervical clear cell adenocarcinoma), [MONDO:0006134](http://purl.obolibrary.org/obo/MONDO_0006134) (cervical adenosquamous carcinoma), [MONDO:0006133](http://purl.obolibrary.org/obo/MONDO_0006133) (cervical adenoid cystic carcinoma), [MONDO:0006374](http://purl.obolibrary.org/obo/MONDO_0006374) (placental choriocarcinoma), [MONDO:0006132](http://purl.obolibrary.org/obo/MONDO_0006132) (cervical adenoid basal carcinoma), [MONDO:0004196](http://purl.obolibrary.org/obo/MONDO_0004196) (rectal sarcomatoid carcinoma), [MONDO:0018352](http://purl.obolibrary.org/obo/MONDO_0018352) (squamous cell carcinoma of penis), [MONDO:0018351](http://purl.obolibrary.org/obo/MONDO_0018351) (adenocarcinoma of penis), [MONDO:0005057](http://purl.obolibrary.org/obo/MONDO_0005057) (large cell neuroendocrine carcinoma), [MONDO:0006388](http://purl.obolibrary.org/obo/MONDO_0006388) (prolactin-producing pituitary gland carcinoma), [MONDO:0005056](http://purl.obolibrary.org/obo/MONDO_0005056) (keratinizing squamous cell carcinoma), [MONDO:0006386](http://purl.obolibrary.org/obo/MONDO_0006386) (primary peritoneal serous adenocarcinoma), [MONDO:0006143](http://purl.obolibrary.org/obo/MONDO_0006143) (cervical squamous cell carcinoma), [MONDO:0006385](http://purl.obolibrary.org/obo/MONDO_0006385) (primary intraosseous squamous cell carcinoma), [MONDO:0006142](http://purl.obolibrary.org/obo/MONDO_0006142) (cervical small cell carcinoma), [MONDO:0005051](http://purl.obolibrary.org/obo/MONDO_0005051) (invasive lobular carcinoma), [MONDO:0006141](http://purl.obolibrary.org/obo/MONDO_0006141) (cervical mucinous adenocarcinoma, villoglandular variant), [MONDO:0006140](http://purl.obolibrary.org/obo/MONDO_0006140) (cervical mucinous adenocarcinoma, minimal deviation variant), [MONDO:0006382](http://purl.obolibrary.org/obo/MONDO_0006382) (poorly differentiated thyroid gland carcinoma), [MONDO:0005050](http://purl.obolibrary.org/obo/MONDO_0005050) (invasive ductal and lobular carcinoma), [MONDO:0002839](http://purl.obolibrary.org/obo/MONDO_0002839) (linitis plastica), [MONDO:0002835](http://purl.obolibrary.org/obo/MONDO_0002835) (papillary transitional carcinoma), [MONDO:0002834](http://purl.obolibrary.org/obo/MONDO_0002834) (primary prostate urothelial carcinoma), [MONDO:0002837](http://purl.obolibrary.org/obo/MONDO_0002837) (sarcomatoid transitional cell carcinoma), [MONDO:0002836](http://purl.obolibrary.org/obo/MONDO_0002836) (urethra transitional cell carcinoma), [MONDO:0000894](http://purl.obolibrary.org/obo/MONDO_0000894) (mucinous bronchioloalveolar adenocarcinoma), [MONDO:0018184](http://purl.obolibrary.org/obo/MONDO_0018184) (gastric linitis plastica), [MONDO:0021116](http://purl.obolibrary.org/obo/MONDO_0021116) (luminal A breast carcinoma), [MONDO:0000895](http://purl.obolibrary.org/obo/MONDO_0000895) (nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0002830](http://purl.obolibrary.org/obo/MONDO_0002830) (ovary transitional cell carcinoma), [MONDO:0002833](http://purl.obolibrary.org/obo/MONDO_0002833) (fallopian tube transitional cell carcinoma), [MONDO:0001502](http://purl.obolibrary.org/obo/MONDO_0001502) (retroperitoneum carcinoma), [MONDO:0003920](http://purl.obolibrary.org/obo/MONDO_0003920) (gastric small cell carcinoma), [MONDO:0002832](http://purl.obolibrary.org/obo/MONDO_0002832) (endometrial transitional cell carcinoma), [MONDO:0000891](http://purl.obolibrary.org/obo/MONDO_0000891) (mixed fibrolamellar hepatocellular carcinoma), [MONDO:0001740](http://purl.obolibrary.org/obo/MONDO_0001740) (cornea squamous cell carcinoma), [MONDO:0000892](http://purl.obolibrary.org/obo/MONDO_0000892) (colon medullary carcinoma), [MONDO:0000893](http://purl.obolibrary.org/obo/MONDO_0000893) (mixed mucinous and nonmucinous bronchioloalveolar adenocarcinoma), [MONDO:0006199](http://purl.obolibrary.org/obo/MONDO_0006199) (endometrial undifferentiated carcinoma), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0006198](http://purl.obolibrary.org/obo/MONDO_0006198) (endometrial squamous cell carcinoma), [MONDO:0006197](http://purl.obolibrary.org/obo/MONDO_0006197) (endometrial small cell carcinoma), [MONDO:0006196](http://purl.obolibrary.org/obo/MONDO_0006196) (endometrial serous adenocarcinoma), [MONDO:0011312](http://purl.obolibrary.org/obo/MONDO_0011312) (thyroid carcinoma, nonmedullary, with or without cell oxyphilia), [MONDO:0006192](http://purl.obolibrary.org/obo/MONDO_0006192) (endometrial endometrioid adenocarcinoma), [MONDO:0006191](http://purl.obolibrary.org/obo/MONDO_0006191) (endometrial clear cell adenocarcinoma), [MONDO:0003938](http://purl.obolibrary.org/obo/MONDO_0003938) (bladder colonic type adenocarcinoma), [MONDO:0003936](http://purl.obolibrary.org/obo/MONDO_0003936) (invasive tubular breast carcinoma), [MONDO:0021343](http://purl.obolibrary.org/obo/MONDO_0021343) (carcinoma of floor of mouth), [MONDO:0003934](http://purl.obolibrary.org/obo/MONDO_0003934) (breast apocrine carcinoma), [MONDO:0021588](http://purl.obolibrary.org/obo/MONDO_0021588) (eyelid sebaceous gland carcinoma), [MONDO:0021345](http://purl.obolibrary.org/obo/MONDO_0021345) (carcinoma of pharynx), [MONDO:0003935](http://purl.obolibrary.org/obo/MONDO_0003935) (oncocytic breast carcinoma), [MONDO:0001995](http://purl.obolibrary.org/obo/MONDO_0001995) (sphenoid sinus squamous cell carcinoma), [MONDO:0003930](http://purl.obolibrary.org/obo/MONDO_0003930) (non-invasive bladder urothelial carcinoma), [MONDO:0001993](http://purl.obolibrary.org/obo/MONDO_0001993) (seminal vesicle adenocarcinoma), [MONDO:0001992](http://purl.obolibrary.org/obo/MONDO_0001992) (rete testis adenocarcinoma), [MONDO:0010456](http://purl.obolibrary.org/obo/MONDO_0010456) (renal cell carcinoma, Xp11-associated), [MONDO:0011543](http://purl.obolibrary.org/obo/MONDO_0011543) (BRCA3), [MONDO:0021333](http://purl.obolibrary.org/obo/MONDO_0021333) (carcinoma of lip), [MONDO:0003904](http://purl.obolibrary.org/obo/MONDO_0003904) (lung occult squamous cell carcinoma), [MONDO:0021335](http://purl.obolibrary.org/obo/MONDO_0021335) (carcinoma of duodenum), [MONDO:0002814](http://purl.obolibrary.org/obo/MONDO_0002814) (adrenal carcinoma), [MONDO:0021337](http://purl.obolibrary.org/obo/MONDO_0021337) (tonsil carcinoma), [MONDO:0021339](http://purl.obolibrary.org/obo/MONDO_0021339) (carcinoma of hard palate), [MONDO:0021331](http://purl.obolibrary.org/obo/MONDO_0021331) (carcinoma of parotid gland), [MONDO:0005086](http://purl.obolibrary.org/obo/MONDO_0005086) (renal cell carcinoma (disease)), [MONDO:0006176](http://purl.obolibrary.org/obo/MONDO_0006176) (cribriform carcinoma), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma, susceptibility to, 1), [MONDO:0006173](http://purl.obolibrary.org/obo/MONDO_0006173) (conjunctival squamous cell carcinoma), [MONDO:0005082](http://purl.obolibrary.org/obo/MONDO_0005082) (prostate adenocarcinoma), [MONDO:0021329](http://purl.obolibrary.org/obo/MONDO_0021329) (carcinoma of soft palate), [MONDO:0002828](http://purl.obolibrary.org/obo/MONDO_0002828) (Bartholin's gland transitional cell carcinoma), [MONDO:0019003](http://purl.obolibrary.org/obo/MONDO_0019003) (multiple endocrine neoplasia type 2), [MONDO:0002829](http://purl.obolibrary.org/obo/MONDO_0002829) (Bartholin's gland carcinoma), [MONDO:0002823](http://purl.obolibrary.org/obo/MONDO_0002823) (thyroid medullary carcinoma), [MONDO:0001978](http://purl.obolibrary.org/obo/MONDO_0001978) (regional ureteric cancer), [MONDO:0002822](http://purl.obolibrary.org/obo/MONDO_0002822) (trabecular adenocarcinoma), [MONDO:0021327](http://purl.obolibrary.org/obo/MONDO_0021327) (carcinoma of urethra), [MONDO:0002821](http://purl.obolibrary.org/obo/MONDO_0002821) (trabecular follicular adenocarcinoma), [MONDO:0000402](http://purl.obolibrary.org/obo/MONDO_0000402) (small cell carcinoma), [MONDO:0006189](http://purl.obolibrary.org/obo/MONDO_0006189) (eccrine porocarcinoma), [MONDO:0005097](http://purl.obolibrary.org/obo/MONDO_0005097) (squamous cell lung carcinoma), [MONDO:0006186](http://purl.obolibrary.org/obo/MONDO_0006186) (duodenal adenocarcinoma), [MONDO:0005096](http://purl.obolibrary.org/obo/MONDO_0005096) (squamous cell carcinoma), [MONDO:0006184](http://purl.obolibrary.org/obo/MONDO_0006184) (ductal breast carcinoma in situ and lobular carcinoma in situ), [MONDO:0006182](http://purl.obolibrary.org/obo/MONDO_0006182) (digestive system mixed Adenoneuroendocrine carcinoma), [MONDO:0006181](http://purl.obolibrary.org/obo/MONDO_0006181) (digestive system carcinoma), [MONDO:0005092](http://purl.obolibrary.org/obo/MONDO_0005092) (signet ring cell carcinoma), [MONDO:0003966](http://purl.obolibrary.org/obo/MONDO_0003966) (testicular monophasic choriocarcinoma), [MONDO:0003960](http://purl.obolibrary.org/obo/MONDO_0003960) (pulmonary large cell neuroendocrine carcinoma), [MONDO:0008177](http://purl.obolibrary.org/obo/MONDO_0008177) (extramammary Paget disease), [MONDO:0002648](http://purl.obolibrary.org/obo/MONDO_0002648) (mammary Paget's disease), [MONDO:0003978](http://purl.obolibrary.org/obo/MONDO_0003978) (colon small cell carcinoma), [MONDO:0002649](http://purl.obolibrary.org/obo/MONDO_0002649) (scrotum Paget's disease), [MONDO:0003975](http://purl.obolibrary.org/obo/MONDO_0003975) (Littre gland carcinoma), [MONDO:0003972](http://purl.obolibrary.org/obo/MONDO_0003972) (gastric body carcinoma), [MONDO:0002881](http://purl.obolibrary.org/obo/MONDO_0002881) (vaginal adenosarcoma), [MONDO:0003970](http://purl.obolibrary.org/obo/MONDO_0003970) (gastric fundus carcinoma), [MONDO:0003971](http://purl.obolibrary.org/obo/MONDO_0003971) (gastric pylorus carcinoma), [MONDO:0002880](http://purl.obolibrary.org/obo/MONDO_0002880) (ovarian mesodermal adenosarcoma), [MONDO:0003707](http://purl.obolibrary.org/obo/MONDO_0003707) (distal biliary tract carcinoma), [MONDO:0003708](http://purl.obolibrary.org/obo/MONDO_0003708) (extrahepatic bile duct small cell adenocarcinoma), [MONDO:0003701](http://purl.obolibrary.org/obo/MONDO_0003701) (nonencapsulated sclerosing carcinoma), [MONDO:0003941](http://purl.obolibrary.org/obo/MONDO_0003941) (classic variant of chromophobe renal cell carcinoma), [MONDO:0003942](http://purl.obolibrary.org/obo/MONDO_0003942) (eosinophilic variant of chromophobe renal cell carcinoma), [MONDO:0011578](http://purl.obolibrary.org/obo/MONDO_0011578) (familial papillary thyroid carcinoma with renal papillary neoplasia), [MONDO:0007063](http://purl.obolibrary.org/obo/MONDO_0007063) (long bone adamantinoma), [MONDO:0002868](http://purl.obolibrary.org/obo/MONDO_0002868) (bile duct cystadenocarcinoma), [MONDO:0003716](http://purl.obolibrary.org/obo/MONDO_0003716) (kidney pelvis papillary carcinoma), [MONDO:0003959](http://purl.obolibrary.org/obo/MONDO_0003959) (breast large cell neuroendocrine carcinoma), [MONDO:0002867](http://purl.obolibrary.org/obo/MONDO_0002867) (pancreatic cystadenocarcinoma), [MONDO:0003714](http://purl.obolibrary.org/obo/MONDO_0003714) (bladder urachal squamous cell carcinoma), [MONDO:0003715](http://purl.obolibrary.org/obo/MONDO_0003715) (bladder urachal carcinoma), [MONDO:0003952](http://purl.obolibrary.org/obo/MONDO_0003952) (adult central nervous system choriocarcinoma), [MONDO:0003950](http://purl.obolibrary.org/obo/MONDO_0003950) (nipple carcinoma), [MONDO:0003768](http://purl.obolibrary.org/obo/MONDO_0003768) (signet ring cell variant cervical mucinous adenocarcinoma), [MONDO:0002672](http://purl.obolibrary.org/obo/MONDO_0002672) (prostate signet ring cell adenocarcinoma), [MONDO:0002671](http://purl.obolibrary.org/obo/MONDO_0002671) (breast signet ring cell adenocarcinoma), [MONDO:0002670](http://purl.obolibrary.org/obo/MONDO_0002670) (ampulla of vater adenocarcinoma), [MONDO:0012004](http://purl.obolibrary.org/obo/MONDO_0012004) (parathyroid gland carcinoma), [MONDO:0002208](http://purl.obolibrary.org/obo/MONDO_0002208) (vulva adenocarcinoma), [MONDO:0002207](http://purl.obolibrary.org/obo/MONDO_0002207) (vulval Paget's disease), [MONDO:0006804](http://purl.obolibrary.org/obo/MONDO_0006804) (inflammatory breast carcinoma), [MONDO:0003534](http://purl.obolibrary.org/obo/MONDO_0003534) (papillary thymic adenocarcinoma), [MONDO:0004623](http://purl.obolibrary.org/obo/MONDO_0004623) (prostate carcinoma in situ), [MONDO:0002447](http://purl.obolibrary.org/obo/MONDO_0002447) (endometrial carcinoma (disease)), [MONDO:0003535](http://purl.obolibrary.org/obo/MONDO_0003535) (fallopian tube papillary adenocarcinoma), [MONDO:0005953](http://purl.obolibrary.org/obo/MONDO_0005953) (scirrhous adenocarcinoma), [MONDO:0003532](http://purl.obolibrary.org/obo/MONDO_0003532) (breast papillary carcinoma), [MONDO:0003530](http://purl.obolibrary.org/obo/MONDO_0003530) (aggressive digital papillary adenocarcinoma), [MONDO:0003531](http://purl.obolibrary.org/obo/MONDO_0003531) (eccrine papillary adenocarcinoma), [MONDO:0003509](http://purl.obolibrary.org/obo/MONDO_0003509) (pineal region choriocarcinoma), [MONDO:0003507](http://purl.obolibrary.org/obo/MONDO_0003507) (choriocarcinoma of ovary), [MONDO:0002416](http://purl.obolibrary.org/obo/MONDO_0002416) (ethmoid sinus squamous cell carcinoma), [MONDO:0003508](http://purl.obolibrary.org/obo/MONDO_0003508) (choriocarcinoma of the testis), [MONDO:0003506](http://purl.obolibrary.org/obo/MONDO_0003506) (pulmonary artery choriocarcinoma), [MONDO:0002418](http://purl.obolibrary.org/obo/MONDO_0002418) (ethmoid sinus adenocarcinoma), [MONDO:0003503](http://purl.obolibrary.org/obo/MONDO_0003503) (fallopian tube squamous cell carcinoma), [MONDO:0002655](http://purl.obolibrary.org/obo/MONDO_0002655) (cutaneous Paget's disease), [MONDO:0002415](http://purl.obolibrary.org/obo/MONDO_0002415) (bone carcinoma), [MONDO:0003501](http://purl.obolibrary.org/obo/MONDO_0003501) (external ear squamous cell carcinoma), [MONDO:0002656](http://purl.obolibrary.org/obo/MONDO_0002656) (skin carcinoma), [MONDO:0003502](http://purl.obolibrary.org/obo/MONDO_0003502) (ureter squamous cell carcinoma), [MONDO:0002651](http://purl.obolibrary.org/obo/MONDO_0002651) (anal Paget's disease), [MONDO:0003983](http://purl.obolibrary.org/obo/MONDO_0003983) (synchronous bilateral breast carcinoma), [MONDO:0003500](http://purl.obolibrary.org/obo/MONDO_0003500) (squamous cell bile duct carcinoma), [MONDO:0002650](http://purl.obolibrary.org/obo/MONDO_0002650) (scrotal carcinoma), [MONDO:0002653](http://purl.obolibrary.org/obo/MONDO_0002653) (Paget disease of the penis), [MONDO:0003981](http://purl.obolibrary.org/obo/MONDO_0003981) (cervix small cell carcinoma), [MONDO:0002652](http://purl.obolibrary.org/obo/MONDO_0002652) (anus adenocarcinoma), [MONDO:0003982](http://purl.obolibrary.org/obo/MONDO_0003982) (bilateral breast carcinoma), [MONDO:0002669](http://purl.obolibrary.org/obo/MONDO_0002669) (ampullary signet ring cell adenocarcinoma), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0002666](http://purl.obolibrary.org/obo/MONDO_0002666) (pancreatic signet ring cell adenocarcinoma), [MONDO:0002424](http://purl.obolibrary.org/obo/MONDO_0002424) (rectosigmoid carcinoma), [MONDO:0002665](http://purl.obolibrary.org/obo/MONDO_0002665) (extrahepatic bile duct adenocarcinoma), [MONDO:0019086](http://purl.obolibrary.org/obo/MONDO_0019086) (carcinoma of esophagus), [MONDO:0005933](http://purl.obolibrary.org/obo/MONDO_0005933) (pulmonary blastoma), [MONDO:0002667](http://purl.obolibrary.org/obo/MONDO_0002667) (gallbladder signet ring cell adenocarcinoma), [MONDO:0002664](http://purl.obolibrary.org/obo/MONDO_0002664) (bile duct signet ring cell carcinoma), [MONDO:0002422](http://purl.obolibrary.org/obo/MONDO_0002422) (adamantinoma), [MONDO:0003990](http://purl.obolibrary.org/obo/MONDO_0003990) (malignant breast myoepithelioma), [MONDO:0003991](http://purl.obolibrary.org/obo/MONDO_0003991) (villoglandular endometrial endometrioid adenocarcinoma), [MONDO:0021165](http://purl.obolibrary.org/obo/MONDO_0021165) (paget disease), [MONDO:0011368](http://purl.obolibrary.org/obo/MONDO_0011368) (papillary thyroid Microcarcinoma), [MONDO:0016644](http://purl.obolibrary.org/obo/MONDO_0016644) (Logopenic progressive aphasia), [MONDO:0004418](http://purl.obolibrary.org/obo/MONDO_0004418) (microcystic variant infiltrating bladder urothelial carcinoma), [MONDO:0004419](http://purl.obolibrary.org/obo/MONDO_0004419) (lymphoma-like variant infiltrating bladder urothelial carcinoma), [MONDO:0004658](http://purl.obolibrary.org/obo/MONDO_0004658) (breast carcinoma in situ), [MONDO:0004416](http://purl.obolibrary.org/obo/MONDO_0004416) (plasmacytoid variant infiltrating bladder urothelial carcinoma), [MONDO:0004659](http://purl.obolibrary.org/obo/MONDO_0004659) (eye carcinoma in situ), [MONDO:0004417](http://purl.obolibrary.org/obo/MONDO_0004417) (nested variant infiltrating bladder urothelial carcinoma), [MONDO:0004415](http://purl.obolibrary.org/obo/MONDO_0004415) (lipid-cell variant infiltrating bladder urothelial carcinoma), [MONDO:0002475](http://purl.obolibrary.org/obo/MONDO_0002475) (lacrimal gland adenocarcinoma), [MONDO:0004412](http://purl.obolibrary.org/obo/MONDO_0004412) (malignant spiradenoma), [MONDO:0004413](http://purl.obolibrary.org/obo/MONDO_0004413) (cervical non-keratinizing squamous cell carcinoma), [MONDO:0004410](http://purl.obolibrary.org/obo/MONDO_0004410) (sarcomatoid penile squamous cell carcinoma), [MONDO:0002472](http://purl.obolibrary.org/obo/MONDO_0002472) (carcinoma ex pleomorphic adenoma), [MONDO:0005519](http://purl.obolibrary.org/obo/MONDO_0005519) (renal pelvis carcinoma), [MONDO:0002486](http://purl.obolibrary.org/obo/MONDO_0002486) (lobular neoplasia), [MONDO:0004663](http://purl.obolibrary.org/obo/MONDO_0004663) (colon carcinoma in situ), [MONDO:0003575](http://purl.obolibrary.org/obo/MONDO_0003575) (comedocarcinoma), [MONDO:0004661](http://purl.obolibrary.org/obo/MONDO_0004661) (trachea carcinoma in situ), [MONDO:0003572](http://purl.obolibrary.org/obo/MONDO_0003572) (lymphoepithelioma-like carcinoma), [MONDO:0004420](http://purl.obolibrary.org/obo/MONDO_0004420) (breast malignant eccrine spiradenoma), [MONDO:0003573](http://purl.obolibrary.org/obo/MONDO_0003573) (pleomorphic carcinoma), [MONDO:0002484](http://purl.obolibrary.org/obo/MONDO_0002484) (breast ductal carcinoma), [MONDO:0003570](http://purl.obolibrary.org/obo/MONDO_0003570) (lipid-rich carcinoma), [MONDO:0004660](http://purl.obolibrary.org/obo/MONDO_0004660) (lung carcinoma in situ), [MONDO:0014681](http://purl.obolibrary.org/obo/MONDO_0014681) (thyroid cancer, nonmedullary, 4), [MONDO:0014682](http://purl.obolibrary.org/obo/MONDO_0014682) (thyroid cancer, nonmedullary, 5), [MONDO:0003549](http://purl.obolibrary.org/obo/MONDO_0003549) (adenosquamous bile duct carcinoma), [MONDO:0004636](http://purl.obolibrary.org/obo/MONDO_0004636) (lip carcinoma in situ), [MONDO:0003789](http://purl.obolibrary.org/obo/MONDO_0003789) (hereditary papillary renal cell carcinoma), [MONDO:0003548](http://purl.obolibrary.org/obo/MONDO_0003548) (adenosquamous breast carcinoma), [MONDO:0003788](http://purl.obolibrary.org/obo/MONDO_0003788) (childhood embryonal testis carcinoma), [MONDO:0002210](http://purl.obolibrary.org/obo/MONDO_0002210) (vulva squamous cell carcinoma), [MONDO:0003786](http://purl.obolibrary.org/obo/MONDO_0003786) (childhood testicular choriocarcinoma), [MONDO:0002455](http://purl.obolibrary.org/obo/MONDO_0002455) (exocervical carcinoma), [MONDO:0003784](http://purl.obolibrary.org/obo/MONDO_0003784) (nasal cavity carcinoma in situ), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0004409](http://purl.obolibrary.org/obo/MONDO_0004409) (nipple duct carcinoma), [MONDO:0004647](http://purl.obolibrary.org/obo/MONDO_0004647) (in situ carcinoma), [MONDO:0003558](http://purl.obolibrary.org/obo/MONDO_0003558) (adenosquamous prostate carcinoma), [MONDO:0004405](http://purl.obolibrary.org/obo/MONDO_0004405) (Barrett adenocarcinoma), [MONDO:0003556](http://purl.obolibrary.org/obo/MONDO_0003556) (endometrial adenosquamous carcinoma), [MONDO:0006824](http://purl.obolibrary.org/obo/MONDO_0006824) (krebs 2 carcinoma), [MONDO:0002469](http://purl.obolibrary.org/obo/MONDO_0002469) (lacrimal gland carcinoma ex pleomorphic adenoma), [MONDO:0003315](http://purl.obolibrary.org/obo/MONDO_0003315) (endometrium carcinoma in situ), [MONDO:0003554](http://purl.obolibrary.org/obo/MONDO_0003554) (adenosquamous colon carcinoma), [MONDO:0003555](http://purl.obolibrary.org/obo/MONDO_0003555) (Bartholin's gland adenosquamous carcinoma), [MONDO:0002463](http://purl.obolibrary.org/obo/MONDO_0002463) (lacrimal gland carcinoma), [MONDO:0004641](http://purl.obolibrary.org/obo/MONDO_0004641) (skin carcinoma in situ), [MONDO:0002466](http://purl.obolibrary.org/obo/MONDO_0002466) (eye carcinoma), [MONDO:0003553](http://purl.obolibrary.org/obo/MONDO_0003553) (ampulla of vater adenosquamous carcinoma), [MONDO:0003795](http://purl.obolibrary.org/obo/MONDO_0003795) (ovarian small cell carcinoma), [MONDO:0003792](http://purl.obolibrary.org/obo/MONDO_0003792) (ovarian carcinosarcoma), [MONDO:0003550](http://purl.obolibrary.org/obo/MONDO_0003550) (esophageal adenosquamous carcinoma), [MONDO:0003551](http://purl.obolibrary.org/obo/MONDO_0003551) (thymus adenosquamous carcinoma), [MONDO:0003790](http://purl.obolibrary.org/obo/MONDO_0003790) (prostatic urethra urothelial carcinoma), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), [MONDO:0006639](http://purl.obolibrary.org/obo/MONDO_0006639) (adrenal cortex carcinoma), [MONDO:0003128](http://purl.obolibrary.org/obo/MONDO_0003128) (classic pulmonary blastoma), [MONDO:0005549](http://purl.obolibrary.org/obo/MONDO_0005549) (renal cell adenocarcinoma), [MONDO:0002038](http://purl.obolibrary.org/obo/MONDO_0002038) (head and neck carcinoma), [MONDO:0004458](http://purl.obolibrary.org/obo/MONDO_0004458) (bladder mixed adenocarcinoma), [MONDO:0004459](http://purl.obolibrary.org/obo/MONDO_0004459) (bladder hepatoid adenocarcinoma), [MONDO:0003129](http://purl.obolibrary.org/obo/MONDO_0003129) (epithelial predominant pulmonary blastoma), [MONDO:0004698](http://purl.obolibrary.org/obo/MONDO_0004698) (intestine carcinoma in situ), [MONDO:0004212](http://purl.obolibrary.org/obo/MONDO_0004212) (vulvar keratoacanthoma-like carcinoma), [MONDO:0004696](http://purl.obolibrary.org/obo/MONDO_0004696) (larynx carcinoma in situ), [MONDO:0004213](http://purl.obolibrary.org/obo/MONDO_0004213) (vulvar non-keratinizing squamous cell carcinoma), [MONDO:0006871](http://purl.obolibrary.org/obo/MONDO_0006871) (non-gestational choriocarcinoma), [MONDO:0004451](http://purl.obolibrary.org/obo/MONDO_0004451) (sarcomatous intrahepatic cholangiocarcinoma), [MONDO:0002032](http://purl.obolibrary.org/obo/MONDO_0002032) (colon carcinoma), [MONDO:0004693](http://purl.obolibrary.org/obo/MONDO_0004693) (cervix uteri carcinoma in situ), [MONDO:0002271](http://purl.obolibrary.org/obo/MONDO_0002271) (colon adenocarcinoma), [MONDO:0006409](http://purl.obolibrary.org/obo/MONDO_0006409) (signet ring cell gastric adenocarcinoma), [MONDO:0004229](http://purl.obolibrary.org/obo/MONDO_0004229) (acantholytic variant squamous cell breast carcinoma), [MONDO:0004469](http://purl.obolibrary.org/obo/MONDO_0004469) (pseudovascular skin squamous cell carcinoma), [MONDO:0006406](http://purl.obolibrary.org/obo/MONDO_0006406) (sarcomatoid carcinoma), [MONDO:0006405](http://purl.obolibrary.org/obo/MONDO_0006405) (salivary gland small cell carcinoma), [MONDO:0006404](http://purl.obolibrary.org/obo/MONDO_0006404) (salivary gland large cell carcinoma), [MONDO:0004468](http://purl.obolibrary.org/obo/MONDO_0004468) (anal canal Paget's disease), [MONDO:0006403](http://purl.obolibrary.org/obo/MONDO_0006403) (salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006402](http://purl.obolibrary.org/obo/MONDO_0006402) (salivary gland basal cell adenocarcinoma), [MONDO:0006886](http://purl.obolibrary.org/obo/MONDO_0006886) (papillary follicular thyroid adenocarcinoma), [MONDO:0004465](http://purl.obolibrary.org/obo/MONDO_0004465) (periampullary adenocarcinoma), [MONDO:0003377](http://purl.obolibrary.org/obo/MONDO_0003377) (extrahepatic bile duct leiomyosarcoma), [MONDO:0006401](http://purl.obolibrary.org/obo/MONDO_0006401) (salivary gland adenosquamous carcinoma), [MONDO:0006400](http://purl.obolibrary.org/obo/MONDO_0006400) (salivary gland acinic cell carcinoma), [MONDO:0006883](http://purl.obolibrary.org/obo/MONDO_0006883) (Pancoast tumor), [MONDO:0004222](http://purl.obolibrary.org/obo/MONDO_0004222) (ovarian clear cell cystadenocarcinoma), [MONDO:0004220](http://purl.obolibrary.org/obo/MONDO_0004220) (endometrial endometrioid adenocarcinoma with spindled epithelial cells), [MONDO:0018843](http://purl.obolibrary.org/obo/MONDO_0018843) (embryonal carcinoma of the central nervous system), [MONDO:0004438](http://purl.obolibrary.org/obo/MONDO_0004438) (sporadic breast cancer), [MONDO:0003345](http://purl.obolibrary.org/obo/MONDO_0003345) (hilar cholangiocarcinoma), [MONDO:0005524](http://purl.obolibrary.org/obo/MONDO_0005524) (sweat gland carcinoma), [MONDO:0002496](http://purl.obolibrary.org/obo/MONDO_0002496) (submucosal invasive colon adenocarcinoma), [MONDO:0004433](http://purl.obolibrary.org/obo/MONDO_0004433) (penis papillary carcinoma), [MONDO:0005522](http://purl.obolibrary.org/obo/MONDO_0005522) (small intestine carcinoma), [MONDO:0004430](http://purl.obolibrary.org/obo/MONDO_0004430) (penis mixed squamous cell carcinoma), [MONDO:0002493](http://purl.obolibrary.org/obo/MONDO_0002493) (prostatic acinar adenocarcinoma), [MONDO:0003581](http://purl.obolibrary.org/obo/MONDO_0003581) (ovarian embryonal carcinoma), [MONDO:0002495](http://purl.obolibrary.org/obo/MONDO_0002495) (colon signet ring adenocarcinoma), [MONDO:0004671](http://purl.obolibrary.org/obo/MONDO_0004671) (penis carcinoma in situ), [MONDO:0014249](http://purl.obolibrary.org/obo/MONDO_0014249) (multiple fibroadenoma of the breast), [MONDO:0007958](http://purl.obolibrary.org/obo/MONDO_0007958) (familial medullary thyroid carcinoma), [MONDO:0004445](http://purl.obolibrary.org/obo/MONDO_0004445) (bladder papillary clear cell adenocarcinoma), [MONDO:0006622](http://purl.obolibrary.org/obo/MONDO_0006622) (vulvar seborrheic keratosis), [MONDO:0006621](http://purl.obolibrary.org/obo/MONDO_0006621) (vulvar inverted follicular keratosis), [MONDO:0004202](http://purl.obolibrary.org/obo/MONDO_0004202) (adrenal medulla carcinoma), [MONDO:0004444](http://purl.obolibrary.org/obo/MONDO_0004444) (bladder tubulo-cystic clear cell adenocarcinoma), [MONDO:0004441](http://purl.obolibrary.org/obo/MONDO_0004441) (childhood ovarian embryonal carcinoma), [MONDO:0004200](http://purl.obolibrary.org/obo/MONDO_0004200) (superficial urinary bladder carcinoma), [MONDO:0006860](http://purl.obolibrary.org/obo/MONDO_0006860) (mucoepidermoid tumor), [MONDO:0016419](http://purl.obolibrary.org/obo/MONDO_0016419) (hereditary breast carcinoma), [MONDO:0018666](http://purl.obolibrary.org/obo/MONDO_0018666) (hepatoblastoma), [MONDO:0004018](http://purl.obolibrary.org/obo/MONDO_0004018) (liver carcinoma), [MONDO:0004019](http://purl.obolibrary.org/obo/MONDO_0004019) (oxyphilic endometrial endometrioid adenocarcinoma), [MONDO:0006436](http://purl.obolibrary.org/obo/MONDO_0006436) (submandibular gland adenoid cystic carcinoma), [MONDO:0004259](http://purl.obolibrary.org/obo/MONDO_0004259) (endocervical carcinoma), [MONDO:0006435](http://purl.obolibrary.org/obo/MONDO_0006435) (submandibular gland adenocarcinoma), [MONDO:0004499](http://purl.obolibrary.org/obo/MONDO_0004499) (hilar lung carcinoma), [MONDO:0004255](http://purl.obolibrary.org/obo/MONDO_0004255) (wolffian adnexal tumor), [MONDO:0007763](http://purl.obolibrary.org/obo/MONDO_0007763) (nonpapillary renal cell carcinoma), [MONDO:0005341](http://purl.obolibrary.org/obo/MONDO_0005341) (skin basal cell carcinoma), [MONDO:0004010](http://purl.obolibrary.org/obo/MONDO_0004010) (infiltrating ureter transitional cell carcinoma), [MONDO:0004490](http://purl.obolibrary.org/obo/MONDO_0004490) (gestational uterine corpus choriocarcinoma), [MONDO:0004491](http://purl.obolibrary.org/obo/MONDO_0004491) (uterine corpus choriocarcinoma), [MONDO:0005580](http://purl.obolibrary.org/obo/MONDO_0005580) (esophageal squamous cell carcinoma), [MONDO:0006208](http://purl.obolibrary.org/obo/MONDO_0006208) (fallopian tube serous adenocarcinoma), [MONDO:0006207](http://purl.obolibrary.org/obo/MONDO_0006207) (fallopian tube carcinosarcoma), [MONDO:0006206](http://purl.obolibrary.org/obo/MONDO_0006206) (fallopian tube carcinoma), [MONDO:0004269](http://purl.obolibrary.org/obo/MONDO_0004269) (breast cystic hypersecretory carcinoma), [MONDO:0006446](http://purl.obolibrary.org/obo/MONDO_0006446) (testicular embryonal carcinoma), [MONDO:0006203](http://purl.obolibrary.org/obo/MONDO_0006203) (extrahepatic bile duct squamous cell carcinoma), [MONDO:0006445](http://purl.obolibrary.org/obo/MONDO_0006445) (testicular choriocarcinoma), [MONDO:0005596](http://purl.obolibrary.org/obo/MONDO_0005596) (cystadenocarcinoma), [MONDO:0006202](http://purl.obolibrary.org/obo/MONDO_0006202) (extrahepatic bile duct adenosquamous carcinoma), [MONDO:0003175](http://purl.obolibrary.org/obo/MONDO_0003175) (salivary gland adenoid cystic carcinoma), [MONDO:0004266](http://purl.obolibrary.org/obo/MONDO_0004266) (anal gland adenocarcinoma), [MONDO:0005597](http://purl.obolibrary.org/obo/MONDO_0005597) (cystic renal cell carcinoma), [MONDO:0003177](http://purl.obolibrary.org/obo/MONDO_0003177) (prostate adenoid cystic carcinoma), [MONDO:0005595](http://purl.obolibrary.org/obo/MONDO_0005595) (laryngeal squamous cell carcinoma), [MONDO:0005590](http://purl.obolibrary.org/obo/MONDO_0005590) (breast ductal adenocarcinoma), [MONDO:0017328](http://purl.obolibrary.org/obo/MONDO_0017328) (non-central nervous system-localized embryonal carcinoma), [MONDO:0017790](http://purl.obolibrary.org/obo/MONDO_0017790) (gastric adenocarcinoma and proximal polyposis of the stomach), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0004239](http://purl.obolibrary.org/obo/MONDO_0004239) (cervical keratinizing squamous cell carcinoma), [MONDO:0003389](http://purl.obolibrary.org/obo/MONDO_0003389) (epithelial-myoepithelial carcinoma), [MONDO:0004237](http://purl.obolibrary.org/obo/MONDO_0004237) (large cell carcinoma with rhabdoid phenotype), [MONDO:0006413](http://purl.obolibrary.org/obo/MONDO_0006413) (skin basosquamous cell carcinoma), [MONDO:0003387](http://purl.obolibrary.org/obo/MONDO_0003387) (urethra clear cell adenocarcinoma), [MONDO:0003388](http://purl.obolibrary.org/obo/MONDO_0003388) (ampulla of vater clear cell adenocarcinoma), [MONDO:0005563](http://purl.obolibrary.org/obo/MONDO_0005563) (nut midline carcinoma), [MONDO:0004232](http://purl.obolibrary.org/obo/MONDO_0004232) (large cell keratinizing variant squamous cell breast carcinoma), [MONDO:0006411](http://purl.obolibrary.org/obo/MONDO_0006411) (sinonasal undifferentiated carcinoma), [MONDO:0004475](http://purl.obolibrary.org/obo/MONDO_0004475) (thymus clear cell carcinoma), [MONDO:0003386](http://purl.obolibrary.org/obo/MONDO_0003386) (bladder clear cell adenocarcinoma), [MONDO:0003383](http://purl.obolibrary.org/obo/MONDO_0003383) (fallopian tube clear cell adenocarcinoma), [MONDO:0004472](http://purl.obolibrary.org/obo/MONDO_0004472) (breast columnar cell mucinous carcinoma), [MONDO:0003384](http://purl.obolibrary.org/obo/MONDO_0003384) (uterine ligament clear cell adenocarcinoma), [MONDO:0004231](http://purl.obolibrary.org/obo/MONDO_0004231) (spindle cell variant squamous cell breast carcinoma), [MONDO:0016216](http://purl.obolibrary.org/obo/MONDO_0016216) (adult hepatocellular carcinoma), [MONDO:0017784](http://purl.obolibrary.org/obo/MONDO_0017784) (Epstein-Barr virus-associated gastric carcinoma), [MONDO:0004009](http://purl.obolibrary.org/obo/MONDO_0004009) (kidney pelvis sarcomatoid transitional cell carcinoma), [MONDO:0004489](http://purl.obolibrary.org/obo/MONDO_0004489) (fallopian tube gestational choriocarcinoma), [MONDO:0004003](http://purl.obolibrary.org/obo/MONDO_0004003) (pancreatic solid pseudopapillary carcinoma), [MONDO:0003158](http://purl.obolibrary.org/obo/MONDO_0003158) (myoepithelial carcinoma), [MONDO:0004481](http://purl.obolibrary.org/obo/MONDO_0004481) (pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma), [MONDO:0003390](http://purl.obolibrary.org/obo/MONDO_0003390) (glycogen-rich clear cell breast carcinoma), [MONDO:0016287](http://purl.obolibrary.org/obo/MONDO_0016287) (adenoid basal carcinoma of the cervix uteri), [MONDO:0016286](http://purl.obolibrary.org/obo/MONDO_0016286) (adenoid cystic carcinoma of the cervix uteri), [MONDO:0016285](http://purl.obolibrary.org/obo/MONDO_0016285) (papillary carcinoma of the cervix uteri), [MONDO:0006479](http://purl.obolibrary.org/obo/MONDO_0006479) (undifferentiated pancreatic carcinoma with Osteoclast-like giant cells), [MONDO:0006478](http://purl.obolibrary.org/obo/MONDO_0006478) (undifferentiated pancreatic carcinoma), [MONDO:0011836](http://purl.obolibrary.org/obo/MONDO_0011836) (thyroid Hurthle cell carcinoma), [MONDO:0006477](http://purl.obolibrary.org/obo/MONDO_0006477) (undifferentiated ovarian carcinoma), [MONDO:0004056](http://purl.obolibrary.org/obo/MONDO_0004056) (bladder papillary urothelial carcinoma), [MONDO:0006476](http://purl.obolibrary.org/obo/MONDO_0006476) (undifferentiated gallbladder carcinoma), [MONDO:0004057](http://purl.obolibrary.org/obo/MONDO_0004057) (micropapillary variant infiltrating bladder urothelial carcinoma), [MONDO:0004299](http://purl.obolibrary.org/obo/MONDO_0004299) (infiltrating bladder lymphoepithelioma-like carcinoma), [MONDO:0004296](http://purl.obolibrary.org/obo/MONDO_0004296) (cervical lymphoepithelioma-like carcinoma), [MONDO:0006475](http://purl.obolibrary.org/obo/MONDO_0006475) (unclassified renal cell carcinoma), [MONDO:0006474](http://purl.obolibrary.org/obo/MONDO_0006474) (transitional cell carcinoma), [MONDO:0004297](http://purl.obolibrary.org/obo/MONDO_0004297) (lymphoepithelioma-like thymic carcinoma), [MONDO:0004294](http://purl.obolibrary.org/obo/MONDO_0004294) (gestational ovarian choriocarcinoma), [MONDO:0004052](http://purl.obolibrary.org/obo/MONDO_0004052) (rectal cloacogenic carcinoma), [MONDO:0006230](http://purl.obolibrary.org/obo/MONDO_0006230) (gastric squamous cell carcinoma), [MONDO:0004053](http://purl.obolibrary.org/obo/MONDO_0004053) (Bartholin's gland squamous cell carcinoma), [MONDO:0004295](http://purl.obolibrary.org/obo/MONDO_0004295) (asbestos-related lung carcinoma), [MONDO:0004292](http://purl.obolibrary.org/obo/MONDO_0004292) (supraglottis verrucous carcinoma), [MONDO:0006471](http://purl.obolibrary.org/obo/MONDO_0006471) (tracheal adenoid cystic carcinoma), [MONDO:0004293](http://purl.obolibrary.org/obo/MONDO_0004293) (supraglottis squamous cell carcinoma), [MONDO:0005140](http://purl.obolibrary.org/obo/MONDO_0005140) (ovarian carcinoma), [MONDO:0006470](http://purl.obolibrary.org/obo/MONDO_0006470) (tonsillar squamous cell carcinoma), [MONDO:0004290](http://purl.obolibrary.org/obo/MONDO_0004290) (subglottis verrucous carcinoma), [MONDO:0004291](http://purl.obolibrary.org/obo/MONDO_0004291) (subglottis squamous cell carcinoma), [MONDO:0016275](http://purl.obolibrary.org/obo/MONDO_0016275) (adenocarcinoma of cervix uteri), [MONDO:0016272](http://purl.obolibrary.org/obo/MONDO_0016272) (transitional cell carcinoma of the corpus uteri), [MONDO:0016271](http://purl.obolibrary.org/obo/MONDO_0016271) (adenoid cystic carcinoma of the corpus uteri), [MONDO:0018691](http://purl.obolibrary.org/obo/MONDO_0018691) (endometrioid carcinoma of ovary), [MONDO:0006006](http://purl.obolibrary.org/obo/MONDO_0006006) (verrucous carcinoma), [MONDO:0005159](http://purl.obolibrary.org/obo/MONDO_0005159) (prostate carcinoma), [MONDO:0004067](http://purl.obolibrary.org/obo/MONDO_0004067) (gallbladder mucinous adenocarcinoma), [MONDO:0006488](http://purl.obolibrary.org/obo/MONDO_0006488) (vaginal carcinosarcoma), [MONDO:0006245](http://purl.obolibrary.org/obo/MONDO_0006245) (hidradenocarcinoma), [MONDO:0006487](http://purl.obolibrary.org/obo/MONDO_0006487) (vaginal adenoid cystic carcinoma), [MONDO:0006244](http://purl.obolibrary.org/obo/MONDO_0006244) (HER2 positive breast carcinoma), [MONDO:0006243](http://purl.obolibrary.org/obo/MONDO_0006243) (hepatoid adenocarcinoma), [MONDO:0005153](http://purl.obolibrary.org/obo/MONDO_0005153) (cervical adenocarcinoma), [MONDO:0006482](http://purl.obolibrary.org/obo/MONDO_0006482) (ureter small cell carcinoma), [MONDO:0006481](http://purl.obolibrary.org/obo/MONDO_0006481) (ureter carcinoma), [MONDO:0018448](http://purl.obolibrary.org/obo/MONDO_0018448) (clear cell papillary renal cell carcinoma), [MONDO:0016268](http://purl.obolibrary.org/obo/MONDO_0016268) (papillary carcinoma of the corpus uteri), [MONDO:0018449](http://purl.obolibrary.org/obo/MONDO_0018449) (acquired cystic disease-associated renal cell carcinoma), [MONDO:0016267](http://purl.obolibrary.org/obo/MONDO_0016267) (undifferentiated carcinoma of the corpus uteri), [MONDO:0016266](http://purl.obolibrary.org/obo/MONDO_0016266) (squamous cell carcinoma of the corpus uteri), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), [MONDO:0006219](http://purl.obolibrary.org/obo/MONDO_0006219) (gallbladder small cell neuroendocrine carcinoma), [MONDO:0006217](http://purl.obolibrary.org/obo/MONDO_0006217) (gallbladder adenosquamous carcinoma), [MONDO:0003189](http://purl.obolibrary.org/obo/MONDO_0003189) (middle ear adenocarcinoma), [MONDO:0004039](http://purl.obolibrary.org/obo/MONDO_0004039) (papillary extrahepatic bile duct adenocarcinoma), [MONDO:0004278](http://purl.obolibrary.org/obo/MONDO_0004278) (infiltrating bladder urothelial carcinoma sarcomatoid variant), [MONDO:0006215](http://purl.obolibrary.org/obo/MONDO_0006215) (gallbladder adenocarcinoma), [MONDO:0006214](http://purl.obolibrary.org/obo/MONDO_0006214) (follicular variant thyroid gland papillary carcinoma), [MONDO:0006455](http://purl.obolibrary.org/obo/MONDO_0006455) (thymic undifferentiated carcinoma), [MONDO:0006213](http://purl.obolibrary.org/obo/MONDO_0006213) (floor of mouth mucoepidermoid carcinoma), [MONDO:0003186](http://purl.obolibrary.org/obo/MONDO_0003186) (esophageal adenoid cystic carcinoma), [MONDO:0003185](http://purl.obolibrary.org/obo/MONDO_0003185) (adenoid cystic breast carcinoma), [MONDO:0004274](http://purl.obolibrary.org/obo/MONDO_0004274) (mixed epithelial/mesenchymal metaplastic breast carcinoma), [MONDO:0006452](http://purl.obolibrary.org/obo/MONDO_0006452) (thymic sarcomatoid carcinoma), [MONDO:0006210](http://purl.obolibrary.org/obo/MONDO_0006210) (fibrolamellar carcinoma), [MONDO:0004275](http://purl.obolibrary.org/obo/MONDO_0004275) (osteosarcoma arising in bone Paget's disease), [MONDO:0003187](http://purl.obolibrary.org/obo/MONDO_0003187) (Bartholin's gland adenoid cystic carcinoma), [MONDO:0004033](http://purl.obolibrary.org/obo/MONDO_0004033) (familial ovarian carcinoma), [MONDO:0006451](http://purl.obolibrary.org/obo/MONDO_0006451) (thymic carcinoma), [MONDO:0004030](http://purl.obolibrary.org/obo/MONDO_0004030) (ureter transitional cell carcinoma), [MONDO:0003181](http://purl.obolibrary.org/obo/MONDO_0003181) (lung adenoid cystic carcinoma), [MONDO:0004031](http://purl.obolibrary.org/obo/MONDO_0004031) (ovary mixed epithelial carcinoma), [MONDO:0003184](http://purl.obolibrary.org/obo/MONDO_0003184) (trachea carcinoma), [MONDO:0003180](http://purl.obolibrary.org/obo/MONDO_0003180) (cutaneous adenocystic carcinoma), [MONDO:0017582](http://purl.obolibrary.org/obo/MONDO_0017582) (pituitary adenocarcinoma (disease)), [MONDO:0006229](http://purl.obolibrary.org/obo/MONDO_0006229) (gastric small cell neuroendocrine carcinoma), [MONDO:0006228](http://purl.obolibrary.org/obo/MONDO_0006228) (gastric papillary adenocarcinoma), [MONDO:0005138](http://purl.obolibrary.org/obo/MONDO_0005138) (lung carcinoma), [MONDO:0006469](http://purl.obolibrary.org/obo/MONDO_0006469) (tibial adamantinoma), [MONDO:0006468](http://purl.obolibrary.org/obo/MONDO_0006468) (thyroid gland undifferentiated (anaplastic) carcinoma), [MONDO:0004289](http://purl.obolibrary.org/obo/MONDO_0004289) (glottis verrucous carcinoma), [MONDO:0006467](http://purl.obolibrary.org/obo/MONDO_0006467) (thyroid gland squamous cell carcinoma), [MONDO:0004287](http://purl.obolibrary.org/obo/MONDO_0004287) (pancreatic foamy gland adenocarcinoma), [MONDO:0003197](http://purl.obolibrary.org/obo/MONDO_0003197) (granular cell carcinoma), [MONDO:0006465](http://purl.obolibrary.org/obo/MONDO_0006465) (thyroid gland oncocytic follicular carcinoma), [MONDO:0003196](http://purl.obolibrary.org/obo/MONDO_0003196) (appendix carcinoma), [MONDO:0004288](http://purl.obolibrary.org/obo/MONDO_0004288) (scirrhous breast carcinoma), [MONDO:0004285](http://purl.obolibrary.org/obo/MONDO_0004285) (pancreatic intraductal papillary-mucinous carcinoma), [MONDO:0006222](http://purl.obolibrary.org/obo/MONDO_0006222) (gastric choriocarcinoma), [MONDO:0003199](http://purl.obolibrary.org/obo/MONDO_0003199) (anal carcinoma), [MONDO:0006463](http://purl.obolibrary.org/obo/MONDO_0006463) (thyroid gland mucoepidermoid carcinoma), [MONDO:0003198](http://purl.obolibrary.org/obo/MONDO_0003198) (small intestine adenocarcinoma), [MONDO:0006220](http://purl.obolibrary.org/obo/MONDO_0006220) (gallbladder squamous cell carcinoma), [MONDO:0003193](http://purl.obolibrary.org/obo/MONDO_0003193) (bile duct adenocarcinoma), [MONDO:0004283](http://purl.obolibrary.org/obo/MONDO_0004283) (vulvar clear cell hidradenocarcinoma), [MONDO:0005131](http://purl.obolibrary.org/obo/MONDO_0005131) (cervical carcinoma), [MONDO:0003195](http://purl.obolibrary.org/obo/MONDO_0003195) (peritoneal serous adenocarcinoma), [MONDO:0004281](http://purl.obolibrary.org/obo/MONDO_0004281) (vulvar eccrine porocarcinoma), [MONDO:0003191](http://purl.obolibrary.org/obo/MONDO_0003191) (rete ovarii adenocarcinoma), [MONDO:0003190](http://purl.obolibrary.org/obo/MONDO_0003190) (middle ear carcinoma), [MONDO:0021431](http://purl.obolibrary.org/obo/MONDO_0021431) (squamous cell carcinoma of buccal mucosa), [MONDO:0006279](http://purl.obolibrary.org/obo/MONDO_0006279) (lung sarcomatoid carcinoma), [MONDO:0006277](http://purl.obolibrary.org/obo/MONDO_0006277) (lung lymphangioleiomyomatosis), [MONDO:0006035](http://purl.obolibrary.org/obo/MONDO_0006035) (gastric tubular adenocarcinoma), [MONDO:0006276](http://purl.obolibrary.org/obo/MONDO_0006276) (lung inflammatory myofibroblastic tumor), [MONDO:0006034](http://purl.obolibrary.org/obo/MONDO_0006034) (gastric adenosquamous carcinoma), [MONDO:0006275](http://purl.obolibrary.org/obo/MONDO_0006275) (lung giant cell carcinoma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0005184](http://purl.obolibrary.org/obo/MONDO_0005184) (pancreatic ductal adenocarcinoma), [MONDO:0004092](http://purl.obolibrary.org/obo/MONDO_0004092) (thymus basaloid carcinoma), [MONDO:0006270](http://purl.obolibrary.org/obo/MONDO_0006270) (lobular breast carcinoma in situ), [MONDO:0004093](http://purl.obolibrary.org/obo/MONDO_0004093) (esophageal basaloid carcinoma), [MONDO:0004090](http://purl.obolibrary.org/obo/MONDO_0004090) (vulvar basaloid squamous cell carcinoma), [MONDO:0004091](http://purl.obolibrary.org/obo/MONDO_0004091) (basaloid squamous cell skin carcinoma), [MONDO:0021429](http://purl.obolibrary.org/obo/MONDO_0021429) (squamous cell carcinoma of floor of mouth), [MONDO:0018017](http://purl.obolibrary.org/obo/MONDO_0018017) (Goblet cell carcinoma), [MONDO:0021663](http://purl.obolibrary.org/obo/MONDO_0021663) (sarcomatoid squamous cell carcinoma), [MONDO:0000503](http://purl.obolibrary.org/obo/MONDO_0000503) (in situ pulmonary adenocarcinoma), [MONDO:0018492](http://purl.obolibrary.org/obo/MONDO_0018492) (hereditary clear cell renal cell carcinoma), [MONDO:0021427](http://purl.obolibrary.org/obo/MONDO_0021427) (squamous cell carcinoma of lip), [MONDO:0000500](http://purl.obolibrary.org/obo/MONDO_0000500) (tongue squamous cell carcinoma), [MONDO:0006049](http://purl.obolibrary.org/obo/MONDO_0006049) (papillary lung adenocarcinoma), [MONDO:0006047](http://purl.obolibrary.org/obo/MONDO_0006047) (pancreatic adenocarcinoma), [MONDO:0006288](http://purl.obolibrary.org/obo/MONDO_0006288) (malignant adrenal gland pheochromocytoma), [MONDO:0006046](http://purl.obolibrary.org/obo/MONDO_0006046) (ovarian serous cystadenocarcinoma), [MONDO:0006045](http://purl.obolibrary.org/obo/MONDO_0006045) (ovarian clear cell adenocarcinoma), [MONDO:0006286](http://purl.obolibrary.org/obo/MONDO_0006286) (major salivary gland mucoepidermoid carcinoma), [MONDO:0006285](http://purl.obolibrary.org/obo/MONDO_0006285) (major salivary gland carcinoma ex pleomorphic adenoma), [MONDO:0006043](http://purl.obolibrary.org/obo/MONDO_0006043) (metaplastic breast carcinoma), [MONDO:0006284](http://purl.obolibrary.org/obo/MONDO_0006284) (major salivary gland carcinoma), [MONDO:0006283](http://purl.obolibrary.org/obo/MONDO_0006283) (lymphoepithelioma-like lung carcinoma), [MONDO:0005192](http://purl.obolibrary.org/obo/MONDO_0005192) (exocrine pancreatic carcinoma), [MONDO:0006281](http://purl.obolibrary.org/obo/MONDO_0006281) (lung signet ring cell carcinoma), [MONDO:0006280](http://purl.obolibrary.org/obo/MONDO_0006280) (lung sclerosing hemangioma), [MONDO:0021659](http://purl.obolibrary.org/obo/MONDO_0021659) (combined carcinoid and adenocarcinoma), [MONDO:0000715](http://purl.obolibrary.org/obo/MONDO_0000715) (lymph node adenoid cystic carcinoma), [MONDO:0021652](http://purl.obolibrary.org/obo/MONDO_0021652) (diffuse type adenocarcinoma), [MONDO:0018482](http://purl.obolibrary.org/obo/MONDO_0018482) (squamous cell carcinoma of stomach), [MONDO:0018480](http://purl.obolibrary.org/obo/MONDO_0018480) (carcinoma of esophagus, salivary gland type), [MONDO:0018481](http://purl.obolibrary.org/obo/MONDO_0018481) (undifferentiated carcinoma of esophagus), [MONDO:0007108](http://purl.obolibrary.org/obo/MONDO_0007108) (anal canal carcinoma), [MONDO:0004078](http://purl.obolibrary.org/obo/MONDO_0004078) (mucinous intrahepatic cholangiocarcinoma), [MONDO:0006256](http://purl.obolibrary.org/obo/MONDO_0006256) (invasive breast carcinoma), [MONDO:0006254](http://purl.obolibrary.org/obo/MONDO_0006254) (intestinal type adenocarcinoma), [MONDO:0006490](http://purl.obolibrary.org/obo/MONDO_0006490) (vaginal squamous cell carcinoma), [MONDO:0008433](http://purl.obolibrary.org/obo/MONDO_0008433) (small cell lung carcinoma), [MONDO:0020552](http://purl.obolibrary.org/obo/MONDO_0020552) (placental site trophoblastic tumor), [MONDO:0020555](http://purl.obolibrary.org/obo/MONDO_0020555) (pleuropulmonary blastoma type 1), [MONDO:0020556](http://purl.obolibrary.org/obo/MONDO_0020556) (pleuropulmonary blastoma type 2), [MONDO:0020557](http://purl.obolibrary.org/obo/MONDO_0020557) (pleuropulmonary blastoma type 3), [MONDO:0006029](http://purl.obolibrary.org/obo/MONDO_0006029) (cecum carcinoma), [MONDO:0006028](http://purl.obolibrary.org/obo/MONDO_0006028) (cecum adenocarcinoma), [MONDO:0004089](http://purl.obolibrary.org/obo/MONDO_0004089) (penis basaloid carcinoma), [MONDO:0006268](http://purl.obolibrary.org/obo/MONDO_0006268) (liver diffuse large B-cell lymphoma), [MONDO:0004087](http://purl.obolibrary.org/obo/MONDO_0004087) (basaloid lung carcinoma), [MONDO:0006024](http://purl.obolibrary.org/obo/MONDO_0006024) (anaplastic lung carcinoma), [MONDO:0020550](http://purl.obolibrary.org/obo/MONDO_0020550) (gestational choriocarcinoma), [MONDO:0006265](http://purl.obolibrary.org/obo/MONDO_0006265) (laryngeal small cell carcinoma), [MONDO:0004088](http://purl.obolibrary.org/obo/MONDO_0004088) (cervical basaloid squamous cell carcinoma), [MONDO:0006264](http://purl.obolibrary.org/obo/MONDO_0006264) (laryngeal adenoid cystic carcinoma), [MONDO:0004083](http://purl.obolibrary.org/obo/MONDO_0004083) (Borst-Jadassohn intraepidermal carcinoma), [MONDO:0006262](http://purl.obolibrary.org/obo/MONDO_0006262) (lacrimal gland adenoid cystic carcinoma), [MONDO:0006261](http://purl.obolibrary.org/obo/MONDO_0006261) (Krukenberg tumor), [MONDO:0004081](http://purl.obolibrary.org/obo/MONDO_0004081) (bile duct clear cell adenocarcinoma), [MONDO:0006260](http://purl.obolibrary.org/obo/MONDO_0006260) (kidney medullary carcinoma), [MONDO:0012933](http://purl.obolibrary.org/obo/MONDO_0012933) (breast-ovarian cancer, familial, susceptibility to, 2), [MONDO:0004080](http://purl.obolibrary.org/obo/MONDO_0004080) (glottis squamous cell carcinoma), [MONDO:0000535](http://purl.obolibrary.org/obo/MONDO_0000535) (tonsil squamous cell carcinoma), [MONDO:0002956](http://purl.obolibrary.org/obo/MONDO_0002956) (skin cystic basal cell carcinoma), [MONDO:0000536](http://purl.obolibrary.org/obo/MONDO_0000536) (pharynx squamous cell carcinoma), [MONDO:0002955](http://purl.obolibrary.org/obo/MONDO_0002955) (vulva basal cell carcinoma), [MONDO:0002958](http://purl.obolibrary.org/obo/MONDO_0002958) (signet ring basal cell carcinoma), [MONDO:0002957](http://purl.obolibrary.org/obo/MONDO_0002957) (sarcomatoid basal cell carcinoma), [MONDO:0000538](http://purl.obolibrary.org/obo/MONDO_0000538) (spindle epithelial tumor with thymus-like differentiation tumor), [MONDO:0000531](http://purl.obolibrary.org/obo/MONDO_0000531) (bronchus mucoepidermoid carcinoma), [MONDO:0002952](http://purl.obolibrary.org/obo/MONDO_0002952) (follicular basal cell carcinoma), [MONDO:0000532](http://purl.obolibrary.org/obo/MONDO_0000532) (lung combined type small cell adenocarcinoma), [MONDO:0002951](http://purl.obolibrary.org/obo/MONDO_0002951) (skin adenoid basal cell carcinoma), [MONDO:0002954](http://purl.obolibrary.org/obo/MONDO_0002954) (superficial basal cell carcinoma), [MONDO:0000534](http://purl.obolibrary.org/obo/MONDO_0000534) (trachea mucoepidermoid carcinoma), [MONDO:0002953](http://purl.obolibrary.org/obo/MONDO_0002953) (skin infiltrative basal cell carcinoma), [MONDO:0002950](http://purl.obolibrary.org/obo/MONDO_0002950) (skin clear cell basal cell carcinoma), [MONDO:0006079](http://purl.obolibrary.org/obo/MONDO_0006079) (ameloblastic carcinoma), [MONDO:0006074](http://purl.obolibrary.org/obo/MONDO_0006074) (adenosquamous carcinoma), [MONDO:0003817](http://purl.obolibrary.org/obo/MONDO_0003817) (peritoneal serous papillary adenocarcinoma), [MONDO:0018055](http://purl.obolibrary.org/obo/MONDO_0018055) (pediatric hepatocellular carcinoma), [MONDO:0003812](http://purl.obolibrary.org/obo/MONDO_0003812) (ovarian endometrial cancer), [MONDO:0003810](http://purl.obolibrary.org/obo/MONDO_0003810) (bladder diffuse clear cell adenocarcinoma), [MONDO:0000545](http://purl.obolibrary.org/obo/MONDO_0000545) (sublingual gland adenoid cystic carcinoma), [MONDO:0000541](http://purl.obolibrary.org/obo/MONDO_0000541) (jejunal adenocarcinoma (disease)), [MONDO:0006089](http://purl.obolibrary.org/obo/MONDO_0006089) (appendix goblet cell carcinoid), [MONDO:0006087](http://purl.obolibrary.org/obo/MONDO_0006087) (appendix adenocarcinoma), [MONDO:0006082](http://purl.obolibrary.org/obo/MONDO_0006082) (anal squamous cell carcinoma), [MONDO:0002938](http://purl.obolibrary.org/obo/MONDO_0002938) (metatypical basal cell carcinoma), [MONDO:0002937](http://purl.obolibrary.org/obo/MONDO_0002937) (nodular basal cell carcinoma), [MONDO:0002939](http://purl.obolibrary.org/obo/MONDO_0002939) (skin pigmented basal cell carcinoma), [MONDO:0000514](http://purl.obolibrary.org/obo/MONDO_0000514) (bone squamous cell carcinoma), [MONDO:0001602](http://purl.obolibrary.org/obo/MONDO_0001602) (labia minora carcinoma), [MONDO:0002936](http://purl.obolibrary.org/obo/MONDO_0002936) (scrotum basal cell carcinoma), [MONDO:0002935](http://purl.obolibrary.org/obo/MONDO_0002935) (penis basal cell carcinoma), [MONDO:0000993](http://purl.obolibrary.org/obo/MONDO_0000993) (prostate squamous cell carcinoma), [MONDO:0006059](http://purl.obolibrary.org/obo/MONDO_0006059) (nasal cavity squamous cell carcinoma), [MONDO:0006056](http://purl.obolibrary.org/obo/MONDO_0006056) (squamous cell breast carcinoma), [MONDO:0006297](http://purl.obolibrary.org/obo/MONDO_0006297) (maxillary sinus adenoid cystic carcinoma), [MONDO:0011653](http://purl.obolibrary.org/obo/MONDO_0011653) (NMTC3), [MONDO:0006050](http://purl.obolibrary.org/obo/MONDO_0006050) (pleomorphic breast carcinoma), [MONDO:0002707](http://purl.obolibrary.org/obo/MONDO_0002707) (breast mucinous carcinoma), [MONDO:0002949](http://purl.obolibrary.org/obo/MONDO_0002949) (morpheaform basal cell carcinoma), [MONDO:0002948](http://purl.obolibrary.org/obo/MONDO_0002948) (skin fibroepithelial basal cell carcinoma), [MONDO:0002703](http://purl.obolibrary.org/obo/MONDO_0002703) (appendix mucinous cystadenocarcinoma), [MONDO:0008234](http://purl.obolibrary.org/obo/MONDO_0008234) (multiple endocrine neoplasia type 2A), [MONDO:0002945](http://purl.obolibrary.org/obo/MONDO_0002945) (micronodular basal cell carcinoma), [MONDO:0002944](http://purl.obolibrary.org/obo/MONDO_0002944) (external ear carcinoma), [MONDO:0002702](http://purl.obolibrary.org/obo/MONDO_0002702) (ovarian cystadenocarcinoma), [MONDO:0002947](http://purl.obolibrary.org/obo/MONDO_0002947) (adamantinoid basal cell epithelioma), [MONDO:0002705](http://purl.obolibrary.org/obo/MONDO_0002705) (breast mucinous cystadenocarcinoma), [MONDO:0002941](http://purl.obolibrary.org/obo/MONDO_0002941) (anal margin carcinoma), [MONDO:0000521](http://purl.obolibrary.org/obo/MONDO_0000521) (salivary gland carcinoma), [MONDO:0002940](http://purl.obolibrary.org/obo/MONDO_0002940) (anal margin basal cell carcinoma), [MONDO:0002943](http://purl.obolibrary.org/obo/MONDO_0002943) (external ear basal cell carcinoma), [MONDO:0002701](http://purl.obolibrary.org/obo/MONDO_0002701) (ovarian mucinous cystadenocarcinoma), [MONDO:0002942](http://purl.obolibrary.org/obo/MONDO_0002942) (sebaceous basal cell carcinoma), [MONDO:0006069](http://purl.obolibrary.org/obo/MONDO_0006069) (ACTH-producing pituitary gland carcinoma), [MONDO:0006067](http://purl.obolibrary.org/obo/MONDO_0006067) (acinar prostate mucinous adenocarcinoma), [MONDO:0006066](http://purl.obolibrary.org/obo/MONDO_0006066) (acinar prostate adenocarcinoma, foamy gland variant), [MONDO:0006060](http://purl.obolibrary.org/obo/MONDO_0006060) (nasopharyngeal squamous cell carcinoma), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0002758](http://purl.obolibrary.org/obo/MONDO_0002758) (vulva verrucous carcinoma), [MONDO:0021279](http://purl.obolibrary.org/obo/MONDO_0021279) (mucoepidermoid carcinoma of submandibular gland), [MONDO:0002759](http://purl.obolibrary.org/obo/MONDO_0002759) (bladder verrucous carcinoma), [MONDO:0002512](http://purl.obolibrary.org/obo/MONDO_0002512) (papillary adenocarcinoma), [MONDO:0002753](http://purl.obolibrary.org/obo/MONDO_0002753) (mucinous stomach adenocarcinoma), [MONDO:0002750](http://purl.obolibrary.org/obo/MONDO_0002750) (bladder colloid adenocarcinoma), [MONDO:0002752](http://purl.obolibrary.org/obo/MONDO_0002752) (ovary adenocarcinoma), [MONDO:0002751](http://purl.obolibrary.org/obo/MONDO_0002751) (bladder adenocarcinoma), [MONDO:0004708](http://purl.obolibrary.org/obo/MONDO_0004708) (esophagus carcinoma in situ), [MONDO:0004707](http://purl.obolibrary.org/obo/MONDO_0004707) (anal canal carcinoma in situ), [MONDO:0002529](http://purl.obolibrary.org/obo/MONDO_0002529) (skin squamous cell carcinoma), [MONDO:0002765](http://purl.obolibrary.org/obo/MONDO_0002765) (plantar verrucous skin carcinoma), [MONDO:0004703](http://purl.obolibrary.org/obo/MONDO_0004703) (bladder carcinoma in situ), [MONDO:0002764](http://purl.obolibrary.org/obo/MONDO_0002764) (urethra squamous cell carcinoma), [MONDO:0003853](http://purl.obolibrary.org/obo/MONDO_0003853) (Bartholin's gland adenocarcinoma), [MONDO:0002766](http://purl.obolibrary.org/obo/MONDO_0002766) (larynx verrucous carcinoma), [MONDO:0002761](http://purl.obolibrary.org/obo/MONDO_0002761) (cervical verrucous carcinoma), [MONDO:0002760](http://purl.obolibrary.org/obo/MONDO_0002760) (bladder squamous cell carcinoma), [MONDO:0002763](http://purl.obolibrary.org/obo/MONDO_0002763) (urethral verrucous carcinoma), [MONDO:0002762](http://purl.obolibrary.org/obo/MONDO_0002762) (esophagus verrucous carcinoma), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0002739](http://purl.obolibrary.org/obo/MONDO_0002739) (bile duct mucinous adenocarcinoma), [MONDO:0011450](http://purl.obolibrary.org/obo/MONDO_0011450) (breast-ovarian cancer, familial, susceptibility to, 1), [MONDO:0002736](http://purl.obolibrary.org/obo/MONDO_0002736) (ampulla of vater mucinous adenocarcinoma), [MONDO:0002735](http://purl.obolibrary.org/obo/MONDO_0002735) (anal canal adenocarcinoma (disease)), [MONDO:0002979](http://purl.obolibrary.org/obo/MONDO_0002979) (papillary squamous carcinoma), [MONDO:0000553](http://purl.obolibrary.org/obo/MONDO_0000553) (uterine corpus endometrial carcinoma), [MONDO:0000554](http://purl.obolibrary.org/obo/MONDO_0000554) (endocervical adenocarcinoma), [MONDO:0002734](http://purl.obolibrary.org/obo/MONDO_0002734) (anal colloid adenocarcinoma), [MONDO:0000552](http://purl.obolibrary.org/obo/MONDO_0000552) (breast lobular carcinoma), [MONDO:0006098](http://purl.obolibrary.org/obo/MONDO_0006098) (atypical lobular breast hyperplasia), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0001419](http://purl.obolibrary.org/obo/MONDO_0001419) (trachea squamous cell carcinoma), [MONDO:0003839](http://purl.obolibrary.org/obo/MONDO_0003839) (ovarian mucinous malignant adenofibroma), [MONDO:0002747](http://purl.obolibrary.org/obo/MONDO_0002747) (endometrial mucinous adenocarcinoma), [MONDO:0002746](http://purl.obolibrary.org/obo/MONDO_0002746) (fallopian tube adenocarcinoma), [MONDO:0003835](http://purl.obolibrary.org/obo/MONDO_0003835) (gastric cardia adenocarcinoma), [MONDO:0002748](http://purl.obolibrary.org/obo/MONDO_0002748) (rectum mucinous adenocarcinoma), [MONDO:0002743](http://purl.obolibrary.org/obo/MONDO_0002743) (prostate colloid adenocarcinoma), [MONDO:0003834](http://purl.obolibrary.org/obo/MONDO_0003834) (gastric cardia carcinoma), [MONDO:0002742](http://purl.obolibrary.org/obo/MONDO_0002742) (cervical mucinous adenocarcinoma), [MONDO:0021009](http://purl.obolibrary.org/obo/MONDO_0021009) (salivary gland mucoepidermoid carcinoma), [MONDO:0002744](http://purl.obolibrary.org/obo/MONDO_0002744) (fallopian tube mucinous adenocarcinoma), [MONDO:0002741](http://purl.obolibrary.org/obo/MONDO_0002741) (uterine ligament adenocarcinoma), [MONDO:0001651](http://purl.obolibrary.org/obo/MONDO_0001651) (scrotum squamous cell carcinoma), [MONDO:0002740](http://purl.obolibrary.org/obo/MONDO_0002740) (uterine ligament mucinous adenocarcinoma), [MONDO:0015873](http://purl.obolibrary.org/obo/MONDO_0015873) (Paget disease of the nipple), [MONDO:0003889](http://purl.obolibrary.org/obo/MONDO_0003889) (infiltrating bladder urothelial carcinoma, clear cell variant), [MONDO:0004973](http://purl.obolibrary.org/obo/MONDO_0004973) (adenosquamous lung carcinoma), [MONDO:0000373](http://purl.obolibrary.org/obo/MONDO_0000373) (gall bladder carcinoma in situ), [MONDO:0004732](http://purl.obolibrary.org/obo/MONDO_0004732) (kidney carcinoma in situ), [MONDO:0000374](http://purl.obolibrary.org/obo/MONDO_0000374) (bile duct carcinoma in situ), [MONDO:0000375](http://purl.obolibrary.org/obo/MONDO_0000375) (bronchus carcinoma in situ), [MONDO:0004971](http://purl.obolibrary.org/obo/MONDO_0004971) (adenoid cystic carcinoma), [MONDO:0003880](http://purl.obolibrary.org/obo/MONDO_0003880) (ceruminous carcinoma), [MONDO:0003881](http://purl.obolibrary.org/obo/MONDO_0003881) (vulvar apocrine adenocarcinoma), [MONDO:0004970](http://purl.obolibrary.org/obo/MONDO_0004970) (adenocarcinoma), [MONDO:0000371](http://purl.obolibrary.org/obo/MONDO_0000371) (oral cavity carcinoma in situ), [MONDO:0000372](http://purl.obolibrary.org/obo/MONDO_0000372) (pharynx carcinoma in situ), [MONDO:0021070](http://purl.obolibrary.org/obo/MONDO_0021070) (sublingual gland carcinoma), [MONDO:0013685](http://purl.obolibrary.org/obo/MONDO_0013685) (pancreatic cancer, susceptibility to, 4), [MONDO:0004988](http://purl.obolibrary.org/obo/MONDO_0004988) (breast adenocarcinoma), [MONDO:0004989](http://purl.obolibrary.org/obo/MONDO_0004989) (breast carcinoma), [MONDO:0004986](http://purl.obolibrary.org/obo/MONDO_0004986) (bladder carcinoma (disease)), [MONDO:0003414](http://purl.obolibrary.org/obo/MONDO_0003414) (skin pilomatrix carcinoma), [MONDO:0004500](http://purl.obolibrary.org/obo/MONDO_0004500) (lung superior sulcus carcinoma), [MONDO:0004984](http://purl.obolibrary.org/obo/MONDO_0004984) (basal-like breast carcinoma), [MONDO:0003651](http://purl.obolibrary.org/obo/MONDO_0003651) (macrotrabecular hepatoblastoma), [MONDO:0003410](http://purl.obolibrary.org/obo/MONDO_0003410) (Wolffian duct adenocarcinoma), [MONDO:0001470](http://purl.obolibrary.org/obo/MONDO_0001470) (anal margin squamous cell carcinoma), [MONDO:0003891](http://purl.obolibrary.org/obo/MONDO_0003891) (bladder signet ring cell adenocarcinoma), [MONDO:0003650](http://purl.obolibrary.org/obo/MONDO_0003650) (mixed hepatoblastoma), [MONDO:0000381](http://purl.obolibrary.org/obo/MONDO_0000381) (infiltrating renal pelvis transitional cell carcinoma), [MONDO:0003892](http://purl.obolibrary.org/obo/MONDO_0003892) (acinar lung adenocarcinoma), [MONDO:0003890](http://purl.obolibrary.org/obo/MONDO_0003890) (infiltrating bladder urothelial carcinoma), [MONDO:0016718](http://purl.obolibrary.org/obo/MONDO_0016718) (choroid plexus carcinoma), [MONDO:0015867](http://purl.obolibrary.org/obo/MONDO_0015867) (vaginal carcinoma), [MONDO:0003629](http://purl.obolibrary.org/obo/MONDO_0003629) (uterine corpus serous adenocarcinoma), [MONDO:0021299](http://purl.obolibrary.org/obo/MONDO_0021299) (carcinoma in situ of extrahepatic bile duct), [MONDO:0003626](http://purl.obolibrary.org/obo/MONDO_0003626) (uterine ligament serous adenocarcinoma), [MONDO:0004715](http://purl.obolibrary.org/obo/MONDO_0004715) (liver carcinoma in situ), [MONDO:0004957](http://purl.obolibrary.org/obo/MONDO_0004957) (mucinous adenocarcinoma), [MONDO:0004716](http://purl.obolibrary.org/obo/MONDO_0004716) (stomach carcinoma in situ), [MONDO:0004958](http://purl.obolibrary.org/obo/MONDO_0004958) (oral squamous cell carcinoma), [MONDO:0003624](http://purl.obolibrary.org/obo/MONDO_0003624) (acinic cell breast carcinoma), [MONDO:0004956](http://purl.obolibrary.org/obo/MONDO_0004956) (metastatic prostate cancer), [MONDO:0003625](http://purl.obolibrary.org/obo/MONDO_0003625) (ovary serous adenocarcinoma), [MONDO:0004953](http://purl.obolibrary.org/obo/MONDO_0004953) (invasive ductal carcinoma), [MONDO:0021292](http://purl.obolibrary.org/obo/MONDO_0021292) (carcinoma in situ of gastric body), [MONDO:0021291](http://purl.obolibrary.org/obo/MONDO_0021291) (carcinoma in situ of fundus of stomach), [MONDO:0004710](http://purl.obolibrary.org/obo/MONDO_0004710) (uterus carcinoma in situ), [MONDO:0021294](http://purl.obolibrary.org/obo/MONDO_0021294) (carcinoma in situ of gastric cardia), [MONDO:0004950](http://purl.obolibrary.org/obo/MONDO_0004950) (gastric carcinoma), [MONDO:0003861](http://purl.obolibrary.org/obo/MONDO_0003861) (vulvar eccrine adenocarcinoma), [MONDO:0021296](http://purl.obolibrary.org/obo/MONDO_0021296) (carcinoma in situ of renal pelvis), [MONDO:0021298](http://purl.obolibrary.org/obo/MONDO_0021298) (carcinoma in situ of oropharynx), [MONDO:0021297](http://purl.obolibrary.org/obo/MONDO_0021297) (carcinoma in situ of nasopharynx), [MONDO:0011014](http://purl.obolibrary.org/obo/MONDO_0011014) (pleuropulmonary blastoma), [MONDO:0021290](http://purl.obolibrary.org/obo/MONDO_0021290) (carcinoma in situ of appendix), [MONDO:0010150](http://purl.obolibrary.org/obo/MONDO_0010150) (head and neck squamous cell carcinoma), [MONDO:0021289](http://purl.obolibrary.org/obo/MONDO_0021289) (carcinoma in situ of cecum), [MONDO:0021288](http://purl.obolibrary.org/obo/MONDO_0021288) (carcinoma in situ of hypopharynx), [MONDO:0003879](http://purl.obolibrary.org/obo/MONDO_0003879) (ovarian endometrioid malignant adenofibroma), [MONDO:0003635](http://purl.obolibrary.org/obo/MONDO_0003635) (sebaceous breast carcinoma), [MONDO:0004724](http://purl.obolibrary.org/obo/MONDO_0004724) (submandibular gland cancer), [MONDO:0004725](http://purl.obolibrary.org/obo/MONDO_0004725) (rectum carcinoma in situ), [MONDO:0003636](http://purl.obolibrary.org/obo/MONDO_0003636) (vulvar sebaceous carcinoma), [MONDO:0003876](http://purl.obolibrary.org/obo/MONDO_0003876) (eyelid carcinoma), [MONDO:0004965](http://purl.obolibrary.org/obo/MONDO_0004965) (acinar cell carcinoma), [MONDO:0003631](http://purl.obolibrary.org/obo/MONDO_0003631) (cervical serous adenocarcinoma), [MONDO:0021280](http://purl.obolibrary.org/obo/MONDO_0021280) (mucoepidermoid carcinoma of parotid gland), [MONDO:0003874](http://purl.obolibrary.org/obo/MONDO_0003874) (ovary papillary carcinoma), [MONDO:0002301](http://purl.obolibrary.org/obo/MONDO_0002301) (frontal sinus squamous cell carcinoma), [MONDO:0003630](http://purl.obolibrary.org/obo/MONDO_0003630) (pancreatic serous cystadenocarcinoma), [MONDO:0021285](http://purl.obolibrary.org/obo/MONDO_0021285) (carcinoma in situ of urethra), [MONDO:0021284](http://purl.obolibrary.org/obo/MONDO_0021284) (carcinoma in situ of ureter), [MONDO:0021287](http://purl.obolibrary.org/obo/MONDO_0021287) (carcinoma in situ of epiglottis), [MONDO:0013669](http://purl.obolibrary.org/obo/MONDO_0013669) (breast-ovarian cancer, familial, susceptibility to, 4), [MONDO:0008082](http://purl.obolibrary.org/obo/MONDO_0008082) (multiple endocrine neoplasia type 2B), [MONDO:0013253](http://purl.obolibrary.org/obo/MONDO_0013253) (breast-ovarian cancer, familial, susceptibility to, 3), [MONDO:0003209](http://purl.obolibrary.org/obo/MONDO_0003209) (thymus adenocarcinoma), [MONDO:0003208](http://purl.obolibrary.org/obo/MONDO_0003208) (breast secretory carcinoma), [MONDO:0005628](http://purl.obolibrary.org/obo/MONDO_0005628) (male breast carcinoma), [MONDO:0002358](http://purl.obolibrary.org/obo/MONDO_0002358) (laryngeal carcinoma), [MONDO:0003205](http://purl.obolibrary.org/obo/MONDO_0003205) (renal pelvis adenocarcinoma), [MONDO:0004537](http://purl.obolibrary.org/obo/MONDO_0004537) (intestinal variant cervical mucinous adenocarcinoma), [MONDO:0004538](http://purl.obolibrary.org/obo/MONDO_0004538) (endocervical type cervical mucinous adenocarcinoma), [MONDO:0003204](http://purl.obolibrary.org/obo/MONDO_0003204) (villous adenocarcinoma), [MONDO:0003207](http://purl.obolibrary.org/obo/MONDO_0003207) (eccrine adenocarcinoma), [MONDO:0004535](http://purl.obolibrary.org/obo/MONDO_0004535) (childhood choriocarcinoma of the ovary), [MONDO:0003200](http://purl.obolibrary.org/obo/MONDO_0003200) (urethra adenocarcinoma), [MONDO:0002113](http://purl.obolibrary.org/obo/MONDO_0002113) (peritoneal carcinoma), [MONDO:0002355](http://purl.obolibrary.org/obo/MONDO_0002355) (glottis carcinoma), [MONDO:0003202](http://purl.obolibrary.org/obo/MONDO_0003202) (pituitary gland basophilic carcinoma), [MONDO:0002592](http://purl.obolibrary.org/obo/MONDO_0002592) (invasive malignant thymoma), [MONDO:0004530](http://purl.obolibrary.org/obo/MONDO_0004530) (early invasive cervical adenocarcinoma), [MONDO:0015423](http://purl.obolibrary.org/obo/MONDO_0015423) (anaplastic thyroid carcinoma (disease)), [MONDO:0003219](http://purl.obolibrary.org/obo/MONDO_0003219) (gastroesophageal junction adenocarcinoma), [MONDO:0003216](http://purl.obolibrary.org/obo/MONDO_0003216) (ureter adenocarcinoma), [MONDO:0002368](http://purl.obolibrary.org/obo/MONDO_0002368) (papillary serous cystadenocarcinoma), [MONDO:0003218](http://purl.obolibrary.org/obo/MONDO_0003218) (adenocarcinoma in situ), [MONDO:0003212](http://purl.obolibrary.org/obo/MONDO_0003212) (nasal cavity carcinoma), [MONDO:0003697](http://purl.obolibrary.org/obo/MONDO_0003697) (non-invasive verrucous carcinoma of the penis), [MONDO:0003211](http://purl.obolibrary.org/obo/MONDO_0003211) (nasal cavity adenocarcinoma), [MONDO:0003698](http://purl.obolibrary.org/obo/MONDO_0003698) (penis verrucous carcinoma), [MONDO:0004542](http://purl.obolibrary.org/obo/MONDO_0004542) (glassy cell variant cervical adenosquamous carcinoma), [MONDO:0003214](http://purl.obolibrary.org/obo/MONDO_0003214) (apocrine adenocarcinoma), [MONDO:0006962](http://purl.obolibrary.org/obo/MONDO_0006962) (sebaceous adenocarcinoma), [MONDO:0003210](http://purl.obolibrary.org/obo/MONDO_0003210) (intrahepatic cholangiocarcinoma), [MONDO:0002120](http://purl.obolibrary.org/obo/MONDO_0002120) (neuroendocrine carcinoma), [MONDO:0013235](http://purl.obolibrary.org/obo/MONDO_0013235) (pancreatic cancer, susceptibility to, 2), [MONDO:0016740](http://purl.obolibrary.org/obo/MONDO_0016740) (choriocarcinoma of the central nervous system), [MONDO:0005606](http://purl.obolibrary.org/obo/MONDO_0005606) (tubular adenocarcinoma), [MONDO:0003666](http://purl.obolibrary.org/obo/MONDO_0003666) (fallopian tube endometrioid adenocarcinoma), [MONDO:0005603](http://purl.obolibrary.org/obo/MONDO_0005603) (pancreatic tubular adenocarcinoma), [MONDO:0003665](http://purl.obolibrary.org/obo/MONDO_0003665) (cervical endometrioid adenocarcinoma), [MONDO:0005601](http://purl.obolibrary.org/obo/MONDO_0005601) (ovarian mucinous adenocarcinoma), [MONDO:0003663](http://purl.obolibrary.org/obo/MONDO_0003663) (uterine ligament endometrioid adenocarcinoma), [MONDO:0004991](http://purl.obolibrary.org/obo/MONDO_0004991) (bronchoalveolar adenocarcinoma), [MONDO:0004990](http://purl.obolibrary.org/obo/MONDO_0004990) (breast tumor luminal A or B), [MONDO:0013236](http://purl.obolibrary.org/obo/MONDO_0013236) (pancreatic cancer, susceptibility to, 3), [MONDO:0021090](http://purl.obolibrary.org/obo/MONDO_0021090) (lipid-rich breast carcinoma), [MONDO:0005617](http://purl.obolibrary.org/obo/MONDO_0005617) (undifferentiated carcinoma), [MONDO:0003437](http://purl.obolibrary.org/obo/MONDO_0003437) (occult small cell lung carcinoma), [MONDO:0005616](http://purl.obolibrary.org/obo/MONDO_0005616) (pulmonary mucoepidermoid carcinoma), [MONDO:0003438](http://purl.obolibrary.org/obo/MONDO_0003438) (combined small cell lung carcinoma), [MONDO:0005858](http://purl.obolibrary.org/obo/MONDO_0005858) (mucinous cystadenocarcinoma), [MONDO:0005613](http://purl.obolibrary.org/obo/MONDO_0005613) (mesonephric adenocarcinoma), [MONDO:0001017](http://purl.obolibrary.org/obo/MONDO_0001017) (epididymis adenocarcinoma), [MONDO:0003436](http://purl.obolibrary.org/obo/MONDO_0003436) (lung oat cell carcinoma), [MONDO:0005614](http://purl.obolibrary.org/obo/MONDO_0005614) (pancreatic adenosquamous carcinoma), [MONDO:0005611](http://purl.obolibrary.org/obo/MONDO_0005611) (bladder transitional cell carcinoma), [MONDO:0004523](http://purl.obolibrary.org/obo/MONDO_0004523) (clear cell squamous cell skin carcinoma), [MONDO:0004520](http://purl.obolibrary.org/obo/MONDO_0004520) (intratubular embryonal carcinoma), [MONDO:0012137](http://purl.obolibrary.org/obo/MONDO_0012137) (Carney complex-trismus-pseudocamptodactyly syndrome), [MONDO:0018503](http://purl.obolibrary.org/obo/MONDO_0018503) (carcinoma of stomach, salivary gland type), [MONDO:0017896](http://purl.obolibrary.org/obo/MONDO_0017896) (familial nonmedullary thyroid carcinoma), [MONDO:0018504](http://purl.obolibrary.org/obo/MONDO_0018504) (undifferentiated carcinoma of stomach), [MONDO:0018501](http://purl.obolibrary.org/obo/MONDO_0018501) (rare carcinoma of stomach), [MONDO:0018502](http://purl.obolibrary.org/obo/MONDO_0018502) (hereditary gastric cancer), [MONDO:0017895](http://purl.obolibrary.org/obo/MONDO_0017895) (familial papillary or follicular thyroid carcinoma), [MONDO:0017890](http://purl.obolibrary.org/obo/MONDO_0017890) (tubulocystic renal cell carcinoma), [MONDO:0003007](http://purl.obolibrary.org/obo/MONDO_0003007) (childhood kidney cell carcinoma), [MONDO:0004337](http://purl.obolibrary.org/obo/MONDO_0004337) (perianal skin Paget's disease), [MONDO:0003008](http://purl.obolibrary.org/obo/MONDO_0003008) (hereditary renal cell carcinoma), [MONDO:0003245](http://purl.obolibrary.org/obo/MONDO_0003245) (aflatoxins-related hepatocellular carcinoma), [MONDO:0004336](http://purl.obolibrary.org/obo/MONDO_0004336) (rectum signet ring adenocarcinoma), [MONDO:0006513](http://purl.obolibrary.org/obo/MONDO_0006513) (estrogen-receptor negative breast cancer), [MONDO:0003486](http://purl.obolibrary.org/obo/MONDO_0003486) (basaloid squamous cell carcinoma), [MONDO:0006512](http://purl.obolibrary.org/obo/MONDO_0006512) (estrogen-receptor positive breast cancer), [MONDO:0003487](http://purl.obolibrary.org/obo/MONDO_0003487) (adenoid squamous cell carcinoma), [MONDO:0003246](http://purl.obolibrary.org/obo/MONDO_0003246) (sclerosing hepatic carcinoma), [MONDO:0004331](http://purl.obolibrary.org/obo/MONDO_0004331) (bladder urachal adenocarcinoma), [MONDO:0003243](http://purl.obolibrary.org/obo/MONDO_0003243) (hepatocellular clear cell carcinoma), [MONDO:0001060](http://purl.obolibrary.org/obo/MONDO_0001060) (microinvasive gastric cancer), [MONDO:0017886](http://purl.obolibrary.org/obo/MONDO_0017886) (MiT family translocation renal cell carcinoma), [MONDO:0017885](http://purl.obolibrary.org/obo/MONDO_0017885) (chromophobe renal cell carcinoma), [MONDO:0017888](http://purl.obolibrary.org/obo/MONDO_0017888) (renal medullary carcinoma), [MONDO:0016314](http://purl.obolibrary.org/obo/MONDO_0016314) (rare carcinoma of pancreas), [MONDO:0017887](http://purl.obolibrary.org/obo/MONDO_0017887) (renal cell carcinoma associated with neuroblastoma), [MONDO:0017884](http://purl.obolibrary.org/obo/MONDO_0017884) (papillary renal cell carcinoma), [MONDO:0005438](http://purl.obolibrary.org/obo/MONDO_0005438) (metastatic malignant neoplasm in the lymph nodes), [MONDO:0003499](http://purl.obolibrary.org/obo/MONDO_0003499) (sarcomatoid squamous cell skin carcinoma), [MONDO:0004346](http://purl.obolibrary.org/obo/MONDO_0004346) (signet ring cell intrahepatic cholangiocarcinoma), [MONDO:0003497](http://purl.obolibrary.org/obo/MONDO_0003497) (renal pelvis squamous cell carcinoma), [MONDO:0002169](http://purl.obolibrary.org/obo/MONDO_0002169) (rectum adenocarcinoma), [MONDO:0004102](http://purl.obolibrary.org/obo/MONDO_0004102) (columnar cell variant papillary carcinoma), [MONDO:0004103](http://purl.obolibrary.org/obo/MONDO_0004103) (tall cell variant thyroid gland papillary carcinoma), [MONDO:0003010](http://purl.obolibrary.org/obo/MONDO_0003010) (multilocular clear cell renal cell carcinoma), [MONDO:0004342](http://purl.obolibrary.org/obo/MONDO_0004342) (osteoclast-like giant cell neoplasm of the pancreas), [MONDO:0004343](http://purl.obolibrary.org/obo/MONDO_0004343) (acinar cell cystadenocarcinoma), [MONDO:0002162](http://purl.obolibrary.org/obo/MONDO_0002162) (fallopian tube adenosarcoma), [MONDO:0004101](http://purl.obolibrary.org/obo/MONDO_0004101) (multicentric papillary thyroid carcinoma), [MONDO:0003012](http://purl.obolibrary.org/obo/MONDO_0003012) (sarcomatoid renal cell carcinoma), [MONDO:0004340](http://purl.obolibrary.org/obo/MONDO_0004340) (mixed ductal-endocrine carcinoma of pancreas), [MONDO:0003493](http://purl.obolibrary.org/obo/MONDO_0003493) (thymus squamous cell carcinoma), [MONDO:0003494](http://purl.obolibrary.org/obo/MONDO_0003494) (ovarian squamous cell carcinoma), [MONDO:0003011](http://purl.obolibrary.org/obo/MONDO_0003011) (mucinous tubular and spindle renal cell carcinoma), [MONDO:0004341](http://purl.obolibrary.org/obo/MONDO_0004341) (colloid carcinoma of the pancreas), [MONDO:0003492](http://purl.obolibrary.org/obo/MONDO_0003492) (lacrimal gland squamous cell carcinoma), [MONDO:0003490](http://purl.obolibrary.org/obo/MONDO_0003490) (ampulla of vater squamous cell carcinoma), [MONDO:0004319](http://purl.obolibrary.org/obo/MONDO_0004319) (hypercalcemic type ovarian small cell carcinoma), [MONDO:0006739](http://purl.obolibrary.org/obo/MONDO_0006739) (ehrlich tumor carcinoma), [MONDO:0004318](http://purl.obolibrary.org/obo/MONDO_0004318) (pulmonary type ovarian small cell carcinoma), [MONDO:0004315](http://purl.obolibrary.org/obo/MONDO_0004315) (cholangiolocellular carcinoma), [MONDO:0004316](http://purl.obolibrary.org/obo/MONDO_0004316) (acantholytic squamous cell skin carcinoma), [MONDO:0004556](http://purl.obolibrary.org/obo/MONDO_0004556) (carcinoma arising in nasal papillomatosis), [MONDO:0004311](http://purl.obolibrary.org/obo/MONDO_0004311) (carcinoma of cowper glands), [MONDO:0006973](http://purl.obolibrary.org/obo/MONDO_0006973) (skin appendage carcinoma), [MONDO:0004552](http://purl.obolibrary.org/obo/MONDO_0004552) (microinvasive cervical squamous cell carcinoma), [MONDO:0003220](http://purl.obolibrary.org/obo/MONDO_0003220) (gallbladder carcinoma), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharyngeal carcinoma), [MONDO:0015442](http://purl.obolibrary.org/obo/MONDO_0015442) (hereditary breast and ovarian cancer syndrome), [MONDO:0006509](http://purl.obolibrary.org/obo/MONDO_0006509) (papillary carcinoma), [MONDO:0004328](http://purl.obolibrary.org/obo/MONDO_0004328) (maxillary sinus adenocarcinoma), [MONDO:0004329](http://purl.obolibrary.org/obo/MONDO_0004329) (pancreatic intraductal papillary-mucinous neoplasm with high grade dysplasia), [MONDO:0004322](http://purl.obolibrary.org/obo/MONDO_0004322) (non-gestational ovarian choriocarcinoma), [MONDO:0005893](http://purl.obolibrary.org/obo/MONDO_0005893) (pancreatic endocrine carcinoma), [MONDO:0004562](http://purl.obolibrary.org/obo/MONDO_0004562) (breast apocrine carcinoma in situ), [MONDO:0004321](http://purl.obolibrary.org/obo/MONDO_0004321) (endometrial mixed adenocarcinoma), [MONDO:0015447](http://purl.obolibrary.org/obo/MONDO_0015447) (differentiated thyroid carcinoma), [MONDO:0015278](http://purl.obolibrary.org/obo/MONDO_0015278) (familial pancreatic carcinoma), [MONDO:0015277](http://purl.obolibrary.org/obo/MONDO_0015277) (medullary thyroid gland carcinoma), [MONDO:0007648](http://purl.obolibrary.org/obo/MONDO_0007648) (hereditary diffuse gastric cancer), [MONDO:0004137](http://purl.obolibrary.org/obo/MONDO_0004137) (hereditary conventional renal cell carcinoma), [MONDO:0003047](http://purl.obolibrary.org/obo/MONDO_0003047) (thymus large cell carcinoma), [MONDO:0004379](http://purl.obolibrary.org/obo/MONDO_0004379) (female breast carcinoma), [MONDO:0003049](http://purl.obolibrary.org/obo/MONDO_0003049) (ovarian large-cell neuroendocrine carcinoma), [MONDO:0005220](http://purl.obolibrary.org/obo/MONDO_0005220) (collecting duct carcinoma), [MONDO:0004131](http://purl.obolibrary.org/obo/MONDO_0004131) (anal Buschke-Lowenstein tumor), [MONDO:0006310](http://purl.obolibrary.org/obo/MONDO_0006310) (mucinuos carcinoma), [MONDO:0005221](http://purl.obolibrary.org/obo/MONDO_0005221) (transitional cell carcinoma of kidney), [MONDO:0004132](http://purl.obolibrary.org/obo/MONDO_0004132) (anal canal squamous cell carcinoma), [MONDO:0004130](http://purl.obolibrary.org/obo/MONDO_0004130) (anus basaloid carcinoma), [MONDO:0005461](http://purl.obolibrary.org/obo/MONDO_0005461) (endometrium adenocarcinoma), [MONDO:0008734](http://purl.obolibrary.org/obo/MONDO_0008734) (adrenocortical carcinoma, hereditary), [MONDO:0004148](http://purl.obolibrary.org/obo/MONDO_0004148) (gallbladder papillary carcinoma), [MONDO:0006327](http://purl.obolibrary.org/obo/MONDO_0006327) (ocular sebaceous carcinoma), [MONDO:0004149](http://purl.obolibrary.org/obo/MONDO_0004149) (gallbladder pleomorphic giant cell adenocarcinoma), [MONDO:0006324](http://purl.obolibrary.org/obo/MONDO_0006324) (normal breast-like subtype of Breast carcinoma), [MONDO:0005233](http://purl.obolibrary.org/obo/MONDO_0005233) (non-small cell lung carcinoma (disease)), [MONDO:0004142](http://purl.obolibrary.org/obo/MONDO_0004142) (lung combined large cell neuroendocrine carcinoma), [MONDO:0005232](http://purl.obolibrary.org/obo/MONDO_0005232) (large cell carcinoma), [MONDO:0003050](http://purl.obolibrary.org/obo/MONDO_0003050) (lung large cell carcinoma), [MONDO:0018525](http://purl.obolibrary.org/obo/MONDO_0018525) (solid pseudopapillary carcinoma of pancreas), [MONDO:0018526](http://purl.obolibrary.org/obo/MONDO_0018526) (serous cystadenocarcinoma of pancreas), [MONDO:0018523](http://purl.obolibrary.org/obo/MONDO_0018523) (pancreatic mucinous cystadenoma), [MONDO:0018521](http://purl.obolibrary.org/obo/MONDO_0018521) (squamous cell carcinoma of pancreas), [MONDO:0004117](http://purl.obolibrary.org/obo/MONDO_0004117) (ampulla of vater small cell carcinoma), [MONDO:0005206](http://purl.obolibrary.org/obo/MONDO_0005206) (renal carcinoma), [MONDO:0005207](http://purl.obolibrary.org/obo/MONDO_0005207) (choriocarcinoma (disease)), [MONDO:0004357](http://purl.obolibrary.org/obo/MONDO_0004357) (carcinoma of supraglottis), [MONDO:0004115](http://purl.obolibrary.org/obo/MONDO_0004115) (gallbladder small cell carcinoma), [MONDO:0010804](http://purl.obolibrary.org/obo/MONDO_0010804) (BRCATA), [MONDO:0004116](http://purl.obolibrary.org/obo/MONDO_0004116) (esophagus small cell carcinoma), [MONDO:0004358](http://purl.obolibrary.org/obo/MONDO_0004358) (subglottis carcinoma), [MONDO:0004114](http://purl.obolibrary.org/obo/MONDO_0004114) (urinary bladder small cell neuroendocrine carcinoma), [MONDO:0005440](http://purl.obolibrary.org/obo/MONDO_0005440) (embryonal carcinoma), [MONDO:0003264](http://purl.obolibrary.org/obo/MONDO_0003264) (basosquamous carcinoma), [MONDO:0018527](http://purl.obolibrary.org/obo/MONDO_0018527) (osteoclastic giant cell tumor of pancreas), [MONDO:0018515](http://purl.obolibrary.org/obo/MONDO_0018515) (squamous cell carcinoma of rectum), [MONDO:0018513](http://purl.obolibrary.org/obo/MONDO_0018513) (squamous cell carcinoma of colon), [MONDO:0006309](http://purl.obolibrary.org/obo/MONDO_0006309) (mucinous gastric adenocarcinoma), [MONDO:0004128](http://purl.obolibrary.org/obo/MONDO_0004128) (lung occult large cell carcinoma), [MONDO:0004129](http://purl.obolibrary.org/obo/MONDO_0004129) (cloacogenic carcinoma), [MONDO:0006306](http://purl.obolibrary.org/obo/MONDO_0006306) (mixed lobular and ductal breast carcinoma), [MONDO:0005215](http://purl.obolibrary.org/obo/MONDO_0005215) (vulvar carcinoma), [MONDO:0003036](http://purl.obolibrary.org/obo/MONDO_0003036) (mucoepidermoid carcinoma), [MONDO:0005216](http://purl.obolibrary.org/obo/MONDO_0005216) (hypopharyngeal carcinoma), [MONDO:0006304](http://purl.obolibrary.org/obo/MONDO_0006304) (minor salivary gland adenocarcinoma), [MONDO:0004127](http://purl.obolibrary.org/obo/MONDO_0004127) (lung occult adenocarcinoma), [MONDO:0006303](http://purl.obolibrary.org/obo/MONDO_0006303) (middle ear squamous cell carcinoma), [MONDO:0005213](http://purl.obolibrary.org/obo/MONDO_0005213) (uterine carcinoma), [MONDO:0006302](http://purl.obolibrary.org/obo/MONDO_0006302) (micropapillary serous carcinoma), [MONDO:0005211](http://purl.obolibrary.org/obo/MONDO_0005211) (ovarian serous adenocarcinoma), [MONDO:0004122](http://purl.obolibrary.org/obo/MONDO_0004122) (thymus small cell carcinoma), [MONDO:0004120](http://purl.obolibrary.org/obo/MONDO_0004120) (Bartholin's gland small cell carcinoma), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0035166](http://purl.obolibrary.org/obo/GO_0035166) (post-embryonic hemopoiesis), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:1901222](http://purl.obolibrary.org/obo/GO_1901222) (regulation of NIK/NF-kappaB signaling), [GO:0048485](http://purl.obolibrary.org/obo/GO_0048485) (sympathetic nervous system development), [GO:0048484](http://purl.obolibrary.org/obo/GO_0048484) (enteric nervous system development), [GO:0050796](http://purl.obolibrary.org/obo/GO_0050796) (regulation of insulin secretion), [GO:0005747](http://purl.obolibrary.org/obo/GO_0005747) (mitochondrial respiratory chain complex I), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0005746](http://purl.obolibrary.org/obo/GO_0005746) (mitochondrial respiratory chain), [GO:0071253](http://purl.obolibrary.org/obo/GO_0071253) (connexin binding), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:0016891](http://purl.obolibrary.org/obo/GO_0016891) (endoribonuclease activity, producing 5'-phosphomonoesters), [GO:0071257](http://purl.obolibrary.org/obo/GO_0071257) (cellular response to electrical stimulus), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0060113](http://purl.obolibrary.org/obo/GO_0060113) (inner ear receptor cell differentiation), [GO:0048009](http://purl.obolibrary.org/obo/GO_0048009) (insulin-like growth factor receptor signaling pathway), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0048012](http://purl.obolibrary.org/obo/GO_0048012) (hepatocyte growth factor receptor signaling pathway), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0072576](http://purl.obolibrary.org/obo/GO_0072576) (liver morphogenesis), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0005759](http://purl.obolibrary.org/obo/GO_0005759) (mitochondrial matrix), [GO:0006606](http://purl.obolibrary.org/obo/GO_0006606) (protein import into nucleus), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0006607](http://purl.obolibrary.org/obo/GO_0006607) (NLS-bearing protein import into nucleus), [GO:0035148](http://purl.obolibrary.org/obo/GO_0035148) (tube formation), [GO:0035143](http://purl.obolibrary.org/obo/GO_0035143) (caudal fin morphogenesis), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0042711](http://purl.obolibrary.org/obo/GO_0042711) (maternal behavior), [GO:0000045](http://purl.obolibrary.org/obo/GO_0000045) (autophagosome assembly), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:2000134](http://purl.obolibrary.org/obo/GO_2000134) (negative regulation of G1/S transition of mitotic cell cycle), [GO:0019900](http://purl.obolibrary.org/obo/GO_0019900) (kinase binding), [GO:0060134](http://purl.obolibrary.org/obo/GO_0060134) (prepulse inhibition), [GO:0036462](http://purl.obolibrary.org/obo/GO_0036462) (TRAIL-activated apoptotic signaling pathway), [GO:0005743](http://purl.obolibrary.org/obo/GO_0005743) (mitochondrial inner membrane), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0072593](http://purl.obolibrary.org/obo/GO_0072593) (reactive oxygen species metabolic process), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0072114](http://purl.obolibrary.org/obo/GO_0072114) (pronephros morphogenesis), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0006644](http://purl.obolibrary.org/obo/GO_0006644) (phospholipid metabolic process), [GO:0008821](http://purl.obolibrary.org/obo/GO_0008821) (crossover junction endodeoxyribonuclease activity), [GO:0005797](http://purl.obolibrary.org/obo/GO_0005797) (Golgi medial cisterna), [GO:0032922](http://purl.obolibrary.org/obo/GO_0032922) (circadian regulation of gene expression), [GO:0070365](http://purl.obolibrary.org/obo/GO_0070365) (hepatocyte differentiation), [GO:0051602](http://purl.obolibrary.org/obo/GO_0051602) (response to electrical stimulus), [GO:0051603](http://purl.obolibrary.org/obo/GO_0051603) (proteolysis involved in cellular protein catabolic process), [GO:0035195](http://purl.obolibrary.org/obo/GO_0035195) (gene silencing by miRNA), [GO:0035196](http://purl.obolibrary.org/obo/GO_0035196) (production of miRNAs involved in gene silencing by miRNA), [GO:0061408](http://purl.obolibrary.org/obo/GO_0061408) (positive regulation of transcription from RNA polymerase II promoter in response to heat stress), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0071681](http://purl.obolibrary.org/obo/GO_0071681) (cellular response to indole-3-methanol), [GO:0003139](http://purl.obolibrary.org/obo/GO_0003139) (secondary heart field specification), [GO:0016442](http://purl.obolibrary.org/obo/GO_0016442) (RISC complex), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:0050765](http://purl.obolibrary.org/obo/GO_0050765) (negative regulation of phagocytosis), [GO:0061430](http://purl.obolibrary.org/obo/GO_0061430) (bone trabecula morphogenesis), [GO:0036035](http://purl.obolibrary.org/obo/GO_0036035) (osteoclast development), [GO:0035189](http://purl.obolibrary.org/obo/GO_0035189) (Rb-E2F complex), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:1902533](http://purl.obolibrary.org/obo/GO_1902533) (positive regulation of intracellular signal transduction), [GO:0006622](http://purl.obolibrary.org/obo/GO_0006622) (protein targeting to lysosome), [GO:0005774](http://purl.obolibrary.org/obo/GO_0005774) (vacuolar membrane), [GO:0006623](http://purl.obolibrary.org/obo/GO_0006623) (protein targeting to vacuole), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0061436](http://purl.obolibrary.org/obo/GO_0061436) (establishment of skin barrier), [GO:0004438](http://purl.obolibrary.org/obo/GO_0004438) (phosphatidylinositol-3-phosphatase activity), [GO:0050771](http://purl.obolibrary.org/obo/GO_0050771) (negative regulation of axonogenesis), [GO:0005769](http://purl.obolibrary.org/obo/GO_0005769) (early endosome), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0000086](http://purl.obolibrary.org/obo/GO_0000086) (G2/M transition of mitotic cell cycle), [GO:1904707](http://purl.obolibrary.org/obo/GO_1904707) (positive regulation of vascular smooth muscle cell proliferation), [GO:0050770](http://purl.obolibrary.org/obo/GO_0050770) (regulation of axonogenesis), [GO:2001028](http://purl.obolibrary.org/obo/GO_2001028) (positive regulation of endothelial cell chemotaxis), [GO:0050775](http://purl.obolibrary.org/obo/GO_0050775) (positive regulation of dendrite morphogenesis), [GO:0035176](http://purl.obolibrary.org/obo/GO_0035176) (social behavior), [GO:0060575](http://purl.obolibrary.org/obo/GO_0060575) (intestinal epithelial cell differentiation), [GO:0061428](http://purl.obolibrary.org/obo/GO_0061428) (negative regulation of transcription from RNA polymerase II promoter in response to hypoxia), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0002275](http://purl.obolibrary.org/obo/GO_0002275) (myeloid cell activation involved in immune response), [GO:0006633](http://purl.obolibrary.org/obo/GO_0006633) (fatty acid biosynthetic process), [GO:1901216](http://purl.obolibrary.org/obo/GO_1901216) (positive regulation of neuron death), [GO:0006631](http://purl.obolibrary.org/obo/GO_0006631) (fatty acid metabolic process), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0004446](http://purl.obolibrary.org/obo/GO_0004446) (inositol-hexakisphosphate phosphatase activity), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0048478](http://purl.obolibrary.org/obo/GO_0048478) (replication fork protection), [GO:0048477](http://purl.obolibrary.org/obo/GO_0048477) (oogenesis), [GO:0070373](http://purl.obolibrary.org/obo/GO_0070373) (negative regulation of ERK1 and ERK2 cascade), [GO:0048476](http://purl.obolibrary.org/obo/GO_0048476) (Holliday junction resolvase complex), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0003170](http://purl.obolibrary.org/obo/GO_0003170) (heart valve development), [GO:0042770](http://purl.obolibrary.org/obo/GO_0042770) (signal transduction in response to DNA damage), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0007530](http://purl.obolibrary.org/obo/GO_0007530) (sex determination), [GO:0007535](http://purl.obolibrary.org/obo/GO_0007535) (donor selection), [GO:0032968](http://purl.obolibrary.org/obo/GO_0032968) (positive regulation of transcription elongation from RNA polymerase II promoter), [GO:0030307](http://purl.obolibrary.org/obo/GO_0030307) (positive regulation of cell growth), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0030308](http://purl.obolibrary.org/obo/GO_0030308) (negative regulation of cell growth), [GO:0097009](http://purl.obolibrary.org/obo/GO_0097009) (energy homeostasis), [GO:0009725](http://purl.obolibrary.org/obo/GO_0009725) (response to hormone), [GO:0006699](http://purl.obolibrary.org/obo/GO_0006699) (bile acid biosynthetic process), [GO:0042787](http://purl.obolibrary.org/obo/GO_0042787) (protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0072181](http://purl.obolibrary.org/obo/GO_0072181) (mesonephric duct formation), [GO:0072176](http://purl.obolibrary.org/obo/GO_0072176) (nephric duct development), [GO:0097011](http://purl.obolibrary.org/obo/GO_0097011) (cellular response to granulocyte macrophage colony-stimulating factor stimulus), [GO:0072175](http://purl.obolibrary.org/obo/GO_0072175) (epithelial tube formation), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0072179](http://purl.obolibrary.org/obo/GO_0072179) (nephric duct formation), [GO:0010705](http://purl.obolibrary.org/obo/GO_0010705) (meiotic DNA double-strand break processing involved in reciprocal meiotic recombination), [GO:0072177](http://purl.obolibrary.org/obo/GO_0072177) (mesonephric duct development), [GO:1902178](http://purl.obolibrary.org/obo/GO_1902178) (fibroblast growth factor receptor apoptotic signaling pathway), [GO:0004003](http://purl.obolibrary.org/obo/GO_0004003) (ATP-dependent DNA helicase activity), [GO:0003157](http://purl.obolibrary.org/obo/GO_0003157) (endocardium development), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0032947](http://purl.obolibrary.org/obo/GO_0032947) (protein complex scaffold activity), [GO:1990269](http://purl.obolibrary.org/obo/GO_1990269) (RNA polymerase II C-terminal domain phosphoserine binding), [GO:0031619](http://purl.obolibrary.org/obo/GO_0031619) (homologous chromosome orientation involved in meiotic metaphase I plate congression), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0098797](http://purl.obolibrary.org/obo/GO_0098797) (plasma membrane protein complex), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0016479](http://purl.obolibrary.org/obo/GO_0016479) (negative regulation of transcription by RNA polymerase I), [GO:0045839](http://purl.obolibrary.org/obo/GO_0045839) (negative regulation of mitotic nuclear division), [GO:0016459](http://purl.obolibrary.org/obo/GO_0016459) (myosin complex), [GO:0036064](http://purl.obolibrary.org/obo/GO_0036064) (ciliary basal body), [GO:1902188](http://purl.obolibrary.org/obo/GO_1902188) (positive regulation of viral release from host cell), [GO:0042326](http://purl.obolibrary.org/obo/GO_0042326) (negative regulation of phosphorylation), [GO:0007517](http://purl.obolibrary.org/obo/GO_0007517) (muscle organ development), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0007519](http://purl.obolibrary.org/obo/GO_0007519) (skeletal muscle tissue development), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0061073](http://purl.obolibrary.org/obo/GO_0061073) (ciliary body morphogenesis), [GO:0085020](http://purl.obolibrary.org/obo/GO_0085020) (protein K6-linked ubiquitination), [GO:0021879](http://purl.obolibrary.org/obo/GO_0021879) (forebrain neuron differentiation), [GO:0021877](http://purl.obolibrary.org/obo/GO_0021877) (forebrain neuron fate commitment), [GO:0061017](http://purl.obolibrary.org/obo/GO_0061017) (hepatoblast differentiation), [GO:0009749](http://purl.obolibrary.org/obo/GO_0009749) (response to glucose), [GO:0048048](http://purl.obolibrary.org/obo/GO_0048048) (embryonic eye morphogenesis), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0072148](http://purl.obolibrary.org/obo/GO_0072148) (epithelial cell fate commitment), [GO:0048041](http://purl.obolibrary.org/obo/GO_0048041) (focal adhesion assembly), [GO:0061002](http://purl.obolibrary.org/obo/GO_0061002) (negative regulation of dendritic spine morphogenesis), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0000940](http://purl.obolibrary.org/obo/GO_0000940) (condensed chromosome outer kinetochore), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0061008](http://purl.obolibrary.org/obo/GO_0061008) (hepaticobiliary system development), [GO:0010748](http://purl.obolibrary.org/obo/GO_0010748) (negative regulation of plasma membrane long-chain fatty acid transport), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0030331](http://purl.obolibrary.org/obo/GO_0030331) (estrogen receptor binding), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0031667](http://purl.obolibrary.org/obo/GO_0031667) (response to nutrient levels), [GO:0030336](http://purl.obolibrary.org/obo/GO_0030336) (negative regulation of cell migration), [GO:0016049](http://purl.obolibrary.org/obo/GO_0016049) (cell growth), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0061031](http://purl.obolibrary.org/obo/GO_0061031) (endodermal digestive tract morphogenesis), [GO:0000910](http://purl.obolibrary.org/obo/GO_0000910) (cytokinesis), [GO:0021854](http://purl.obolibrary.org/obo/GO_0021854) (hypothalamus development), [GO:1903468](http://purl.obolibrary.org/obo/GO_1903468) (positive regulation of DNA replication initiation), [GO:0042753](http://purl.obolibrary.org/obo/GO_0042753) (positive regulation of circadian rhythm), [GO:0031659](http://purl.obolibrary.org/obo/GO_0031659) (positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0010718](http://purl.obolibrary.org/obo/GO_0010718) (positive regulation of epithelial to mesenchymal transition), [GO:0048066](http://purl.obolibrary.org/obo/GO_0048066) (developmental pigmentation), [GO:0030326](http://purl.obolibrary.org/obo/GO_0030326) (embryonic limb morphogenesis), [GO:0072164](http://purl.obolibrary.org/obo/GO_0072164) (mesonephric tubule development), [GO:0051222](http://purl.obolibrary.org/obo/GO_0051222) (positive regulation of protein transport), [GO:0010719](http://purl.obolibrary.org/obo/GO_0010719) (negative regulation of epithelial to mesenchymal transition), [GO:0031658](http://purl.obolibrary.org/obo/GO_0031658) (negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle), [GO:0048069](http://purl.obolibrary.org/obo/GO_0048069) (eye pigmentation), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0032982](http://purl.obolibrary.org/obo/GO_0032982) (myosin filament), [GO:0010712](http://purl.obolibrary.org/obo/GO_0010712) (regulation of collagen metabolic process), [GO:0032981](http://purl.obolibrary.org/obo/GO_0032981) (mitochondrial respiratory chain complex I assembly), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0060179](http://purl.obolibrary.org/obo/GO_0060179) (male mating behavior), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:1901299](http://purl.obolibrary.org/obo/GO_1901299) (negative regulation of hydrogen peroxide-mediated programmed cell death), [GO:0007568](http://purl.obolibrary.org/obo/GO_0007568) (aging), [GO:0007569](http://purl.obolibrary.org/obo/GO_0007569) (cell aging), [GO:0031648](http://purl.obolibrary.org/obo/GO_0031648) (protein destabilization), [GO:0030315](http://purl.obolibrary.org/obo/GO_0030315) (T-tubule), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0030317](http://purl.obolibrary.org/obo/GO_0030317) (flagellated sperm motility), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0031641](http://purl.obolibrary.org/obo/GO_0031641) (regulation of myelination), [GO:0031642](http://purl.obolibrary.org/obo/GO_0031642) (negative regulation of myelination), [GO:1901291](http://purl.obolibrary.org/obo/GO_1901291) (negative regulation of double-strand break repair via single-strand annealing), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0008340](http://purl.obolibrary.org/obo/GO_0008340) (determination of adult lifespan), [GO:0021797](http://purl.obolibrary.org/obo/GO_0021797) (forebrain anterior/posterior pattern specification), [GO:0007498](http://purl.obolibrary.org/obo/GO_0007498) (mesoderm development), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0045765](http://purl.obolibrary.org/obo/GO_0045765) (regulation of angiogenesis), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0043588](http://purl.obolibrary.org/obo/GO_0043588) (skin development), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0021795](http://purl.obolibrary.org/obo/GO_0021795) (cerebral cortex cell migration), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001702](http://purl.obolibrary.org/obo/GO_0001702) (gastrulation with mouth forming second), [GO:0019003](http://purl.obolibrary.org/obo/GO_0019003) (GDP binding), [GO:0019002](http://purl.obolibrary.org/obo/GO_0019002) (GMP binding), [GO:0001706](http://purl.obolibrary.org/obo/GO_0001706) (endoderm formation), [GO:0031116](http://purl.obolibrary.org/obo/GO_0031116) (positive regulation of microtubule polymerization), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0046628](http://purl.obolibrary.org/obo/GO_0046628) (positive regulation of insulin receptor signaling pathway), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0090344](http://purl.obolibrary.org/obo/GO_0090344) (negative regulation of cell aging), [GO:0046622](http://purl.obolibrary.org/obo/GO_0046622) (positive regulation of organ growth), [GO:0007026](http://purl.obolibrary.org/obo/GO_0007026) (negative regulation of microtubule depolymerization), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0009202](http://purl.obolibrary.org/obo/GO_0009202) (deoxyribonucleoside triphosphate biosynthetic process), [GO:0046621](http://purl.obolibrary.org/obo/GO_0046621) (negative regulation of organ growth), [GO:0008354](http://purl.obolibrary.org/obo/GO_0008354) (germ cell migration), [GO:0021782](http://purl.obolibrary.org/obo/GO_0021782) (glial cell development), [GO:0001711](http://purl.obolibrary.org/obo/GO_0001711) (endodermal cell fate commitment), [GO:0001714](http://purl.obolibrary.org/obo/GO_0001714) (endodermal cell fate specification), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0010666](http://purl.obolibrary.org/obo/GO_0010666) (positive regulation of cardiac muscle cell apoptotic process), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0031103](http://purl.obolibrary.org/obo/GO_0031103) (axon regeneration), [GO:0034613](http://purl.obolibrary.org/obo/GO_0034613) (cellular protein localization), [GO:0034612](http://purl.obolibrary.org/obo/GO_0034612) (response to tumor necrosis factor), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0009653](http://purl.obolibrary.org/obo/GO_0009653) (anatomical structure morphogenesis), [GO:0045785](http://purl.obolibrary.org/obo/GO_0045785) (positive regulation of cell adhesion), [GO:0043124](http://purl.obolibrary.org/obo/GO_0043124) (negative regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0045793](http://purl.obolibrary.org/obo/GO_0045793) (positive regulation of cell size), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0045792](http://purl.obolibrary.org/obo/GO_0045792) (negative regulation of cell size), [GO:0030242](http://purl.obolibrary.org/obo/GO_0030242) (autophagy of peroxisome), [GO:0010632](http://purl.obolibrary.org/obo/GO_0010632) (regulation of epithelial cell migration), [GO:0010634](http://purl.obolibrary.org/obo/GO_0010634) (positive regulation of epithelial cell migration), [GO:0031578](http://purl.obolibrary.org/obo/GO_0031578) (mitotic spindle orientation checkpoint), [GO:0032423](http://purl.obolibrary.org/obo/GO_0032423) (regulation of mismatch repair), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0007004](http://purl.obolibrary.org/obo/GO_0007004) (telomere maintenance via telomerase), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0021766](http://purl.obolibrary.org/obo/GO_0021766) (hippocampus development), [GO:0008333](http://purl.obolibrary.org/obo/GO_0008333) (endosome to lysosome transport), [GO:0021762](http://purl.obolibrary.org/obo/GO_0021762) (substantia nigra development), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0030239](http://purl.obolibrary.org/obo/GO_0030239) (myofibril assembly), [GO:0055113](http://purl.obolibrary.org/obo/GO_0055113) (epiboly involved in gastrulation with mouth forming second), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0035924](http://purl.obolibrary.org/obo/GO_0035924) (cellular response to vascular endothelial growth factor stimulus), [GO:0030235](http://purl.obolibrary.org/obo/GO_0030235) (nitric-oxide synthase regulator activity), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0007051](http://purl.obolibrary.org/obo/GO_0007051) (spindle organization), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0034672](http://purl.obolibrary.org/obo/GO_0034672) (anterior/posterior pattern specification involved in pronephros development), [GO:0042693](http://purl.obolibrary.org/obo/GO_0042693) (muscle cell fate commitment), [GO:0007059](http://purl.obolibrary.org/obo/GO_0007059) (chromosome segregation), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0042696](http://purl.obolibrary.org/obo/GO_0042696) (menarche), [GO:0045725](http://purl.obolibrary.org/obo/GO_0045725) (positive regulation of glycogen biosynthetic process), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0001743](http://purl.obolibrary.org/obo/GO_0001743) (optic placode formation), [GO:0015908](http://purl.obolibrary.org/obo/GO_0015908) (fatty acid transport), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0033334](http://purl.obolibrary.org/obo/GO_0033334) (fin morphogenesis), [GO:0033333](http://purl.obolibrary.org/obo/GO_0033333) (fin development), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:1902072](http://purl.obolibrary.org/obo/GO_1902072) (negative regulation of hypoxia-inducible factor-1alpha signaling pathway), [GO:0010212](http://purl.obolibrary.org/obo/GO_0010212) (response to ionizing radiation), [GO:0045739](http://purl.obolibrary.org/obo/GO_0045739) (positive regulation of DNA repair), [GO:0045737](http://purl.obolibrary.org/obo/GO_0045737) (positive regulation of cyclin-dependent protein serine/threonine kinase activity), [GO:1905594](http://purl.obolibrary.org/obo/GO_1905594) (resveratrol binding), [GO:0090303](http://purl.obolibrary.org/obo/GO_0090303) (positive regulation of wound healing), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0045732](http://purl.obolibrary.org/obo/GO_0045732) (positive regulation of protein catabolic process), [GO:0000422](http://purl.obolibrary.org/obo/GO_0000422) (autophagy of mitochondrion), [GO:0001754](http://purl.obolibrary.org/obo/GO_0001754) (eye photoreceptor cell differentiation), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0001756](http://purl.obolibrary.org/obo/GO_0001756) (somitogenesis), [GO:0001757](http://purl.obolibrary.org/obo/GO_0001757) (somite specification), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0010225](http://purl.obolibrary.org/obo/GO_0010225) (response to UV-C), [GO:0032474](http://purl.obolibrary.org/obo/GO_0032474) (otolith morphogenesis), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0008360](http://purl.obolibrary.org/obo/GO_0008360) (regulation of cell shape), [GO:0030295](http://purl.obolibrary.org/obo/GO_0030295) (protein kinase activator activity), [GO:0007030](http://purl.obolibrary.org/obo/GO_0007030) (Golgi organization), [GO:0045742](http://purl.obolibrary.org/obo/GO_0045742) (positive regulation of epidermal growth factor receptor signaling pathway), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0045740](http://purl.obolibrary.org/obo/GO_0045740) (positive regulation of DNA replication), [GO:0007034](http://purl.obolibrary.org/obo/GO_0007034) (vacuolar transport), [GO:2000617](http://purl.obolibrary.org/obo/GO_2000617) (positive regulation of histone H3-K9 acetylation), [GO:0043570](http://purl.obolibrary.org/obo/GO_0043570) (maintenance of DNA repeat elements), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0031134](http://purl.obolibrary.org/obo/GO_0031134) (sister chromatid biorientation), [GO:0001726](http://purl.obolibrary.org/obo/GO_0001726) (ruffle), [GO:0032465](http://purl.obolibrary.org/obo/GO_0032465) (regulation of cytokinesis), [GO:0032463](http://purl.obolibrary.org/obo/GO_0032463) (negative regulation of protein homooligomerization), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:0035970](http://purl.obolibrary.org/obo/GO_0035970) (peptidyl-threonine dephosphorylation), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0030284](http://purl.obolibrary.org/obo/GO_0030284) (estrogen receptor activity), [GO:0000407](http://purl.obolibrary.org/obo/GO_0000407) (phagophore assembly site), [GO:0043576](http://purl.obolibrary.org/obo/GO_0043576) (regulation of respiratory gaseous exchange), [GO:0000400](http://purl.obolibrary.org/obo/GO_0000400) (four-way junction DNA binding), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:1990239](http://purl.obolibrary.org/obo/GO_1990239) (steroid hormone binding), [GO:0030275](http://purl.obolibrary.org/obo/GO_0030275) (LRR domain binding), [GO:2000620](http://purl.obolibrary.org/obo/GO_2000620) (positive regulation of histone H4-K16 acetylation), [GO:0031124](http://purl.obolibrary.org/obo/GO_0031124) (mRNA 3'-end processing), [GO:0031122](http://purl.obolibrary.org/obo/GO_0031122) (cytoplasmic microtubule organization), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0031128](http://purl.obolibrary.org/obo/GO_0031128) (developmental induction), [GO:0007094](http://purl.obolibrary.org/obo/GO_0007094) (mitotic spindle assembly checkpoint), [GO:0007093](http://purl.obolibrary.org/obo/GO_0007093) (mitotic cell cycle checkpoint), [GO:0007098](http://purl.obolibrary.org/obo/GO_0007098) (centrosome cycle), [GO:0048877](http://purl.obolibrary.org/obo/GO_0048877) (homeostasis of number of retina cells), [GO:0060527](http://purl.obolibrary.org/obo/GO_0060527) (prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis), [GO:0060523](http://purl.obolibrary.org/obo/GO_0060523) (prostate epithelial cord elongation), [GO:0001784](http://purl.obolibrary.org/obo/GO_0001784) (phosphotyrosine residue binding), [GO:0043195](http://purl.obolibrary.org/obo/GO_0043195) (terminal bouton), [GO:0043197](http://purl.obolibrary.org/obo/GO_0043197) (dendritic spine), [GO:0050715](http://purl.obolibrary.org/obo/GO_0050715) (positive regulation of cytokine secretion), [GO:0007091](http://purl.obolibrary.org/obo/GO_0007091) (metaphase/anaphase transition of mitotic cell cycle), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:2000630](http://purl.obolibrary.org/obo/GO_2000630) (positive regulation of miRNA metabolic process), [GO:0060993](http://purl.obolibrary.org/obo/GO_0060993) (kidney morphogenesis), [GO:0060510](http://purl.obolibrary.org/obo/GO_0060510) (Type II pneumocyte differentiation), [GO:0060997](http://purl.obolibrary.org/obo/GO_0060997) (dendritic spine morphogenesis), [GO:0048406](http://purl.obolibrary.org/obo/GO_0048406) (nerve growth factor binding), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:2000641](http://purl.obolibrary.org/obo/GO_2000641) (regulation of early endosome to late endosome transport), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0090394](http://purl.obolibrary.org/obo/GO_0090394) (negative regulation of excitatory postsynaptic potential), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0072520](http://purl.obolibrary.org/obo/GO_0072520) (seminiferous tubule development), [GO:2000653](http://purl.obolibrary.org/obo/GO_2000653) (regulation of genetic imprinting), [GO:0071678](http://purl.obolibrary.org/obo/GO_0071678) (olfactory bulb axon guidance), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0071679](http://purl.obolibrary.org/obo/GO_0071679) (commissural neuron axon guidance), [GO:0031174](http://purl.obolibrary.org/obo/GO_0031174) (lifelong otolith mineralization), [GO:0031175](http://purl.obolibrary.org/obo/GO_0031175) (neuron projection development), [GO:1901653](http://purl.obolibrary.org/obo/GO_1901653) (cellular response to peptide), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:1903827](http://purl.obolibrary.org/obo/GO_1903827) (regulation of cellular protein localization), [GO:0019051](http://purl.obolibrary.org/obo/GO_0019051) (induction by virus of host apoptotic process), [GO:0003954](http://purl.obolibrary.org/obo/GO_0003954) (NADH dehydrogenase activity), [GO:0001779](http://purl.obolibrary.org/obo/GO_0001779) (natural killer cell differentiation), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0032094](http://purl.obolibrary.org/obo/GO_0032094) (response to food), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0045324](http://purl.obolibrary.org/obo/GO_0045324) (late endosome to vacuole transport), [GO:0043149](http://purl.obolibrary.org/obo/GO_0043149) (stress fiber assembly), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0048840](http://purl.obolibrary.org/obo/GO_0048840) (otolith development), [GO:0043154](http://purl.obolibrary.org/obo/GO_0043154) (negative regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0055123](http://purl.obolibrary.org/obo/GO_0055123) (digestive system development), [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis), [GO:0034260](http://purl.obolibrary.org/obo/GO_0034260) (negative regulation of GTPase activity), [GO:0060956](http://purl.obolibrary.org/obo/GO_0060956) (endocardial cell differentiation), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0048846](http://purl.obolibrary.org/obo/GO_0048846) (axon extension involved in axon guidance), [GO:1900745](http://purl.obolibrary.org/obo/GO_1900745) (positive regulation of p38MAPK cascade), [GO:0043161](http://purl.obolibrary.org/obo/GO_0043161) (proteasome-mediated ubiquitin-dependent protein catabolic process), [GO:1902915](http://purl.obolibrary.org/obo/GO_1902915) (negative regulation of protein polyubiquitination), [GO:0043162](http://purl.obolibrary.org/obo/GO_0043162) (ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway), [GO:0032079](http://purl.obolibrary.org/obo/GO_0032079) (positive regulation of endodeoxyribonuclease activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0043169](http://purl.obolibrary.org/obo/GO_0043169) (cation binding), [GO:0048853](http://purl.obolibrary.org/obo/GO_0048853) (forebrain morphogenesis), [GO:0003993](http://purl.obolibrary.org/obo/GO_0003993) (acid phosphatase activity), [GO:2000219](http://purl.obolibrary.org/obo/GO_2000219) (positive regulation of invasive growth in response to glucose limitation), [GO:0048863](http://purl.obolibrary.org/obo/GO_0048863) (stem cell differentiation), [GO:0046685](http://purl.obolibrary.org/obo/GO_0046685) (response to arsenic-containing substance), [GO:0070307](http://purl.obolibrary.org/obo/GO_0070307) (lens fiber cell development), [GO:0071635](http://purl.obolibrary.org/obo/GO_0071635) (negative regulation of transforming growth factor beta production), [GO:0034244](http://purl.obolibrary.org/obo/GO_0034244) (negative regulation of transcription elongation from RNA polymerase II promoter), [GO:0034243](http://purl.obolibrary.org/obo/GO_0034243) (regulation of transcription elongation from RNA polymerase II promoter), [GO:0016817](http://purl.obolibrary.org/obo/GO_0016817) (hydrolase activity, acting on acid anhydrides), [GO:0016818](http://purl.obolibrary.org/obo/GO_0016818) (hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides), [GO:0044029](http://purl.obolibrary.org/obo/GO_0044029) (hypomethylation of CpG island), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0044030](http://purl.obolibrary.org/obo/GO_0044030) (regulation of DNA methylation), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:2000221](http://purl.obolibrary.org/obo/GO_2000221) (negative regulation of pseudohyphal growth), [GO:0035565](http://purl.obolibrary.org/obo/GO_0035565) (regulation of pronephros size), [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0071380](http://purl.obolibrary.org/obo/GO_0071380) (cellular response to prostaglandin E stimulus), [GO:0005874](http://purl.obolibrary.org/obo/GO_0005874) (microtubule), [GO:0003697](http://purl.obolibrary.org/obo/GO_0003697) (single-stranded DNA binding), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0003688](http://purl.obolibrary.org/obo/GO_0003688) (DNA replication origin binding), [GO:0071375](http://purl.obolibrary.org/obo/GO_0071375) (cellular response to peptide hormone stimulus), [GO:0036126](http://purl.obolibrary.org/obo/GO_0036126) (sperm flagellum), [GO:0035279](http://purl.obolibrary.org/obo/GO_0035279) (mRNA cleavage involved in gene silencing by miRNA), [GO:1903774](http://purl.obolibrary.org/obo/GO_1903774) (positive regulation of viral budding via host ESCRT complex), [GO:0036120](http://purl.obolibrary.org/obo/GO_0036120) (cellular response to platelet-derived growth factor stimulus), [GO:1903772](http://purl.obolibrary.org/obo/GO_1903772) (regulation of viral budding via host ESCRT complex), [GO:0005881](http://purl.obolibrary.org/obo/GO_0005881) (cytoplasmic microtubule), [GO:0035270](http://purl.obolibrary.org/obo/GO_0035270) (endocrine system development), [GO:0005884](http://purl.obolibrary.org/obo/GO_0005884) (actin filament), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0071361](http://purl.obolibrary.org/obo/GO_0071361) (cellular response to ethanol), [GO:0001046](http://purl.obolibrary.org/obo/GO_0001046) (core promoter sequence-specific DNA binding), [GO:0071363](http://purl.obolibrary.org/obo/GO_0071363) (cellular response to growth factor stimulus), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0060261](http://purl.obolibrary.org/obo/GO_0060261) (positive regulation of transcription initiation from RNA polymerase II promoter), [GO:0004520](http://purl.obolibrary.org/obo/GO_0004520) (endodeoxyribonuclease activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0070063](http://purl.obolibrary.org/obo/GO_0070063) (RNA polymerase binding), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0001012](http://purl.obolibrary.org/obo/GO_0001012) (RNA polymerase II regulatory region DNA binding), [GO:0071392](http://purl.obolibrary.org/obo/GO_0071392) (cellular response to estradiol stimulus), [GO:0071393](http://purl.obolibrary.org/obo/GO_0071393) (cellular response to progesterone stimulus), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0051300](http://purl.obolibrary.org/obo/GO_0051300) (spindle pole body organization), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0004519](http://purl.obolibrary.org/obo/GO_0004519) (endonuclease activity), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:1903799](http://purl.obolibrary.org/obo/GO_1903799) (negative regulation of production of miRNAs involved in gene silencing by miRNA), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0071391](http://purl.obolibrary.org/obo/GO_0071391) (cellular response to estrogen stimulus), [GO:0004530](http://purl.obolibrary.org/obo/GO_0004530) (deoxyribonuclease I activity), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0004525](http://purl.obolibrary.org/obo/GO_0004525) (ribonuclease III activity), [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:1900212](http://purl.obolibrary.org/obo/GO_1900212) (negative regulation of mesenchymal cell apoptotic process involved in metanephros development), [GO:0048557](http://purl.obolibrary.org/obo/GO_0048557) (embryonic digestive tract morphogenesis), [GO:1903721](http://purl.obolibrary.org/obo/GO_1903721) (positive regulation of I-kappaB phosphorylation), [GO:0007613](http://purl.obolibrary.org/obo/GO_0007613) (memory), [GO:0060687](http://purl.obolibrary.org/obo/GO_0060687) (regulation of branching involved in prostate gland morphogenesis), [GO:0007611](http://purl.obolibrary.org/obo/GO_0007611) (learning or memory), [GO:0048562](http://purl.obolibrary.org/obo/GO_0048562) (embryonic organ morphogenesis), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0045056](http://purl.obolibrary.org/obo/GO_0045056) (transcytosis), [GO:0048566](http://purl.obolibrary.org/obo/GO_0048566) (embryonic digestive tract development), [GO:0048565](http://purl.obolibrary.org/obo/GO_0048565) (digestive tract development), [GO:0071333](http://purl.obolibrary.org/obo/GO_0071333) (cellular response to glucose stimulus), [GO:0016570](http://purl.obolibrary.org/obo/GO_0016570) (histone modification), [GO:0016572](http://purl.obolibrary.org/obo/GO_0016572) (histone phosphorylation), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0030864](http://purl.obolibrary.org/obo/GO_0030864) (cortical actin cytoskeleton), [GO:0051721](http://purl.obolibrary.org/obo/GO_0051721) (protein phosphatase 2A binding), [GO:2000054](http://purl.obolibrary.org/obo/GO_2000054) (negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0007623](http://purl.obolibrary.org/obo/GO_0007623) (circadian rhythm), [GO:0060677](http://purl.obolibrary.org/obo/GO_0060677) (ureteric bud elongation), [GO:0030855](http://purl.obolibrary.org/obo/GO_0030855) (epithelial cell differentiation), [GO:0001089](http://purl.obolibrary.org/obo/GO_0001089) (transcription factor activity, TFIIF-class transcription factor binding), [GO:0030856](http://purl.obolibrary.org/obo/GO_0030856) (regulation of epithelial cell differentiation), [GO:0072656](http://purl.obolibrary.org/obo/GO_0072656) (maintenance of protein location in mitochondrion), [GO:0072655](http://purl.obolibrary.org/obo/GO_0072655) (establishment of protein localization to mitochondrion), [GO:0015238](http://purl.obolibrary.org/obo/GO_0015238) (drug transmembrane transporter activity), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:2000060](http://purl.obolibrary.org/obo/GO_2000060) (positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0090071](http://purl.obolibrary.org/obo/GO_0090071) (negative regulation of ribosome biogenesis), [GO:0001047](http://purl.obolibrary.org/obo/GO_0001047) (core promoter binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0090080](http://purl.obolibrary.org/obo/GO_0090080) (positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway), [GO:0071356](http://purl.obolibrary.org/obo/GO_0071356) (cellular response to tumor necrosis factor), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0042803](http://purl.obolibrary.org/obo/GO_0042803) (protein homodimerization activity), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0090090](http://purl.obolibrary.org/obo/GO_0090090) (negative regulation of canonical Wnt signaling pathway), [GO:0030833](http://purl.obolibrary.org/obo/GO_0030833) (regulation of actin filament polymerization), [GO:0048593](http://purl.obolibrary.org/obo/GO_0048593) (camera-type eye morphogenesis), [GO:0048598](http://purl.obolibrary.org/obo/GO_0048598) (embryonic morphogenesis), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0070495](http://purl.obolibrary.org/obo/GO_0070495) (negative regulation of thrombin-activated receptor signaling pathway), [GO:0051754](http://purl.obolibrary.org/obo/GO_0051754) (meiotic sister chromatid cohesion, centromeric), [GO:0021955](http://purl.obolibrary.org/obo/GO_0021955) (central nervous system neuron axonogenesis), [GO:0021952](http://purl.obolibrary.org/obo/GO_0021952) (central nervous system projection neuron axonogenesis), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0030426](http://purl.obolibrary.org/obo/GO_0030426) (growth cone), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0061180](http://purl.obolibrary.org/obo/GO_0061180) (mammary gland epithelium development), [GO:0061181](http://purl.obolibrary.org/obo/GO_0061181) (regulation of chondrocyte development), [GO:0030422](http://purl.obolibrary.org/obo/GO_0030422) (production of siRNA involved in RNA interference), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0030423](http://purl.obolibrary.org/obo/GO_0030423) (targeting of mRNA for destruction involved in RNA interference), [GO:1902042](http://purl.obolibrary.org/obo/GO_1902042) (negative regulation of extrinsic apoptotic signaling pathway via death domain receptors), [GO:0005004](http://purl.obolibrary.org/obo/GO_0005004) (GPI-linked ephrin receptor activity), [GO:0008514](http://purl.obolibrary.org/obo/GO_0008514) (organic anion transmembrane transporter activity), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0010828](http://purl.obolibrary.org/obo/GO_0010828) (positive regulation of glucose transport), [GO:0030891](http://purl.obolibrary.org/obo/GO_0030891) (VCB complex), [GO:0006783](http://purl.obolibrary.org/obo/GO_0006783) (heme biosynthetic process), [GO:0007631](http://purl.obolibrary.org/obo/GO_0007631) (feeding behavior), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0006301](http://purl.obolibrary.org/obo/GO_0006301) (postreplication repair), [GO:0006302](http://purl.obolibrary.org/obo/GO_0006302) (double-strand break repair), [GO:0007626](http://purl.obolibrary.org/obo/GO_0007626) (locomotory behavior), [GO:0097105](http://purl.obolibrary.org/obo/GO_0097105) (presynaptic membrane assembly), [GO:0097108](http://purl.obolibrary.org/obo/GO_0097108) (hedgehog family protein binding), [GO:0016593](http://purl.obolibrary.org/obo/GO_0016593) (Cdc73/Paf1 complex), [GO:0001093](http://purl.obolibrary.org/obo/GO_0001093) (TFIIB-class transcription factor binding), [GO:0097107](http://purl.obolibrary.org/obo/GO_0097107) (postsynaptic density assembly), [GO:0061188](http://purl.obolibrary.org/obo/GO_0061188) (negative regulation of chromatin silencing at rDNA), [GO:0061186](http://purl.obolibrary.org/obo/GO_0061186) (negative regulation of chromatin silencing at silent mating-type cassette), [GO:0006310](http://purl.obolibrary.org/obo/GO_0006310) (DNA recombination), [GO:0030877](http://purl.obolibrary.org/obo/GO_0030877) (beta-catenin destruction complex), [GO:0097110](http://purl.obolibrary.org/obo/GO_0097110) (scaffold protein binding), [GO:0030879](http://purl.obolibrary.org/obo/GO_0030879) (mammary gland development), [GO:0030878](http://purl.obolibrary.org/obo/GO_0030878) (thyroid gland development), [GO:0006306](http://purl.obolibrary.org/obo/GO_0006306) (DNA methylation), [GO:0010801](http://purl.obolibrary.org/obo/GO_0010801) (negative regulation of peptidyl-threonine phosphorylation), [GO:0006309](http://purl.obolibrary.org/obo/GO_0006309) (apoptotic DNA fragmentation), [GO:0010800](http://purl.obolibrary.org/obo/GO_0010800) (positive regulation of peptidyl-threonine phosphorylation), [GO:0021999](http://purl.obolibrary.org/obo/GO_0021999) (neural plate anterior/posterior regionalization), [GO:0006362](http://purl.obolibrary.org/obo/GO_0006362) (transcription elongation from RNA polymerase I promoter), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0005030](http://purl.obolibrary.org/obo/GO_0005030) (neurotrophin receptor activity), [GO:0008544](http://purl.obolibrary.org/obo/GO_0008544) (epidermis development), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0006369](http://purl.obolibrary.org/obo/GO_0006369) (termination of RNA polymerase II transcription), [GO:0021510](http://purl.obolibrary.org/obo/GO_0021510) (spinal cord development), [GO:0006368](http://purl.obolibrary.org/obo/GO_0006368) (transcription elongation from RNA polymerase II promoter), [GO:0048169](http://purl.obolibrary.org/obo/GO_0048169) (regulation of long-term neuronal synaptic plasticity), [GO:0060291](http://purl.obolibrary.org/obo/GO_0060291) (long-term synaptic potentiation), [GO:0060292](http://purl.obolibrary.org/obo/GO_0060292) (long term synaptic depression), [GO:0017025](http://purl.obolibrary.org/obo/GO_0017025) (TBP-class protein binding), [GO:0031798](http://purl.obolibrary.org/obo/GO_0031798) (type 1 metabotropic glutamate receptor binding), [GO:0021508](http://purl.obolibrary.org/obo/GO_0021508) (floor plate formation), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0060272](http://purl.obolibrary.org/obo/GO_0060272) (embryonic skeletal joint morphogenesis), [GO:0005042](http://purl.obolibrary.org/obo/GO_0005042) (netrin receptor activity), [GO:0009880](http://purl.obolibrary.org/obo/GO_0009880) (embryonic pattern specification), [GO:0004197](http://purl.obolibrary.org/obo/GO_0004197) (cysteine-type endopeptidase activity), [GO:0021984](http://purl.obolibrary.org/obo/GO_0021984) (adenohypophysis development), [GO:1904669](http://purl.obolibrary.org/obo/GO_1904669) (ATP export), [GO:1904668](http://purl.obolibrary.org/obo/GO_1904668) (positive regulation of ubiquitin protein ligase activity), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:1990182](http://purl.obolibrary.org/obo/GO_1990182) (exosomal secretion), [GO:0005048](http://purl.obolibrary.org/obo/GO_0005048) (signal sequence binding), [GO:0006378](http://purl.obolibrary.org/obo/GO_0006378) (mRNA polyadenylation), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0009887](http://purl.obolibrary.org/obo/GO_0009887) (animal organ morphogenesis), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0045907](http://purl.obolibrary.org/obo/GO_0045907) (positive regulation of vasoconstriction), [GO:1901166](http://purl.obolibrary.org/obo/GO_1901166) (neural crest cell migration involved in autonomic nervous system development), [GO:0015293](http://purl.obolibrary.org/obo/GO_0015293) (symporter activity), [GO:0006342](http://purl.obolibrary.org/obo/GO_0006342) (chromatin silencing), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0005008](http://purl.obolibrary.org/obo/GO_0005008) (hepatocyte growth factor-activated receptor activity), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0030447](http://purl.obolibrary.org/obo/GO_0030447) (filamentous growth), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0061144](http://purl.obolibrary.org/obo/GO_0061144) (alveolar secondary septum development), [GO:0061146](http://purl.obolibrary.org/obo/GO_0061146) (Peyer's patch morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0004175](http://purl.obolibrary.org/obo/GO_0004175) (endopeptidase activity), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007202](http://purl.obolibrary.org/obo/GO_0007202) (activation of phospholipase C activity), [GO:0007200](http://purl.obolibrary.org/obo/GO_0007200) (phospholipase C-activating G-protein coupled receptor signaling pathway), [GO:0021960](http://purl.obolibrary.org/obo/GO_0021960) (anterior commissure morphogenesis), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0045910](http://purl.obolibrary.org/obo/GO_0045910) (negative regulation of DNA recombination), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0008534](http://purl.obolibrary.org/obo/GO_0008534) (oxidized purine nucleobase lesion DNA N-glycosylase activity), [GO:0097550](http://purl.obolibrary.org/obo/GO_0097550) (transcriptional preinitiation complex), [GO:0006349](http://purl.obolibrary.org/obo/GO_0006349) (regulation of gene expression by genetic imprinting), [GO:0048193](http://purl.obolibrary.org/obo/GO_0048193) (Golgi vesicle transport), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0006285](http://purl.obolibrary.org/obo/GO_0006285) (base-excision repair, AP site formation), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0006289](http://purl.obolibrary.org/obo/GO_0006289) (nucleotide-excision repair), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0001824](http://purl.obolibrary.org/obo/GO_0001824) (blastocyst development), [GO:0031234](http://purl.obolibrary.org/obo/GO_0031234) (extrinsic component of cytoplasmic side of plasma membrane), [GO:0001826](http://purl.obolibrary.org/obo/GO_0001826) (inner cell mass cell differentiation), [GO:0031235](http://purl.obolibrary.org/obo/GO_0031235) (intrinsic component of the cytoplasmic side of the plasma membrane), [GO:0065004](http://purl.obolibrary.org/obo/GO_0065004) (protein-DNA complex assembly), [GO:0007141](http://purl.obolibrary.org/obo/GO_0007141) (male meiosis I), [GO:0000988](http://purl.obolibrary.org/obo/GO_0000988) (transcription factor activity, protein binding), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0048920](http://purl.obolibrary.org/obo/GO_0048920) (posterior lateral line neuromast primordium migration), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0045899](http://purl.obolibrary.org/obo/GO_0045899) (positive regulation of RNA polymerase II transcriptional preinitiation complex assembly), [GO:0001833](http://purl.obolibrary.org/obo/GO_0001833) (inner cell mass cell proliferation), [GO:0030374](http://purl.obolibrary.org/obo/GO_0030374) (ligand-dependent nuclear receptor transcription coactivator activity), [GO:0001838](http://purl.obolibrary.org/obo/GO_0001838) (embryonic epithelial tube formation), [GO:0001839](http://purl.obolibrary.org/obo/GO_0001839) (neural plate morphogenesis), [GO:0045429](http://purl.obolibrary.org/obo/GO_0045429) (positive regulation of nitric oxide biosynthetic process), [GO:0021897](http://purl.obolibrary.org/obo/GO_0021897) (forebrain astrocyte development), [GO:0046755](http://purl.obolibrary.org/obo/GO_0046755) (viral budding), [GO:0007595](http://purl.obolibrary.org/obo/GO_0007595) (lactation), [GO:0021892](http://purl.obolibrary.org/obo/GO_0021892) (cerebral cortex GABAergic interneuron differentiation), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0021895](http://purl.obolibrary.org/obo/GO_0021895) (cerebral cortex neuron differentiation), [GO:0034727](http://purl.obolibrary.org/obo/GO_0034727) (piecemeal microautophagy of the nucleus), [GO:0019104](http://purl.obolibrary.org/obo/GO_0019104) (DNA N-glycosylase activity), [GO:0006270](http://purl.obolibrary.org/obo/GO_0006270) (DNA replication initiation), [GO:0007120](http://purl.obolibrary.org/obo/GO_0007120) (axial cellular bud site selection), [GO:0007121](http://purl.obolibrary.org/obo/GO_0007121) (bipolar cellular bud site selection), [GO:0021881](http://purl.obolibrary.org/obo/GO_0021881) (Wnt-activated signaling pathway involved in forebrain neuron fate commitment), [GO:0007129](http://purl.obolibrary.org/obo/GO_0007129) (synapsis), [GO:0010765](http://purl.obolibrary.org/obo/GO_0010765) (positive regulation of sodium ion transport), [GO:0030352](http://purl.obolibrary.org/obo/GO_0030352) (inositol-1,4,5,6-tetrakisphosphate 6-phosphatase activity), [GO:0030351](http://purl.obolibrary.org/obo/GO_0030351) (inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity), [GO:0070851](http://purl.obolibrary.org/obo/GO_0070851) (growth factor receptor binding), [GO:0032535](http://purl.obolibrary.org/obo/GO_0032535) (regulation of cellular component size), [GO:0010763](http://purl.obolibrary.org/obo/GO_0010763) (positive regulation of fibroblast migration), [GO:0007171](http://purl.obolibrary.org/obo/GO_0007171) (activation of transmembrane receptor protein tyrosine kinase activity), [GO:0007175](http://purl.obolibrary.org/obo/GO_0007175) (negative regulation of epidermal growth factor-activated receptor activity), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0007179](http://purl.obolibrary.org/obo/GO_0007179) (transforming growth factor beta receptor signaling pathway), [GO:0008026](http://purl.obolibrary.org/obo/GO_0008026) (ATP-dependent helicase activity), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0008024](http://purl.obolibrary.org/obo/GO_0008024) (cyclin/CDK positive transcription elongation factor complex), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0090419](http://purl.obolibrary.org/obo/GO_0090419) (negative regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0045860](http://purl.obolibrary.org/obo/GO_0045860) (positive regulation of protein kinase activity), [GO:0051298](http://purl.obolibrary.org/obo/GO_0051298) (centrosome duplication), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0014707](http://purl.obolibrary.org/obo/GO_0014707) (branchiomeric skeletal muscle development), [GO:0014704](http://purl.obolibrary.org/obo/GO_0014704) (intercalated disc), [GO:0031264](http://purl.obolibrary.org/obo/GO_0031264) (death-inducing signaling complex), [GO:0031265](http://purl.obolibrary.org/obo/GO_0031265) (CD95 death-inducing signaling complex), [GO:0035622](http://purl.obolibrary.org/obo/GO_0035622) (intrahepatic bile duct development), [GO:0035623](http://purl.obolibrary.org/obo/GO_0035623) (renal glucose absorption), [GO:0007158](http://purl.obolibrary.org/obo/GO_0007158) (neuron cell-cell adhesion), [GO:0045861](http://purl.obolibrary.org/obo/GO_0045861) (negative regulation of proteolysis), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0045862](http://purl.obolibrary.org/obo/GO_0045862) (positive regulation of proteolysis), [GO:0007156](http://purl.obolibrary.org/obo/GO_0007156) (homophilic cell adhesion via plasma membrane adhesion molecules), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0001841](http://purl.obolibrary.org/obo/GO_0001841) (neural tube formation), [GO:0001843](http://purl.obolibrary.org/obo/GO_0001843) (neural tube closure), [GO:0043691](http://purl.obolibrary.org/obo/GO_0043691) (reverse cholesterol transport), [GO:0032587](http://purl.obolibrary.org/obo/GO_0032587) (ruffle membrane), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007162](http://purl.obolibrary.org/obo/GO_0007162) (negative regulation of cell adhesion), [GO:0007163](http://purl.obolibrary.org/obo/GO_0007163) (establishment or maintenance of cell polarity), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0008017](http://purl.obolibrary.org/obo/GO_0008017) (microtubule binding), [GO:0043220](http://purl.obolibrary.org/obo/GO_0043220) (Schmidt-Lanterman incisure), [GO:0045880](http://purl.obolibrary.org/obo/GO_0045880) (positive regulation of smoothened signaling pathway), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0090055](http://purl.obolibrary.org/obo/GO_0090055) (positive regulation of chromatin silencing at silent mating-type cassette), [GO:0045003](http://purl.obolibrary.org/obo/GO_0045003) (double-strand break repair via synthesis-dependent strand annealing), [GO:0000578](http://purl.obolibrary.org/obo/GO_0000578) (embryonic axis specification), [GO:0060644](http://purl.obolibrary.org/obo/GO_0060644) (mammary gland epithelial cell differentiation), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0010390](http://purl.obolibrary.org/obo/GO_0010390) (histone monoubiquitination), [GO:0048524](http://purl.obolibrary.org/obo/GO_0048524) (positive regulation of viral process), [GO:0050847](http://purl.obolibrary.org/obo/GO_0050847) (progesterone receptor signaling pathway), [GO:0034334](http://purl.obolibrary.org/obo/GO_0034334) (adherens junction maintenance), [GO:0034333](http://purl.obolibrary.org/obo/GO_0034333) (adherens junction assembly), [GO:0010389](http://purl.obolibrary.org/obo/GO_0010389) (regulation of G2/M transition of mitotic cell cycle), [GO:0034332](http://purl.obolibrary.org/obo/GO_0034332) (adherens junction organization), [GO:0061515](http://purl.obolibrary.org/obo/GO_0061515) (myeloid cell development), [GO:0001890](http://purl.obolibrary.org/obo/GO_0001890) (placenta development), [GO:0060665](http://purl.obolibrary.org/obo/GO_0060665) (regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling), [GO:0001893](http://purl.obolibrary.org/obo/GO_0001893) (maternal placenta development), [GO:0001886](http://purl.obolibrary.org/obo/GO_0001886) (endothelial cell morphogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0032148](http://purl.obolibrary.org/obo/GO_0032148) (activation of protein kinase B activity), [GO:0035655](http://purl.obolibrary.org/obo/GO_0035655) (interleukin-18-mediated signaling pathway), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0071316](http://purl.obolibrary.org/obo/GO_0071316) (cellular response to nicotine), [GO:0031290](http://purl.obolibrary.org/obo/GO_0031290) (retinal ganglion cell axon guidance), [GO:0045039](http://purl.obolibrary.org/obo/GO_0045039) (protein import into mitochondrial inner membrane), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0071300](http://purl.obolibrary.org/obo/GO_0071300) (cellular response to retinoic acid), [GO:0004925](http://purl.obolibrary.org/obo/GO_0004925) (prolactin receptor activity), [GO:0051717](http://purl.obolibrary.org/obo/GO_0051717) (inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity), [GO:0015630](http://purl.obolibrary.org/obo/GO_0015630) (microtubule cytoskeleton), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0000138](http://purl.obolibrary.org/obo/GO_0000138) (Golgi trans cisterna), [GO:0000137](http://purl.obolibrary.org/obo/GO_0000137) (Golgi cis cisterna), [GO:0000142](http://purl.obolibrary.org/obo/GO_0000142) (cellular bud neck contractile ring), [GO:0045453](http://purl.obolibrary.org/obo/GO_0045453) (bone resorption), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0070883](http://purl.obolibrary.org/obo/GO_0070883) (pre-miRNA binding), [GO:0000149](http://purl.obolibrary.org/obo/GO_0000149) (SNARE binding), [GO:0000146](http://purl.obolibrary.org/obo/GO_0000146) (microfilament motor activity), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0046790](http://purl.obolibrary.org/obo/GO_0046790) (virion binding), [GO:0043281](http://purl.obolibrary.org/obo/GO_0043281) (regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0050804](http://purl.obolibrary.org/obo/GO_0050804) (modulation of chemical synaptic transmission), [GO:0000118](http://purl.obolibrary.org/obo/GO_0000118) (histone deacetylase complex), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0045471](http://purl.obolibrary.org/obo/GO_0045471) (response to ethanol), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0005801](http://purl.obolibrary.org/obo/GO_0005801) (cis-Golgi network), [GO:0045475](http://purl.obolibrary.org/obo/GO_0045475) (locomotor rhythm), [GO:1902808](http://purl.obolibrary.org/obo/GO_1902808) (positive regulation of cell cycle G1/S phase transition), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0008094](http://purl.obolibrary.org/obo/GO_0008094) (DNA-dependent ATPase activity), [GO:1905098](http://purl.obolibrary.org/obo/GO_1905098) (negative regulation of guanyl-nucleotide exchange factor activity), [GO:0033032](http://purl.obolibrary.org/obo/GO_0033032) (regulation of myeloid cell apoptotic process), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0046326](http://purl.obolibrary.org/obo/GO_0046326) (positive regulation of glucose import), [GO:0046323](http://purl.obolibrary.org/obo/GO_0046323) (glucose import), [GO:0046329](http://purl.obolibrary.org/obo/GO_0046329) (negative regulation of JNK cascade), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0000123](http://purl.obolibrary.org/obo/GO_0000123) (histone acetyltransferase complex), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0000131](http://purl.obolibrary.org/obo/GO_0000131) (incipient cellular bud site), [GO:0048511](http://purl.obolibrary.org/obo/GO_0048511) (rhythmic process), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0015616](http://purl.obolibrary.org/obo/GO_0015616) (DNA translocase activity), [GO:0070411](http://purl.obolibrary.org/obo/GO_0070411) (I-SMAD binding), [GO:0050821](http://purl.obolibrary.org/obo/GO_0050821) (protein stabilization), [GO:1990090](http://purl.obolibrary.org/obo/GO_1990090) (cellular response to nerve growth factor stimulus), [GO:0030947](http://purl.obolibrary.org/obo/GO_0030947) (regulation of vascular endothelial growth factor receptor signaling pathway), [GO:0071498](http://purl.obolibrary.org/obo/GO_0071498) (cellular response to fluid shear stress), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:2001209](http://purl.obolibrary.org/obo/GO_2001209) (positive regulation of transcription elongation from RNA polymerase I promoter), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0051895](http://purl.obolibrary.org/obo/GO_0051895) (negative regulation of focal adhesion assembly), [GO:0051896](http://purl.obolibrary.org/obo/GO_0051896) (regulation of protein kinase B signaling), [GO:0071480](http://purl.obolibrary.org/obo/GO_0071480) (cellular response to gamma radiation), [GO:0005516](http://purl.obolibrary.org/obo/GO_0005516) (calmodulin binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0001161](http://purl.obolibrary.org/obo/GO_0001161) (intronic transcription regulatory region sequence-specific DNA binding), [GO:0048255](http://purl.obolibrary.org/obo/GO_0048255) (mRNA stabilization), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0052745](http://purl.obolibrary.org/obo/GO_0052745) (inositol phosphate phosphatase activity), [GO:0051898](http://purl.obolibrary.org/obo/GO_0051898) (negative regulation of protein kinase B signaling), [GO:0060385](http://purl.obolibrary.org/obo/GO_0060385) (axonogenesis involved in innervation), [GO:0034056](http://purl.obolibrary.org/obo/GO_0034056) (estrogen response element binding), [GO:0060384](http://purl.obolibrary.org/obo/GO_0060384) (innervation), [GO:0006820](http://purl.obolibrary.org/obo/GO_0006820) (anion transport), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0000287](http://purl.obolibrary.org/obo/GO_0000287) (magnesium ion binding), [GO:0048265](http://purl.obolibrary.org/obo/GO_0048265) (response to pain), [GO:0048264](http://purl.obolibrary.org/obo/GO_0048264) (determination of ventral identity), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0048262](http://purl.obolibrary.org/obo/GO_0048262) (determination of dorsal/ventral asymmetry), [GO:0003306](http://purl.obolibrary.org/obo/GO_0003306) (Wnt signaling pathway involved in heart development), [GO:0000281](http://purl.obolibrary.org/obo/GO_0000281) (mitotic cytokinesis), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0051427](http://purl.obolibrary.org/obo/GO_0051427) (hormone receptor binding), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:2000378](http://purl.obolibrary.org/obo/GO_2000378) (negative regulation of reactive oxygen species metabolic process), [GO:2001241](http://purl.obolibrary.org/obo/GO_2001241) (positive regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0035371](http://purl.obolibrary.org/obo/GO_0035371) (microtubule plus-end), [GO:2000394](http://purl.obolibrary.org/obo/GO_2000394) (positive regulation of lamellipodium morphogenesis), [GO:0034045](http://purl.obolibrary.org/obo/GO_0034045) (phagophore assembly site membrane), [GO:0030917](http://purl.obolibrary.org/obo/GO_0030917) (midbrain-hindbrain boundary development), [GO:1901017](http://purl.obolibrary.org/obo/GO_1901017) (negative regulation of potassium ion transmembrane transporter activity), [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development), [GO:0030910](http://purl.obolibrary.org/obo/GO_0030910) (olfactory placode formation), [GO:0003313](http://purl.obolibrary.org/obo/GO_0003313) (heart rudiment development), [GO:0005975](http://purl.obolibrary.org/obo/GO_0005975) (carbohydrate metabolic process), [GO:0005978](http://purl.obolibrary.org/obo/GO_0005978) (glycogen biosynthetic process), [GO:0005977](http://purl.obolibrary.org/obo/GO_0005977) (glycogen metabolic process), [GO:0005979](http://purl.obolibrary.org/obo/GO_0005979) (regulation of glycogen biosynthetic process), [GO:0030916](http://purl.obolibrary.org/obo/GO_0030916) (otic vesicle formation), [GO:0034039](http://purl.obolibrary.org/obo/GO_0034039) (8-oxo-7,8-dihydroguanine DNA N-glycosylase activity), [GO:2001237](http://purl.obolibrary.org/obo/GO_2001237) (negative regulation of extrinsic apoptotic signaling pathway), [GO:2000386](http://purl.obolibrary.org/obo/GO_2000386) (positive regulation of ovarian follicle development), [GO:2001238](http://purl.obolibrary.org/obo/GO_2001238) (positive regulation of extrinsic apoptotic signaling pathway), [GO:2001233](http://purl.obolibrary.org/obo/GO_2001233) (regulation of apoptotic signaling pathway), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0036294](http://purl.obolibrary.org/obo/GO_0036294) (cellular response to decreased oxygen levels), [GO:0003370](http://purl.obolibrary.org/obo/GO_0003370) (cell-cell adhesion involved in mesendodermal cell migration), [GO:0048679](http://purl.obolibrary.org/obo/GO_0048679) (regulation of axon regeneration), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005547](http://purl.obolibrary.org/obo/GO_0005547) (phosphatidylinositol-3,4,5-trisphosphate binding), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0048681](http://purl.obolibrary.org/obo/GO_0048681) (negative regulation of axon regeneration), [GO:0072300](http://purl.obolibrary.org/obo/GO_0072300) (positive regulation of metanephric glomerulus development), [GO:2000397](http://purl.obolibrary.org/obo/GO_2000397) (positive regulation of ubiquitin-dependent endocytosis), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:2001243](http://purl.obolibrary.org/obo/GO_2001243) (negative regulation of intrinsic apoptotic signaling pathway), [GO:0071459](http://purl.obolibrary.org/obo/GO_0071459) (protein localization to chromosome, centromeric region), [GO:0030501](http://purl.obolibrary.org/obo/GO_0030501) (positive regulation of bone mineralization), [GO:0014033](http://purl.obolibrary.org/obo/GO_0014033) (neural crest cell differentiation), [GO:0006897](http://purl.obolibrary.org/obo/GO_0006897) (endocytosis), [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0010907](http://purl.obolibrary.org/obo/GO_0010907) (positive regulation of glucose metabolic process), [GO:0048696](http://purl.obolibrary.org/obo/GO_0048696) (regulation of collateral sprouting in absence of injury), [GO:0046034](http://purl.obolibrary.org/obo/GO_0046034) (ATP metabolic process), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:2001255](http://purl.obolibrary.org/obo/GO_2001255) (positive regulation of histone H3-K36 trimethylation), [GO:0060341](http://purl.obolibrary.org/obo/GO_0060341) (regulation of cellular localization), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0002020](http://purl.obolibrary.org/obo/GO_0002020) (protease binding), [GO:0004683](http://purl.obolibrary.org/obo/GO_0004683) (calmodulin-dependent protein kinase activity), [GO:1900119](http://purl.obolibrary.org/obo/GO_1900119) (positive regulation of execution phase of apoptosis), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0070141](http://purl.obolibrary.org/obo/GO_0070141) (response to UV-A), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0002016](http://purl.obolibrary.org/obo/GO_0002016) (regulation of blood volume by renin-angiotensin), [GO:0006858](http://purl.obolibrary.org/obo/GO_0006858) (extracellular transport), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0036267](http://purl.obolibrary.org/obo/GO_0036267) (invasive filamentous growth), [GO:2001286](http://purl.obolibrary.org/obo/GO_2001286) (regulation of caveolin-mediated endocytosis), [GO:0005540](http://purl.obolibrary.org/obo/GO_0005540) (hyaluronic acid binding), [GO:0071466](http://purl.obolibrary.org/obo/GO_0071466) (cellular response to xenobiotic stimulus), [GO:0016661](http://purl.obolibrary.org/obo/GO_0016661) (oxidoreductase activity, acting on other nitrogenous compounds as donors), [GO:1990918](http://purl.obolibrary.org/obo/GO_1990918) (double-strand break repair involved in meiotic recombination), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0042538](http://purl.obolibrary.org/obo/GO_0042538) (hyperosmotic salinity response), [GO:0014065](http://purl.obolibrary.org/obo/GO_0014065) (phosphatidylinositol 3-kinase signaling), [GO:0061296](http://purl.obolibrary.org/obo/GO_0061296) (negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0009950](http://purl.obolibrary.org/obo/GO_0009950) (dorsal/ventral axis specification), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0008625](http://purl.obolibrary.org/obo/GO_0008625) (extrinsic apoptotic signaling pathway via death domain receptors), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:0005113](http://purl.obolibrary.org/obo/GO_0005113) (patched binding), [GO:0009954](http://purl.obolibrary.org/obo/GO_0009954) (proximal/distal pattern formation), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0051000](http://purl.obolibrary.org/obo/GO_0051000) (positive regulation of nitric-oxide synthase activity), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0005123](http://purl.obolibrary.org/obo/GO_0005123) (death receptor binding), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0051015](http://purl.obolibrary.org/obo/GO_0051015) (actin filament binding), [GO:0051497](http://purl.obolibrary.org/obo/GO_0051497) (negative regulation of stress fiber assembly), [GO:0005119](http://purl.obolibrary.org/obo/GO_0005119) (smoothened binding), [GO:0009957](http://purl.obolibrary.org/obo/GO_0009957) (epidermal cell fate specification), [GO:0051493](http://purl.obolibrary.org/obo/GO_0051493) (regulation of cytoskeleton organization), [GO:0010941](http://purl.obolibrary.org/obo/GO_0010941) (regulation of cell death), [GO:0016242](http://purl.obolibrary.org/obo/GO_0016242) (negative regulation of macroautophagy), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0051019](http://purl.obolibrary.org/obo/GO_0051019) (mitogen-activated protein kinase binding), [GO:0030534](http://purl.obolibrary.org/obo/GO_0030534) (adult behavior), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0043405](http://purl.obolibrary.org/obo/GO_0043405) (regulation of MAP kinase activity), [GO:0014042](http://purl.obolibrary.org/obo/GO_0014042) (positive regulation of neuron maturation), [GO:0042551](http://purl.obolibrary.org/obo/GO_0042551) (neuron maturation), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0006417](http://purl.obolibrary.org/obo/GO_0006417) (regulation of translation), [GO:0051026](http://purl.obolibrary.org/obo/GO_0051026) (chiasma assembly), [GO:0010918](http://purl.obolibrary.org/obo/GO_0010918) (positive regulation of mitochondrial membrane potential), [GO:0009925](http://purl.obolibrary.org/obo/GO_0009925) (basal plasma membrane), [GO:0030529](http://purl.obolibrary.org/obo/GO_0030529) (intracellular ribonucleoprotein complex), [GO:0051020](http://purl.obolibrary.org/obo/GO_0051020) (GTPase binding), [GO:0030520](http://purl.obolibrary.org/obo/GO_0030520) (intracellular estrogen receptor signaling pathway), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0038006](http://purl.obolibrary.org/obo/GO_0038006) (netrin receptor activity involved in chemoattraction), [GO:0038002](http://purl.obolibrary.org/obo/GO_0038002) (endocrine signaling), [GO:0004252](http://purl.obolibrary.org/obo/GO_0004252) (serine-type endopeptidase activity), [GO:0042562](http://purl.obolibrary.org/obo/GO_0042562) (hormone binding), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0030516](http://purl.obolibrary.org/obo/GO_0030516) (regulation of axon extension), [GO:0030518](http://purl.obolibrary.org/obo/GO_0030518) (intracellular steroid hormone receptor signaling pathway), [GO:0030512](http://purl.obolibrary.org/obo/GO_0030512) (negative regulation of transforming growth factor beta receptor signaling pathway), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0097200](http://purl.obolibrary.org/obo/GO_0097200) (cysteine-type endopeptidase activity involved in execution phase of apoptosis), [GO:0097202](http://purl.obolibrary.org/obo/GO_0097202) (activation of cysteine-type endopeptidase activity), [GO:0033619](http://purl.obolibrary.org/obo/GO_0033619) (membrane protein proteolysis), [GO:0010976](http://purl.obolibrary.org/obo/GO_0010976) (positive regulation of neuron projection development), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0031436](http://purl.obolibrary.org/obo/GO_0031436) (BRCA1-BARD1 complex), [GO:1900182](http://purl.obolibrary.org/obo/GO_1900182) (positive regulation of protein localization to nucleus), [GO:1903690](http://purl.obolibrary.org/obo/GO_1903690) (negative regulation of wound healing, spreading of epidermal cells), [GO:0038066](http://purl.obolibrary.org/obo/GO_0038066) (p38MAPK cascade), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0060395](http://purl.obolibrary.org/obo/GO_0060395) (SMAD protein signal transduction), [GO:0000702](http://purl.obolibrary.org/obo/GO_0000702) (oxidized base lesion DNA N-glycosylase activity), [GO:0038061](http://purl.obolibrary.org/obo/GO_0038061) (NIK/NF-kappaB signaling), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0005166](http://purl.obolibrary.org/obo/GO_0005166) (neurotrophin p75 receptor binding), [GO:0010507](http://purl.obolibrary.org/obo/GO_0010507) (negative regulation of autophagy), [GO:0051450](http://purl.obolibrary.org/obo/GO_0051450) (myoblast proliferation), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0017137](http://purl.obolibrary.org/obo/GO_0017137) (Rab GTPase binding), [GO:0033600](http://purl.obolibrary.org/obo/GO_0033600) (negative regulation of mammary gland epithelial cell proliferation), [GO:0008643](http://purl.obolibrary.org/obo/GO_0008643) (carbohydrate transport), [GO:0006464](http://purl.obolibrary.org/obo/GO_0006464) (cellular protein modification process), [GO:0038052](http://purl.obolibrary.org/obo/GO_0038052) (RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0006469](http://purl.obolibrary.org/obo/GO_0006469) (negative regulation of protein kinase activity), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0008637](http://purl.obolibrary.org/obo/GO_0008637) (apoptotic mitochondrial changes), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0010951](http://purl.obolibrary.org/obo/GO_0010951) (negative regulation of endopeptidase activity), [GO:0010954](http://purl.obolibrary.org/obo/GO_0010954) (positive regulation of protein processing), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0008656](http://purl.obolibrary.org/obo/GO_0008656) (cysteine-type endopeptidase activator activity involved in apoptotic process), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0031404](http://purl.obolibrary.org/obo/GO_0031404) (chloride ion binding), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0022407](http://purl.obolibrary.org/obo/GO_0022407) (regulation of cell-cell adhesion), [GO:0030030](http://purl.obolibrary.org/obo/GO_0030030) (cell projection organization), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0046854](http://purl.obolibrary.org/obo/GO_0046854) (phosphatidylinositol phosphorylation), [GO:0007257](http://purl.obolibrary.org/obo/GO_0007257) (activation of JUN kinase activity), [GO:0008585](http://purl.obolibrary.org/obo/GO_0008585) (female gonad development), [GO:0046855](http://purl.obolibrary.org/obo/GO_0046855) (inositol phosphate dephosphorylation), [GO:0046856](http://purl.obolibrary.org/obo/GO_0046856) (phosphatidylinositol dephosphorylation), [GO:0007259](http://purl.obolibrary.org/obo/GO_0007259) (JAK-STAT cascade), [GO:0021554](http://purl.obolibrary.org/obo/GO_0021554) (optic nerve development), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0090102](http://purl.obolibrary.org/obo/GO_0090102) (cochlea development), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0007264](http://purl.obolibrary.org/obo/GO_0007264) (small GTPase mediated signal transduction), [GO:0005085](http://purl.obolibrary.org/obo/GO_0005085) (guanyl-nucleotide exchange factor activity), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0007266](http://purl.obolibrary.org/obo/GO_0007266) (Rho protein signal transduction), [GO:2000808](http://purl.obolibrary.org/obo/GO_2000808) (negative regulation of synaptic vesicle clustering), [GO:0021542](http://purl.obolibrary.org/obo/GO_0021542) (dentate gyrus development), [GO:0030018](http://purl.obolibrary.org/obo/GO_0030018) (Z disc), [GO:0001953](http://purl.obolibrary.org/obo/GO_0001953) (negative regulation of cell-matrix adhesion), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0001957](http://purl.obolibrary.org/obo/GO_0001957) (intramembranous ossification), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0019233](http://purl.obolibrary.org/obo/GO_0019233) (sensory perception of pain), [GO:0030496](http://purl.obolibrary.org/obo/GO_0030496) (midbody), [GO:0086098](http://purl.obolibrary.org/obo/GO_0086098) (angiotensin-activated signaling pathway involved in heart process), [GO:0071803](http://purl.obolibrary.org/obo/GO_0071803) (positive regulation of podosome assembly), [GO:0019237](http://purl.obolibrary.org/obo/GO_0019237) (centromeric DNA binding), [GO:0071801](http://purl.obolibrary.org/obo/GO_0071801) (regulation of podosome assembly), [GO:0033523](http://purl.obolibrary.org/obo/GO_0033523) (histone H2B ubiquitination), [GO:0021537](http://purl.obolibrary.org/obo/GO_0021537) (telencephalon development), [GO:0030491](http://purl.obolibrary.org/obo/GO_0030491) (heteroduplex formation), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0046875](http://purl.obolibrary.org/obo/GO_0046875) (ephrin receptor binding), [GO:0097191](http://purl.obolibrary.org/obo/GO_0097191) (extrinsic apoptotic signaling pathway), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0044213](http://purl.obolibrary.org/obo/GO_0044213) (intronic transcription regulatory region DNA binding), [GO:0021536](http://purl.obolibrary.org/obo/GO_0021536) (diencephalon development), [GO:0009410](http://purl.obolibrary.org/obo/GO_0009410) (response to xenobiotic stimulus), [GO:0097194](http://purl.obolibrary.org/obo/GO_0097194) (execution phase of apoptosis), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0060709](http://purl.obolibrary.org/obo/GO_0060709) (glycogen cell differentiation involved in embryonic placenta development), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:2000811](http://purl.obolibrary.org/obo/GO_2000811) (negative regulation of anoikis), [GO:0046883](http://purl.obolibrary.org/obo/GO_0046883) (regulation of hormone secretion), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:1990426](http://purl.obolibrary.org/obo/GO_1990426) (mitotic recombination-dependent replication fork processing), [GO:0017046](http://purl.obolibrary.org/obo/GO_0017046) (peptide hormone binding), [GO:1990429](http://purl.obolibrary.org/obo/GO_1990429) (peroxisomal importomer complex), [GO:0017048](http://purl.obolibrary.org/obo/GO_0017048) (Rho GTPase binding), [GO:0070987](http://purl.obolibrary.org/obo/GO_0070987) (error-free translesion synthesis), [GO:0021529](http://purl.obolibrary.org/obo/GO_0021529) (spinal cord oligodendrocyte cell differentiation), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0021523](http://purl.obolibrary.org/obo/GO_0021523) (somatic motor neuron differentiation), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0007249](http://purl.obolibrary.org/obo/GO_0007249) (I-kappaB kinase/NF-kappaB signaling), [GO:0021520](http://purl.obolibrary.org/obo/GO_0021520) (spinal cord motor neuron cell fate specification), [GO:0046889](http://purl.obolibrary.org/obo/GO_0046889) (positive regulation of lipid biosynthetic process), [GO:0097199](http://purl.obolibrary.org/obo/GO_0097199) (cysteine-type endopeptidase activity involved in apoptotic signaling pathway), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0001934](http://purl.obolibrary.org/obo/GO_0001934) (positive regulation of protein phosphorylation), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0070977](http://purl.obolibrary.org/obo/GO_0070977) (bone maturation), [GO:0030476](http://purl.obolibrary.org/obo/GO_0030476) (ascospore wall assembly), [GO:0030073](http://purl.obolibrary.org/obo/GO_0030073) (insulin secretion), [GO:0008142](http://purl.obolibrary.org/obo/GO_0008142) (oxysterol binding), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0014812](http://purl.obolibrary.org/obo/GO_0014812) (muscle cell migration), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0008158](http://purl.obolibrary.org/obo/GO_0008158) (hedgehog receptor activity), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0001512](http://purl.obolibrary.org/obo/GO_0001512) (dihydronicotinamide riboside quinone reductase activity), [GO:0035749](http://purl.obolibrary.org/obo/GO_0035749) (myelin sheath adaxonal region), [GO:0042472](http://purl.obolibrary.org/obo/GO_0042472) (inner ear morphogenesis), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0033564](http://purl.obolibrary.org/obo/GO_0033564) (anterior/posterior axon guidance), [GO:0014823](http://purl.obolibrary.org/obo/GO_0014823) (response to activity), [GO:0034417](http://purl.obolibrary.org/obo/GO_0034417) (bisphosphoglycerate 3-phosphatase activity), [GO:0010465](http://purl.obolibrary.org/obo/GO_0010465) (nerve growth factor receptor activity), [GO:0007270](http://purl.obolibrary.org/obo/GO_0007270) (neuron-neuron synaptic transmission), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0042476](http://purl.obolibrary.org/obo/GO_0042476) (odontogenesis), [GO:0043325](http://purl.obolibrary.org/obo/GO_0043325) (phosphatidylinositol-3,4-bisphosphate binding), [GO:0021575](http://purl.obolibrary.org/obo/GO_0021575) (hindbrain morphogenesis), [GO:0097153](http://purl.obolibrary.org/obo/GO_0097153) (cysteine-type endopeptidase activity involved in apoptotic process), [GO:0001965](http://purl.obolibrary.org/obo/GO_0001965) (G-protein alpha-subunit binding), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0033555](http://purl.obolibrary.org/obo/GO_0033555) (multicellular organismal response to stress), [GO:0034402](http://purl.obolibrary.org/obo/GO_0034402) (recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex), [GO:0034405](http://purl.obolibrary.org/obo/GO_0034405) (response to fluid shear stress), [GO:0032228](http://purl.obolibrary.org/obo/GO_0032228) (regulation of synaptic transmission, GABAergic), [GO:0030049](http://purl.obolibrary.org/obo/GO_0030049) (muscle filament sliding), [GO:0007281](http://purl.obolibrary.org/obo/GO_0007281) (germ cell development), [GO:0007286](http://purl.obolibrary.org/obo/GO_0007286) (spermatid development), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007284](http://purl.obolibrary.org/obo/GO_0007284) (spermatogonial cell division), [GO:0008137](http://purl.obolibrary.org/obo/GO_0008137) (NADH dehydrogenase (ubiquinone) activity), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0008138](http://purl.obolibrary.org/obo/GO_0008138) (protein tyrosine/serine/threonine phosphatase activity), [GO:0021571](http://purl.obolibrary.org/obo/GO_0021571) (rhombomere 5 development), [GO:0042490](http://purl.obolibrary.org/obo/GO_0042490) (mechanoreceptor differentiation), [GO:0021572](http://purl.obolibrary.org/obo/GO_0021572) (rhombomere 6 development), [GO:0046850](http://purl.obolibrary.org/obo/GO_0046850) (regulation of bone remodeling), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0032211](http://purl.obolibrary.org/obo/GO_0032211) (negative regulation of telomere maintenance via telomerase), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0033141](http://purl.obolibrary.org/obo/GO_0033141) (positive regulation of peptidyl-serine phosphorylation of STAT protein), [GO:0022006](http://purl.obolibrary.org/obo/GO_0022006) (zona limitans intrathalamica formation), [GO:0048635](http://purl.obolibrary.org/obo/GO_0048635) (negative regulation of muscle organ development), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0005901](http://purl.obolibrary.org/obo/GO_0005901) (caveola), [GO:0001545](http://purl.obolibrary.org/obo/GO_0001545) (primary ovarian follicle growth), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0005902](http://purl.obolibrary.org/obo/GO_0005902) (microvillus), [GO:0048642](http://purl.obolibrary.org/obo/GO_0048642) (negative regulation of skeletal muscle tissue development), [GO:0001547](http://purl.obolibrary.org/obo/GO_0001547) (antral ovarian follicle growth), [GO:0048640](http://purl.obolibrary.org/obo/GO_0048640) (negative regulation of developmental growth), [GO:0032287](http://purl.obolibrary.org/obo/GO_0032287) (peripheral nervous system myelin maintenance), [GO:0051800](http://purl.obolibrary.org/obo/GO_0051800) (phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity), [GO:0033138](http://purl.obolibrary.org/obo/GO_0033138) (positive regulation of peptidyl-serine phosphorylation), [GO:0035799](http://purl.obolibrary.org/obo/GO_0035799) (ureter maturation), [GO:0010498](http://purl.obolibrary.org/obo/GO_0010498) (proteasomal protein catabolic process), [GO:0010033](http://purl.obolibrary.org/obo/GO_0010033) (response to organic substance), [GO:0060750](http://purl.obolibrary.org/obo/GO_0060750) (epithelial cell proliferation involved in mammary gland duct elongation), [GO:0032286](http://purl.obolibrary.org/obo/GO_0032286) (central nervous system myelin maintenance), [GO:0048646](http://purl.obolibrary.org/obo/GO_0048646) (anatomical structure formation involved in morphogenesis), [GO:0009048](http://purl.obolibrary.org/obo/GO_0009048) (dosage compensation by inactivation of X chromosome), [GO:0044291](http://purl.obolibrary.org/obo/GO_0044291) (cell-cell contact zone), [GO:0005912](http://purl.obolibrary.org/obo/GO_0005912) (adherens junction), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0001556](http://purl.obolibrary.org/obo/GO_0001556) (oocyte maturation), [GO:0005913](http://purl.obolibrary.org/obo/GO_0005913) (cell-cell adherens junction), [GO:0001558](http://purl.obolibrary.org/obo/GO_0001558) (regulation of cell growth), [GO:0005915](http://purl.obolibrary.org/obo/GO_0005915) (zonula adherens), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0035307](http://purl.obolibrary.org/obo/GO_0035307) (positive regulation of protein dephosphorylation), [GO:0050966](http://purl.obolibrary.org/obo/GO_0050966) (detection of mechanical stimulus involved in sensory perception of pain), [GO:0034454](http://purl.obolibrary.org/obo/GO_0034454) (microtubule anchoring at centrosome), [GO:0071406](http://purl.obolibrary.org/obo/GO_0071406) (cellular response to methylmercury), [GO:0071407](http://purl.obolibrary.org/obo/GO_0071407) (cellular response to organic cyclic compound), [GO:0050965](http://purl.obolibrary.org/obo/GO_0050965) (detection of temperature stimulus involved in sensory perception of pain), [GO:0071889](http://purl.obolibrary.org/obo/GO_0071889) (14-3-3 protein binding), [GO:0032270](http://purl.obolibrary.org/obo/GO_0032270) (positive regulation of cellular protein metabolic process), [GO:0010484](http://purl.obolibrary.org/obo/GO_0010484) (H3 histone acetyltransferase activity), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0048665](http://purl.obolibrary.org/obo/GO_0048665) (neuron fate specification), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0048663](http://purl.obolibrary.org/obo/GO_0048663) (neuron fate commitment), [GO:0003705](http://purl.obolibrary.org/obo/GO_0003705) (transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding), [GO:0048662](http://purl.obolibrary.org/obo/GO_0048662) (negative regulation of smooth muscle cell proliferation), [GO:0034446](http://purl.obolibrary.org/obo/GO_0034446) (substrate adhesion-dependent cell spreading), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0033597](http://purl.obolibrary.org/obo/GO_0033597) (mitotic checkpoint complex), [GO:0070586](http://purl.obolibrary.org/obo/GO_0070586) (cell-cell adhesion involved in gastrulation), [GO:0033593](http://purl.obolibrary.org/obo/GO_0033593) (BRCA2-MAGE-D1 complex), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0003712](http://purl.obolibrary.org/obo/GO_0003712) (transcription cofactor activity), [GO:0003713](http://purl.obolibrary.org/obo/GO_0003713) (transcription coactivator activity), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0070578](http://purl.obolibrary.org/obo/GO_0070578) (RISC-loading complex), [GO:0010008](http://purl.obolibrary.org/obo/GO_0010008) (endosome membrane), [GO:0010002](http://purl.obolibrary.org/obo/GO_0010002) (cardioblast differentiation), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), [GO:0032258](http://purl.obolibrary.org/obo/GO_0032258) (protein localization by the Cvt pathway), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0050918](http://purl.obolibrary.org/obo/GO_0050918) (positive chemotaxis), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0042059](http://purl.obolibrary.org/obo/GO_0042059) (negative regulation of epidermal growth factor receptor signaling pathway), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0045569](http://purl.obolibrary.org/obo/GO_0045569) (TRAIL binding), [GO:0003774](http://purl.obolibrary.org/obo/GO_0003774) (motor activity), [GO:0005943](http://purl.obolibrary.org/obo/GO_0005943) (phosphatidylinositol 3-kinase complex, class IA), [GO:0005942](http://purl.obolibrary.org/obo/GO_0005942) (phosphatidylinositol 3-kinase complex), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:1990841](http://purl.obolibrary.org/obo/GO_1990841) (promoter-specific chromatin binding), [GO:0043393](http://purl.obolibrary.org/obo/GO_0043393) (regulation of protein binding), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0042069](http://purl.obolibrary.org/obo/GO_0042069) (regulation of catecholamine metabolic process), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0002446](http://purl.obolibrary.org/obo/GO_0002446) (neutrophil mediated immunity), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0003779](http://purl.obolibrary.org/obo/GO_0003779) (actin binding), [GO:0042074](http://purl.obolibrary.org/obo/GO_0042074) (cell migration involved in gastrulation), [GO:0070512](http://purl.obolibrary.org/obo/GO_0070512) (positive regulation of histone H4-K20 methylation), [GO:0015758](http://purl.obolibrary.org/obo/GO_0015758) (glucose transport), [GO:0033160](http://purl.obolibrary.org/obo/GO_0033160) (positive regulation of protein import into nucleus, translocation), [GO:0034497](http://purl.obolibrary.org/obo/GO_0034497) (protein localization to phagophore assembly site), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0060745](http://purl.obolibrary.org/obo/GO_0060745) (mammary gland branching involved in pregnancy), [GO:0022029](http://purl.obolibrary.org/obo/GO_0022029) (telencephalon cell migration), [GO:0090594](http://purl.obolibrary.org/obo/GO_0090594) (inflammatory response to wounding), [GO:0001570](http://purl.obolibrary.org/obo/GO_0001570) (vasculogenesis), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0045596](http://purl.obolibrary.org/obo/GO_0045596) (negative regulation of cell differentiation), [GO:0005929](http://purl.obolibrary.org/obo/GO_0005929) (cilium), [GO:0033158](http://purl.obolibrary.org/obo/GO_0033158) (regulation of protein import into nucleus, translocation), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0015721](http://purl.obolibrary.org/obo/GO_0015721) (bile acid and bile salt transport), [GO:0042088](http://purl.obolibrary.org/obo/GO_0042088) (T-helper 1 type immune response), [GO:0045599](http://purl.obolibrary.org/obo/GO_0045599) (negative regulation of fat cell differentiation), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0005935](http://purl.obolibrary.org/obo/GO_0005935) (cellular bud neck), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0045120](http://purl.obolibrary.org/obo/GO_0045120) (pronucleus), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin), [GO:0033147](http://purl.obolibrary.org/obo/GO_0033147) (negative regulation of intracellular estrogen receptor signaling pathway), [GO:0033146](http://purl.obolibrary.org/obo/GO_0033146) (regulation of intracellular estrogen receptor signaling pathway), [GO:2000463](http://purl.obolibrary.org/obo/GO_2000463) (positive regulation of excitatory postsynaptic potential), [GO:0032298](http://purl.obolibrary.org/obo/GO_0032298) (positive regulation of DNA-dependent DNA replication initiation), [GO:0070531](http://purl.obolibrary.org/obo/GO_0070531) (BRCA1-A complex), [GO:0060486](http://purl.obolibrary.org/obo/GO_0060486) (Clara cell differentiation), [GO:0060009](http://purl.obolibrary.org/obo/GO_0060009) (Sertoli cell development), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0050673](http://purl.obolibrary.org/obo/GO_0050673) (epithelial cell proliferation), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0005628](http://purl.obolibrary.org/obo/GO_0005628) (prospore membrane), [GO:0048365](http://purl.obolibrary.org/obo/GO_0048365) (Rac GTPase binding), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:2000251](http://purl.obolibrary.org/obo/GO_2000251) (positive regulation of actin cytoskeleton reorganization), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:1900029](http://purl.obolibrary.org/obo/GO_1900029) (positive regulation of ruffle assembly), [GO:0006975](http://purl.obolibrary.org/obo/GO_0006975) (DNA damage induced protein phosphorylation), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0051539](http://purl.obolibrary.org/obo/GO_0051539) (4 iron, 4 sulfur cluster binding), [GO:0051536](http://purl.obolibrary.org/obo/GO_0051536) (iron-sulfur cluster binding), [GO:0060022](http://purl.obolibrary.org/obo/GO_0060022) (hard palate development), [GO:0035022](http://purl.obolibrary.org/obo/GO_0035022) (positive regulation of Rac protein signal transduction), [GO:0035023](http://purl.obolibrary.org/obo/GO_0035023) (regulation of Rho protein signal transduction), [GO:0060023](http://purl.obolibrary.org/obo/GO_0060023) (soft palate development), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0035024](http://purl.obolibrary.org/obo/GO_0035024) (negative regulation of Rho protein signal transduction), [GO:0060024](http://purl.obolibrary.org/obo/GO_0060024) (rhythmic synaptic transmission), [GO:0015893](http://purl.obolibrary.org/obo/GO_0015893) (drug transport), [GO:1903543](http://purl.obolibrary.org/obo/GO_1903543) (positive regulation of exosomal secretion), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0060026](http://purl.obolibrary.org/obo/GO_0060026) (convergent extension), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0048384](http://purl.obolibrary.org/obo/GO_0048384) (retinoic acid receptor signaling pathway), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0071158](http://purl.obolibrary.org/obo/GO_0071158) (positive regulation of cell cycle arrest), [GO:0051548](http://purl.obolibrary.org/obo/GO_0051548) (negative regulation of keratinocyte migration), [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis), [GO:2000270](http://purl.obolibrary.org/obo/GO_2000270) (negative regulation of fibroblast apoptotic process), [GO:0060011](http://purl.obolibrary.org/obo/GO_0060011) (Sertoli cell proliferation), [GO:0060491](http://purl.obolibrary.org/obo/GO_0060491) (regulation of cell projection assembly), [GO:2000272](http://purl.obolibrary.org/obo/GO_2000272) (negative regulation of receptor activity), [GO:1903551](http://purl.obolibrary.org/obo/GO_1903551) (regulation of extracellular exosome assembly), [GO:1904888](http://purl.obolibrary.org/obo/GO_1904888) (cranial skeletal system development), [GO:1904408](http://purl.obolibrary.org/obo/GO_1904408) (melatonin binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0071141](http://purl.obolibrary.org/obo/GO_0071141) (SMAD protein complex), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0035005](http://purl.obolibrary.org/obo/GO_0035005) (1-phosphatidylinositol-4-phosphate 3-kinase activity), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0016328](http://purl.obolibrary.org/obo/GO_0016328) (lateral plasma membrane), [GO:0060444](http://purl.obolibrary.org/obo/GO_0060444) (branching involved in mammary gland duct morphogenesis), [GO:0045294](http://purl.obolibrary.org/obo/GO_0045294) (alpha-catenin binding), [GO:0048320](http://purl.obolibrary.org/obo/GO_0048320) (axial mesoderm formation), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0031954](http://purl.obolibrary.org/obo/GO_0031954) (positive regulation of protein autophosphorylation), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0070243](http://purl.obolibrary.org/obo/GO_0070243) (regulation of thymocyte apoptotic process), [GO:0003009](http://purl.obolibrary.org/obo/GO_0003009) (skeletal muscle contraction), [GO:0070244](http://purl.obolibrary.org/obo/GO_0070244) (negative regulation of thymocyte apoptotic process), [GO:0045296](http://purl.obolibrary.org/obo/GO_0045296) (cadherin binding), [GO:0072425](http://purl.obolibrary.org/obo/GO_0072425) (signal transduction involved in G2 DNA damage checkpoint), [GO:0051968](http://purl.obolibrary.org/obo/GO_0051968) (positive regulation of synaptic transmission, glutamatergic), [GO:0051965](http://purl.obolibrary.org/obo/GO_0051965) (positive regulation of synapse assembly), [GO:0060430](http://purl.obolibrary.org/obo/GO_0060430) (lung saccule development), [GO:0019827](http://purl.obolibrary.org/obo/GO_0019827) (stem cell population maintenance), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0052826](http://purl.obolibrary.org/obo/GO_0052826) (inositol hexakisphosphate 2-phosphatase activity), [GO:0051974](http://purl.obolibrary.org/obo/GO_0051974) (negative regulation of telomerase activity), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0035066](http://purl.obolibrary.org/obo/GO_0035066) (positive regulation of histone acetylation), [GO:0035067](http://purl.obolibrary.org/obo/GO_0035067) (negative regulation of histone acetylation), [GO:0035068](http://purl.obolibrary.org/obo/GO_0035068) (micro-ribonucleoprotein complex), [GO:0035064](http://purl.obolibrary.org/obo/GO_0035064) (methylated histone binding), [GO:1903984](http://purl.obolibrary.org/obo/GO_1903984) (positive regulation of TRAIL-activated apoptotic signaling pathway), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0048341](http://purl.obolibrary.org/obo/GO_0048341) (paraxial mesoderm formation), [GO:0031939](http://purl.obolibrary.org/obo/GO_0031939) (negative regulation of chromatin silencing at telomere), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0071599](http://purl.obolibrary.org/obo/GO_0071599) (otic vesicle development), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0016314](http://purl.obolibrary.org/obo/GO_0016314) (phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity), [GO:0016798](http://purl.obolibrary.org/obo/GO_0016798) (hydrolase activity, acting on glycosyl bonds), [GO:2001165](http://purl.obolibrary.org/obo/GO_2001165) (positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0006513](http://purl.obolibrary.org/obo/GO_0006513) (protein monoubiquitination), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0006508](http://purl.obolibrary.org/obo/GO_0006508) (proteolysis), [GO:2001159](http://purl.obolibrary.org/obo/GO_2001159) (regulation of protein localization by the Cvt pathway), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016303](http://purl.obolibrary.org/obo/GO_0016303) (1-phosphatidylinositol-3-kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:2001173](http://purl.obolibrary.org/obo/GO_2001173) (regulation of histone H2B conserved C-terminal lysine ubiquitination), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0004386](http://purl.obolibrary.org/obo/GO_0004386) (helicase activity), [GO:0031999](http://purl.obolibrary.org/obo/GO_0031999) (negative regulation of fatty acid beta-oxidation), [GO:0031518](http://purl.obolibrary.org/obo/GO_0031518) (CBF3 complex), [GO:0019887](http://purl.obolibrary.org/obo/GO_0019887) (protein kinase regulator activity), [GO:0030663](http://purl.obolibrary.org/obo/GO_0030663) (COPI-coated vesicle membrane), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0060079](http://purl.obolibrary.org/obo/GO_0060079) (excitatory postsynaptic potential), [GO:0060074](http://purl.obolibrary.org/obo/GO_0060074) (synapse maturation), [GO:0060076](http://purl.obolibrary.org/obo/GO_0060076) (excitatory synapse), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:1990381](http://purl.obolibrary.org/obo/GO_1990381) (ubiquitin-specific protease binding), [GO:0042663](http://purl.obolibrary.org/obo/GO_0042663) (regulation of endodermal cell fate specification), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0032837](http://purl.obolibrary.org/obo/GO_0032837) (distributive segregation), [GO:0007416](http://purl.obolibrary.org/obo/GO_0007416) (synapse assembly), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle), [GO:0016363](http://purl.obolibrary.org/obo/GO_0016363) (nuclear matrix), [GO:0031985](http://purl.obolibrary.org/obo/GO_0031985) (Golgi cisterna), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0005694](http://purl.obolibrary.org/obo/GO_0005694) (chromosome), [GO:0043523](http://purl.obolibrary.org/obo/GO_0043523) (regulation of neuron apoptotic process), [GO:0072095](http://purl.obolibrary.org/obo/GO_0072095) (regulation of branch elongation involved in ureteric bud branching), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0043524](http://purl.obolibrary.org/obo/GO_0043524) (negative regulation of neuron apoptotic process), [GO:0097342](http://purl.obolibrary.org/obo/GO_0097342) (ripoptosome), [GO:0051146](http://purl.obolibrary.org/obo/GO_0051146) (striated muscle cell differentiation), [GO:0016358](http://purl.obolibrary.org/obo/GO_0016358) (dendrite development), [GO:0045717](http://purl.obolibrary.org/obo/GO_0045717) (negative regulation of fatty acid biosynthetic process), [GO:0035094](http://purl.obolibrary.org/obo/GO_0035094) (response to nicotine), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0043536](http://purl.obolibrary.org/obo/GO_0043536) (positive regulation of blood vessel endothelial cell migration), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0031966](http://purl.obolibrary.org/obo/GO_0031966) (mitochondrial membrane), [GO:0016342](http://purl.obolibrary.org/obo/GO_0016342) (catenin complex), [GO:0060044](http://purl.obolibrary.org/obo/GO_0060044) (negative regulation of cardiac muscle cell proliferation), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:1900052](http://purl.obolibrary.org/obo/GO_1900052) (regulation of retinoic acid biosynthetic process), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:0003094](http://purl.obolibrary.org/obo/GO_0003094) (glomerular filtration), [GO:0021759](http://purl.obolibrary.org/obo/GO_0021759) (globus pallidus development), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0000813](http://purl.obolibrary.org/obo/GO_0000813) (ESCRT I complex), [GO:0060048](http://purl.obolibrary.org/obo/GO_0060048) (cardiac muscle contraction), [GO:0061380](http://purl.obolibrary.org/obo/GO_0061380) (superior colliculus development), [GO:0035912](http://purl.obolibrary.org/obo/GO_0035912) (dorsal aorta morphogenesis), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0032880](http://purl.obolibrary.org/obo/GO_0032880) (regulation of protein localization), [GO:0061368](http://purl.obolibrary.org/obo/GO_0061368) (behavioral response to formalin induced pain), [GO:0006139](http://purl.obolibrary.org/obo/GO_0006139) (nucleobase-containing compound metabolic process), [GO:0038180](http://purl.obolibrary.org/obo/GO_0038180) (nerve growth factor signaling pathway), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:0051574](http://purl.obolibrary.org/obo/GO_0051574) (positive regulation of histone H3-K9 methylation), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0051572](http://purl.obolibrary.org/obo/GO_0051572) (negative regulation of histone H3-K4 methylation), [GO:0051573](http://purl.obolibrary.org/obo/GO_0051573) (negative regulation of histone H3-K9 methylation), [GO:0071168](http://purl.obolibrary.org/obo/GO_0071168) (protein localization to chromatin), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0051571](http://purl.obolibrary.org/obo/GO_0051571) (positive regulation of histone H3-K4 methylation), [GO:0010623](http://purl.obolibrary.org/obo/GO_0010623) (programmed cell death involved in cell development), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0018107](http://purl.obolibrary.org/obo/GO_0018107) (peptidyl-threonine phosphorylation), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0043966](http://purl.obolibrary.org/obo/GO_0043966) (histone H3 acetylation), [GO:0060068](http://purl.obolibrary.org/obo/GO_0060068) (vagina development), [GO:0044818](http://purl.obolibrary.org/obo/GO_0044818) (mitotic G2/M transition checkpoint), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0006582](http://purl.obolibrary.org/obo/GO_0006582) (melanin metabolic process), [GO:0060065](http://purl.obolibrary.org/obo/GO_0060065) (uterus development), [GO:0030690](http://purl.obolibrary.org/obo/GO_0030690) (Noc1p-Noc2p complex), [GO:0039020](http://purl.obolibrary.org/obo/GO_0039020) (pronephric nephron tubule development), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0042633](http://purl.obolibrary.org/obo/GO_0042633) (hair cycle), [GO:0032869](http://purl.obolibrary.org/obo/GO_0032869) (cellular response to insulin stimulus), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0006590](http://purl.obolibrary.org/obo/GO_0006590) (thyroid hormone generation), [GO:0038161](http://purl.obolibrary.org/obo/GO_0038161) (prolactin signaling pathway), [GO:0000800](http://purl.obolibrary.org/obo/GO_0000800) (lateral element), [GO:0042640](http://purl.obolibrary.org/obo/GO_0042640) (anagen), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0019898](http://purl.obolibrary.org/obo/GO_0019898) (extrinsic component of membrane), [GO:0030674](http://purl.obolibrary.org/obo/GO_0030674) (protein binding, bridging), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0034508](http://purl.obolibrary.org/obo/GO_0034508) (centromere complex assembly), [GO:0008219](http://purl.obolibrary.org/obo/GO_0008219) (cell death), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0045651](http://purl.obolibrary.org/obo/GO_0045651) (positive regulation of macrophage differentiation), [GO:0044320](http://purl.obolibrary.org/obo/GO_0044320) (cellular response to leptin stimulus), [GO:0034501](http://purl.obolibrary.org/obo/GO_0034501) (protein localization to kinetochore), [GO:0071930](http://purl.obolibrary.org/obo/GO_0071930) (negative regulation of transcription involved in G1/S transition of mitotic cell cycle), [GO:0070602](http://purl.obolibrary.org/obo/GO_0070602) (regulation of centromeric sister chromatid cohesion), [GO:0030141](http://purl.obolibrary.org/obo/GO_0030141) (secretory granule), [GO:0008236](http://purl.obolibrary.org/obo/GO_0008236) (serine-type peptidase activity), [GO:0007389](http://purl.obolibrary.org/obo/GO_0007389) (pattern specification process), [GO:0008234](http://purl.obolibrary.org/obo/GO_0008234) (cysteine-type peptidase activity), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0021667](http://purl.obolibrary.org/obo/GO_0021667) (rhombomere 6 morphogenesis), [GO:0008233](http://purl.obolibrary.org/obo/GO_0008233) (peptidase activity), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0021664](http://purl.obolibrary.org/obo/GO_0021664) (rhombomere 5 morphogenesis), [GO:0014902](http://purl.obolibrary.org/obo/GO_0014902) (myotube differentiation), [GO:0031462](http://purl.obolibrary.org/obo/GO_0031462) (Cul2-RING ubiquitin ligase complex), [GO:0030133](http://purl.obolibrary.org/obo/GO_0030133) (transport vesicle), [GO:0032794](http://purl.obolibrary.org/obo/GO_0032794) (GTPase activating protein binding), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0045665](http://purl.obolibrary.org/obo/GO_0045665) (negative regulation of neuron differentiation), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0060823](http://purl.obolibrary.org/obo/GO_0060823) (canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation), [GO:0045666](http://purl.obolibrary.org/obo/GO_0045666) (positive regulation of neuron differentiation), [GO:0043005](http://purl.obolibrary.org/obo/GO_0043005) (neuron projection), [GO:0045668](http://purl.obolibrary.org/obo/GO_0045668) (negative regulation of osteoblast differentiation), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0043491](http://purl.obolibrary.org/obo/GO_0043491) (protein kinase B signaling), [GO:0042162](http://purl.obolibrary.org/obo/GO_0042162) (telomeric DNA binding), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:0010518](http://purl.obolibrary.org/obo/GO_0010518) (positive regulation of phospholipase activity), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0017166](http://purl.obolibrary.org/obo/GO_0017166) (vinculin binding), [GO:0033630](http://purl.obolibrary.org/obo/GO_0033630) (positive regulation of cell adhesion mediated by integrin), [GO:0010997](http://purl.obolibrary.org/obo/GO_0010997) (anaphase-promoting complex binding), [GO:0071949](http://purl.obolibrary.org/obo/GO_0071949) (FAD binding), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0090201](http://purl.obolibrary.org/obo/GO_0090201) (negative regulation of release of cytochrome c from mitochondria), [GO:0055001](http://purl.obolibrary.org/obo/GO_0055001) (muscle cell development), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0000724](http://purl.obolibrary.org/obo/GO_0000724) (double-strand break repair via homologous recombination), [GO:0038083](http://purl.obolibrary.org/obo/GO_0038083) (peptidyl-tyrosine autophosphorylation), [GO:0000723](http://purl.obolibrary.org/obo/GO_0000723) (telomere maintenance), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0000722](http://purl.obolibrary.org/obo/GO_0000722) (telomere maintenance via recombination), [GO:0043015](http://purl.obolibrary.org/obo/GO_0043015) (gamma-tubulin binding), [GO:0042169](http://purl.obolibrary.org/obo/GO_0042169) (SH2 domain binding), [GO:0007368](http://purl.obolibrary.org/obo/GO_0007368) (determination of left/right symmetry), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0008209](http://purl.obolibrary.org/obo/GO_0008209) (androgen metabolic process), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:1990314](http://purl.obolibrary.org/obo/GO_1990314) (cellular response to insulin-like growth factor stimulus), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0002902](http://purl.obolibrary.org/obo/GO_0002902) (regulation of B cell apoptotic process), [GO:1990316](http://purl.obolibrary.org/obo/GO_1990316) (Atg1/ULK1 kinase complex), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0031442](http://purl.obolibrary.org/obo/GO_0031442) (positive regulation of mRNA 3'-end processing), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0030111](http://purl.obolibrary.org/obo/GO_0030111) (regulation of Wnt signaling pathway), [GO:0090209](http://purl.obolibrary.org/obo/GO_0090209) (negative regulation of triglyceride metabolic process), [GO:0045606](http://purl.obolibrary.org/obo/GO_0045606) (positive regulation of epidermal cell differentiation), [GO:0045600](http://purl.obolibrary.org/obo/GO_0045600) (positive regulation of fat cell differentiation), [GO:0000778](http://purl.obolibrary.org/obo/GO_0000778) (condensed nuclear chromosome kinetochore), [GO:0000777](http://purl.obolibrary.org/obo/GO_0000777) (condensed chromosome kinetochore), [GO:0043422](http://purl.obolibrary.org/obo/GO_0043422) (protein kinase B binding), [GO:0000776](http://purl.obolibrary.org/obo/GO_0000776) (kinetochore), [GO:0000775](http://purl.obolibrary.org/obo/GO_0000775) (chromosome, centromeric region), [GO:0046934](http://purl.obolibrary.org/obo/GO_0046934) (phosphatidylinositol-4,5-bisphosphate 3-kinase activity), [GO:0042577](http://purl.obolibrary.org/obo/GO_0042577) (lipid phosphatase activity), [GO:0044754](http://purl.obolibrary.org/obo/GO_0044754) (autolysosome), [GO:0045602](http://purl.obolibrary.org/obo/GO_0045602) (negative regulation of endothelial cell differentiation), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0000780](http://purl.obolibrary.org/obo/GO_0000780) (condensed nuclear chromosome, centromeric region), [GO:0035877](http://purl.obolibrary.org/obo/GO_0035877) (death effector domain binding), [GO:0033698](http://purl.obolibrary.org/obo/GO_0033698) (Rpd3L complex), [GO:0010575](http://purl.obolibrary.org/obo/GO_0010575) (positive regulation of vascular endothelial growth factor production), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0030183](http://purl.obolibrary.org/obo/GO_0030183) (B cell differentiation), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0043433](http://purl.obolibrary.org/obo/GO_0043433) (negative regulation of DNA binding transcription factor activity), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0000301](http://purl.obolibrary.org/obo/GO_0000301) (retrograde transport, vesicle recycling within Golgi), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0000793](http://purl.obolibrary.org/obo/GO_0000793) (condensed chromosome), [GO:0051057](http://purl.obolibrary.org/obo/GO_0051057) (positive regulation of small GTPase mediated signal transduction), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0032355](http://purl.obolibrary.org/obo/GO_0032355) (response to estradiol), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0030177](http://purl.obolibrary.org/obo/GO_0030177) (positive regulation of Wnt signaling pathway), [GO:0032357](http://purl.obolibrary.org/obo/GO_0032357) (oxidized purine DNA binding), [GO:0042119](http://purl.obolibrary.org/obo/GO_0042119) (neutrophil activation), [GO:0090630](http://purl.obolibrary.org/obo/GO_0090630) (activation of GTPase activity), [GO:0033683](http://purl.obolibrary.org/obo/GO_0033683) (nucleotide-excision repair, DNA incision), [GO:0007399](http://purl.obolibrary.org/obo/GO_0007399) (nervous system development), [GO:0044773](http://purl.obolibrary.org/obo/GO_0044773) (mitotic DNA damage checkpoint), [GO:0044774](http://purl.obolibrary.org/obo/GO_0044774) (mitotic DNA integrity checkpoint), [GO:0007398](http://purl.obolibrary.org/obo/GO_0007398) (ectoderm development), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0030165](http://purl.obolibrary.org/obo/GO_0030165) (PDZ domain binding), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0030168](http://purl.obolibrary.org/obo/GO_0030168) (platelet activation), [GO:0031016](http://purl.obolibrary.org/obo/GO_0031016) (pancreas development), [GO:0045638](http://purl.obolibrary.org/obo/GO_0045638) (negative regulation of myeloid cell differentiation), [GO:1903078](http://purl.obolibrary.org/obo/GO_1903078) (positive regulation of protein localization to plasma membrane), [GO:0030163](http://purl.obolibrary.org/obo/GO_0030163) (protein catabolic process), [GO:0043457](http://purl.obolibrary.org/obo/GO_0043457) (regulation of cellular respiration), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0097284](http://purl.obolibrary.org/obo/GO_0097284) (hepatocyte apoptotic process), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0030155](http://purl.obolibrary.org/obo/GO_0030155) (regulation of cell adhesion), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0071902](http://purl.obolibrary.org/obo/GO_0071902) (positive regulation of protein serine/threonine kinase activity), [GO:0030159](http://purl.obolibrary.org/obo/GO_0030159) (receptor signaling complex scaffold activity), [GO:0043068](http://purl.obolibrary.org/obo/GO_0043068) (positive regulation of programmed cell death), [GO:0046579](http://purl.obolibrary.org/obo/GO_0046579) (positive regulation of Ras protein signal transduction), [GO:0048754](http://purl.obolibrary.org/obo/GO_0048754) (branching morphogenesis of an epithelial tube), [GO:1900407](http://purl.obolibrary.org/obo/GO_1900407) (regulation of cellular response to oxidative stress), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0070200](http://purl.obolibrary.org/obo/GO_0070200) (establishment of protein localization to telomere), [GO:0071539](http://purl.obolibrary.org/obo/GO_0071539) (protein localization to centrosome), [GO:0070206](http://purl.obolibrary.org/obo/GO_0070206) (protein trimerization), [GO:0031076](http://purl.obolibrary.org/obo/GO_0031076) (embryonic camera-type eye development), [GO:0061723](http://purl.obolibrary.org/obo/GO_0061723) (glycophagy), [GO:0043087](http://purl.obolibrary.org/obo/GO_0043087) (regulation of GTPase activity), [GO:0031069](http://purl.obolibrary.org/obo/GO_0031069) (hair follicle morphogenesis), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0032392](http://purl.obolibrary.org/obo/GO_0032392) (DNA geometric change), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008286](http://purl.obolibrary.org/obo/GO_0008286) (insulin receptor signaling pathway), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0060429](http://purl.obolibrary.org/obo/GO_0060429) (epithelium development), [GO:0000794](http://purl.obolibrary.org/obo/GO_0000794) (condensed nuclear chromosome), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0001649](http://purl.obolibrary.org/obo/GO_0001649) (osteoblast differentiation), [GO:2000774](http://purl.obolibrary.org/obo/GO_2000774) (positive regulation of cellular senescence), [GO:0035414](http://purl.obolibrary.org/obo/GO_0035414) (negative regulation of catenin import into nucleus), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0031054](http://purl.obolibrary.org/obo/GO_0031054) (pre-miRNA processing), [GO:0048306](http://purl.obolibrary.org/obo/GO_0048306) (calcium-dependent protein binding), [GO:0060896](http://purl.obolibrary.org/obo/GO_0060896) (neural plate pattern specification), [GO:0090282](http://purl.obolibrary.org/obo/GO_0090282) (positive regulation of transcription involved in G2/M transition of mitotic cell cycle), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0070210](http://purl.obolibrary.org/obo/GO_0070210) (Rpd3L-Expanded complex), [GO:0001657](http://purl.obolibrary.org/obo/GO_0001657) (ureteric bud development), [GO:0048795](http://purl.obolibrary.org/obo/GO_0048795) (swim bladder morphogenesis), [GO:0048794](http://purl.obolibrary.org/obo/GO_0048794) (swim bladder development), [GO:0030198](http://purl.obolibrary.org/obo/GO_0030198) (extracellular matrix organization), [GO:0031047](http://purl.obolibrary.org/obo/GO_0031047) (gene silencing by RNA), [GO:0060844](http://purl.obolibrary.org/obo/GO_0060844) (arterial endothelial cell fate commitment), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0045202](http://purl.obolibrary.org/obo/GO_0045202) (synapse), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0001223](http://purl.obolibrary.org/obo/GO_0001223) (transcription coactivator binding), [GO:0045211](http://purl.obolibrary.org/obo/GO_0045211) (postsynaptic membrane), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0055002](http://purl.obolibrary.org/obo/GO_0055002) (striated muscle cell development), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0035479](http://purl.obolibrary.org/obo/GO_0035479) (angioblast cell migration from lateral mesoderm to midline), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0090262](http://purl.obolibrary.org/obo/GO_0090262) (regulation of transcription-coupled nucleotide-excision repair), [GO:0060830](http://purl.obolibrary.org/obo/GO_0060830) (ciliary receptor clustering involved in smoothened signaling pathway), [GO:0003413](http://purl.obolibrary.org/obo/GO_0003413) (chondrocyte differentiation involved in endochondral bone morphogenesis), [GO:0006924](http://purl.obolibrary.org/obo/GO_0006924) (activation-induced cell death of T cells), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0003419](http://purl.obolibrary.org/obo/GO_0003419) (growth plate cartilage chondrocyte proliferation), [GO:0055013](http://purl.obolibrary.org/obo/GO_0055013) (cardiac muscle cell development), [GO:0036310](http://purl.obolibrary.org/obo/GO_0036310) (annealing helicase activity), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0036312](http://purl.obolibrary.org/obo/GO_0036312) (phosphatidylinositol 3-kinase regulatory subunit binding), [GO:0048739](http://purl.obolibrary.org/obo/GO_0048739) (cardiac muscle fiber development), [GO:0048738](http://purl.obolibrary.org/obo/GO_0048738) (cardiac muscle tissue development), [GO:0043049](http://purl.obolibrary.org/obo/GO_0043049) (otic placode formation), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004712](http://purl.obolibrary.org/obo/GO_0004712) (protein serine/threonine/tyrosine kinase activity), [GO:0004715](http://purl.obolibrary.org/obo/GO_0004715) (non-membrane spanning protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0048741](http://purl.obolibrary.org/obo/GO_0048741) (skeletal muscle fiber development), [GO:0051902](http://purl.obolibrary.org/obo/GO_0051902) (negative regulation of mitochondrial depolarization), [GO:0035458](http://purl.obolibrary.org/obo/GO_0035458) (cellular response to interferon-beta), [GO:0034121](http://purl.obolibrary.org/obo/GO_0034121) (regulation of toll-like receptor signaling pathway), [GO:0090244](http://purl.obolibrary.org/obo/GO_0090244) (Wnt signaling pathway involved in somitogenesis), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0004722](http://purl.obolibrary.org/obo/GO_0004722) (protein serine/threonine phosphatase activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0001221](http://purl.obolibrary.org/obo/GO_0001221) (transcription cofactor binding), [GO:0004724](http://purl.obolibrary.org/obo/GO_0004724) (magnesium-dependent protein serine/threonine phosphatase activity), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0048752](http://purl.obolibrary.org/obo/GO_0048752) (semicircular canal morphogenesis), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0061709](http://purl.obolibrary.org/obo/GO_0061709) (reticulophagy), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), 

**Class expressions from DL-Learner:**

- Thing 66.27%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 53.04%
- [GO:0072176](http://purl.obolibrary.org/obo/GO_0072176) (nephric duct development) 50.15%
- [GO:0072164](http://purl.obolibrary.org/obo/GO_0072164) (mesonephric tubule development) 50.15%
- [GO:0072163](http://purl.obolibrary.org/obo/GO_0072163) (mesonephric epithelium development) 50.15%
- [GO:0060135](http://purl.obolibrary.org/obo/GO_0060135) (maternal process involved in female pregnancy) 50.15%
- [GO:0048799](http://purl.obolibrary.org/obo/GO_0048799) (animal organ maturation) 50.15%
- [GO:0032505](http://purl.obolibrary.org/obo/GO_0032505) (reproduction of a single-celled organism) 50.15%
- [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis) 50.15%
- [GO:0019954](http://purl.obolibrary.org/obo/GO_0019954) (asexual reproduction) 50.15%
- [GO:0008406](http://purl.obolibrary.org/obo/GO_0008406) (gonad development) 50.15%
- [GO:0007276](http://purl.obolibrary.org/obo/GO_0007276) (gamete generation) 50.15%
- [GO:0007114](http://purl.obolibrary.org/obo/GO_0007114) (cell budding) 50.15%
- [GO:0003143](http://purl.obolibrary.org/obo/GO_0003143) (embryonic heart tube morphogenesis) 50.15%
- [GO:0035295](http://purl.obolibrary.org/obo/GO_0035295) (tube development) and [GO:0072163](http://purl.obolibrary.org/obo/GO_0072163) (mesonephric epithelium development) 50.15%


